Investigating the 2005 Singaporean Dengue Outbreak by LUKAS TANNER
 INVESTIGATING THE 2005 SINGAPOREAN  
DENGUE OUTBREAK  
 
LUKAS TANNER 
B.Sc. (Major in Molecular Biology), University of Basel 
 
A THESIS SUBMITTED 
 
FOR THE DEGREE OF A MASTER OF SCIENCE 
IN INFECTIOUS DISEASES,  
VACCINOLOGY & DRUG DISCOVERY 
 
YONG LOO LIN SCHOOL OF MEDICINE 
NATIONAL UNIVERSITY OF SINGAPORE 
& 
BIOZENTRUM  




I would like to thank my supervisor Mark Schreiber for his patience and support 
during my masters project. His guidance made my time at NITD a scientific and 
educational experience which is invaluable for my future career.  
 
I also thank Liu Wei for taking the time to introduce me to virus work and to the 
sequencing project. He provided great support during the vicious times of PCR 
optimization. 
 
I would also like to thank Subhash Vasudevan for his fair comments on the project and 
for giving me the opportunity to pursue my masters project at NITD.  
 
I am also very grateful to Feng Gu, Katja Fink and Cedric Ng who critically read the 
manuscript and provided me with the necessary amendments. I also would like to 
mention Robert Zweighardt who took the time to give suggestions from a non-dengue 
perspective.  
 
From GIS, I thank Pauline Aw Poh Kim for her part in the sequencing. Without her 
effort it would not have been possible to sequence the EDEN isolates. In particular, I 
am grateful to Ong Swee Hoe for his phylogenetic analyses and for his helpful 
discussions with regard to sequence alignments. He provided me with the necessary 
background to be able to understand dengue virus phylogeny. I additionally express 
my gratitude to Martin Hibberd for his advice on dengue immunology. 
 
2 
 I express thanks to the whole EDEN team but especially, to Eng Eong Ooi who 
provided me with the clinical and immunological data. It was a pleasure to collaborate 
with him and he gave me useful suggestions. 
 
I wish to thank Reinhard Bergmann from NIBR who was helpful in the statistical 
analyses. He provided me with the necessary knowledge and always had time to 
answer my many questions.  
 
I would like to express my thanks to all the people in the dengue unit who made my 
time at NITD not only a scientific but also a personal experience. In particular, I 
express my gratitude to Cedric, Viral, Sarah, Joanne, Katja, Indira, Anne, Dina, Mee, 
Cheryl, Celine, Alex, Jasmin and Selina who provided me with the necessary 
friendship and motivation. It was nice to have Stevie and Tommy as flat mates and 
friends. The time with all of you was great and hopefully we will meet someday, 
somewhere again… 
 
I am most grateful to my parents Suzanne and Marcel who gave me this unique 
opportunity to come to Singapore. Their support in good but especially in difficult 
times is invaluable and I am happy to have them as parents. A special thanks goes to 
my two sisters Sabine and Catherine. Talking and spending time with them is great and 
gives me new energy to go on in my life. 
 
Last but not least, I show gratitude to my friends back home in Switzerland who 
always had time to talk to me on the phone. I’ve realized that without their good 
friendship I would not have the energy to fulfill my goals…Merci vielmol! 
3 
 Table of Contents 
Acknowledgments .......................................................................................................................2 
Table of Contents ........................................................................................................................4 
Summary....................................................................................................................................10 
List of Tables .............................................................................................................................12 
List of Figures............................................................................................................................18 
List of Abbreviations ................................................................................................................22 
1 Introduction ......................................................................................................................24 
1.1 Epidemiology of Dengue...........................................................................................25
 
1.1.1 The Global Emergence of Dengue....................................................................25 
 
1.1.1.1 Situation in the Americas ...................................................................... 26
 
1.1.1.2 Situation in the Asia/Pacific .................................................................. 27 
 
1.1.1.3 Reasons for the Global Emergence of Dengue ........................................ 28 
 
1.1.2 Public Health, Social & Economic Impacts of Dengue ....................................29 
 
1.1.2.1 Impact on Public Health........................................................................ 29 
 
1.1.2.2 Impact on Society................................................................................. 29 
 
1.1.2.3 Impact on Economy.............................................................................. 30 
 
1.1.3 Epidemiological Situation in Singapore ...........................................................31 
 
1.1.3.1 Dengue Epidemiology in Singapore....................................................... 31 
 
1.1.3.2 The Early DENgue (EDEN) Study......................................................... 33 
 
1.2 Classical Dengue Fever, Dengue Haemorrhagic Fever & Dengue Shock Syndrome34 
 
1.2.1 Clinical Manifestations of Dengue ...................................................................34 
 
1.2.1.1 Classical Dengue Fever......................................................................... 34 
 
1.2.1.2 Dengue Hemorrhagic Fever and Dengue Shock Syndrome ...................... 35 
 
1.2.2 Dengue Diagnosis and Discussion of the WHO Classification Scheme...........36 
 
1.2.2.1 Important Laboratory Tests for Dengue Diagnosis .................................. 36 
 
1.2.2.2 WHO Classification Scheme ................................................................. 37 
4 
 1.2.3 Prevention and Treatment of Dengue ...............................................................39 
 
1.2.3.1 Vector Control ..................................................................................... 39 
 
1.2.3.2 Dengue Vaccines.................................................................................. 39 
 
1.2.3.3 Drugs against Dengue ........................................................................... 40 
 
1.2.3.4 Current Treatment of DF and DHF/DSS................................................. 40
 
1.3 The Causative Agent: Dengue Virus .........................................................................42 
 
1.3.1 Phylogeny .........................................................................................................42 
 
1.3.1.1 Dengue Serotype 1 ............................................................................... 43 
 
1.3.1.2 Dengue Serotype 2 ............................................................................... 44 
 
1.3.1.3 Dengue Serotype 3 ............................................................................... 45 
 
1.3.1.4 Dengue Serotype 4 ............................................................................... 46 
 
1.3.1.5 Serotype Switch & Clade Replacement .................................................. 47 
 
1.3.2 Dengue Virus Lifecycle ....................................................................................48 
 
1.3.2.1 Structure of Dengue Virions .................................................................. 48 
 
1.3.2.2 Viral Entry ........................................................................................... 50 
 
1.3.2.3 Viral Replication, Assembly and Exocytosis........................................... 51 
 
1.3.2.4 Extrinsic versus Intrinsic Lifecycle ........................................................ 53
 
1.4 Immunology of Dengue Virus Infections ..................................................................56 
 
1.4.1 Dengue Pathogenesis and Host Immune Response ..........................................56 
 
1.4.1.1 Early Events in the Host after Infection.................................................. 56 
 
1.4.1.2 Important Mediators of Innate Immunity during Infection ....................... 57 
 
1.4.1.3 Antibody-Dependent Enhancement (ADE)............................................. 57 
 
1.4.1.4 Differences in Secondary T-Cell Responses ........................................... 58 
 
1.4.1.5 Important Cytokines during Infection..................................................... 60 
 
1.4.1.6 DHF/DSS: An Immune-Mediated Machanism........................................ 60 
 
1.4.1.7 Viral Determinants and Disease Outcome .............................................. 61 
 
1.5 Aims of the Studies....................................................................................................64 
5 
 2 Materials & Methods .......................................................................................................65 
2.1 Analysis of Clinical Data...........................................................................................66 
 
2.1.1 Collection and Preprocessing of Clinical Data .................................................66 
 
2.1.1.1 Clinical Data used for Analyses ............................................................. 67 
 
2.1.1.2 Clinical Data used for Severity Modeling ............................................... 68 
 
2.1.1.3 Immunological and Clinical Data used for Analyses ............................... 69 
 
2.1.1.4 Summary of Clinical and Immunological Data used for Analyses ............ 70 
 
2.1.2 Statistical Analyses used for the Description of Clinical and Immunological 
Data……. ..........................................................................................................................73
 
2.1.2.1 Univariate Analyses.............................................................................. 73 
 
2.1.2.2 Multivariate Analyses ........................................................................... 74 
 
2.1.3 Decision Tree Analyses for Disease Modeling.................................................74 
 
2.1.3.1 Classifier Modeling .............................................................................. 77 
 
2.1.3.2 Classifier Evaluation............................................................................. 78 
 
2.1.3.3 Epidemiological Analyses of Parameters included into the Models .......... 81 
 
2.1.3.4 Summary of generated Models included in the Thesis ............................. 82 
 
2.2 Full Length Genome Sequencing of Dengue Virus Isolates......................................83 
 
2.2.1 Preparative RT-PCR Step .................................................................................83 
 
2.2.1.1 Propagation of Virus............................................................................. 84 
 
2.2.1.2 Quantification of Virus by Plaque Assay ................................................ 84 
 
2.2.1.3 Extraction of viral RNA and cDNA Synthesis ........................................ 85 
 
2.2.1.4 Amplification of cDNA by Polymerase Chain Reaction .......................... 87
 
2.2.2 Phylogenetic Analyses of Dengue Virus Genomes ..........................................90 
 
2.2.2.1 Sequencing Process, Assembly and Quality Control................................ 90 
 





3 Results ...............................................................................................................................91 
3.1 Decision Tree Analyses of Clinical Data...................................................................92 
 
3.1.1 Distinguishing Dengue Fever from other febrile Illnesses ...............................92 
 
3.1.1.1 Dengue Prediction based on Clinical Data .............................................. 92 
 
3.1.1.2 Dengue Prediction based on Cytokine and Clinical Data ......................... 97 
 
3.1.1.3 Dengue Prediction based on Cytokine Data .......................................... 108 
 
3.1.2 Prediction of Disease Severity in Dengue Patients .........................................114 
 
3.1.2.1 Prediction of Hospitalization based on Clinical Data ............................. 114 
 
3.1.2.2 Prediction of Hospitalization based on Cytokine and Clinical Data ........ 117 
 
3.1.2.3 Prediction of Hospitalization based on Cytokine Data ........................... 120 
 
3.1.2.4 Using a Platelet Count <=50,000/mm3 as a Marker of Severity .............. 123 
 
3.1.2.5 Severity Prediction based on Clinical Data ........................................... 134 
 
3.1.2.6 Severity Prediction based on Clinical Data and only using hospitalized 
Cases…… .......................................................................................................... 138 
 
3.1.2.7 Severity Prediction based on Cytokine and Clinical Data....................... 142 
 
3.1.2.8 Severity Prediction based on Cytokine Data ......................................... 149 
 
3.1.2.9 Severity Prediction based on Cytokine and Clinical Data but only using 
hospitalized Cases .............................................................................................. 154 
 
3.1.2.10 Severity Prediction based on Cytokine Data but only using hospitalized 
Cases…… .......................................................................................................... 161 
 
3.2 Sequence Analyses of Virus Isolates from the 2005 Singaporean Dengue    
Outbreak ...............................................................................................................................164 
 
3.2.1 Description of Differences between Serotype 1 and Serotype 3.....................164 
 
3.2.1.1 Serotype specific Differences with regard to Severity............................ 164 
 
3.2.2 Phylogenetic Analysis of 94 Virus Strains from the EDEN Study .................166 
 
3.2.2.1 Full Length Genome Sequencing of 94 Virus Isolates ........................... 166 
 
3.2.2.2 Phylogenetic Analyses of the 94 sequenced Virus Genomes .................. 168 
 
7 
 3.2.3 Comparison of Clinical Parameters between the four EDEN DENV-3     
Clades….. ........................................................................................................................174 
4 Discussion........................................................................................................................177 
4.1 Decision Tree Analyses ...........................................................................................178 
 
4.1.1 Modeling of Disease Data...............................................................................178 
 
4.1.1.1 Decision Tree Models ......................................................................... 178 
 
4.1.1.2 Modeling of Dengue Infection............................................................. 179 
 
4.1.1.3 Modeling of Disease Severity.............................................................. 179 
 
4.1.1.4 Important Considerations of our Approach ........................................... 180 
 
4.1.2 Distinguishing Dengue from other Febrile Illnesses in an early Stage of 
Disease…. ........................................................................................................................182 
 
4.1.2.1 White Blood Cell Count, absolute Numbers of Lymphocytes and 
Temperature, but not Symptoms can Diagnose Dengue Infection in an early Stage of 
Disease…. .......................................................................................................... 182 
 
4.1.2.2 Lower IL-2 and decreased TNF-α, but elevated IL-10 Levels along with an 
increase of IP-10 may be highly specific for an early Stage of Dengue Disease....... 185 
 
4.1.2.3 Lower IL-2 Levels, higher IP-10 Levels as well as increased IFN-γ 
combined with clinical Data are strong Predictors for Dengue Infection in an early 
Stage of Disease ................................................................................................. 190
 
4.1.3 Severity Prediction in an early Stage of Disease ............................................193 
 
4.1.3.1 Platelet Group Classification shows Consistency and Coherence with the 
two Cases classified as DHF after the WHO Guidelines ........................................ 193 
 
4.1.3.2 A high viral Load combined with a secondary Infection is a genuine Risk 
Factor for the Development of Thrombocytopenia ................................................ 195 
 
4.1.3.3 Higher IP-10 Levels show strong Correlation to viral Load and a similar 
Classifier Performance........................................................................................ 198 
 
4.1.3.4 IL-10 as an early Predictor of severe Dengue Infection shows higher 
Sensitivity than IL-8, but has a narrower predictive Window ................................. 199 
 
4.1.3.5 Higher Levels of I-TAC are highly predictive of severe Cases in a more 
homogenous Population ...................................................................................... 203 
 
4.1.4 Concluding Remarks and Outlook..................................................................204
 
4.2 The Virus and its Effect on Clinical Outcome.........................................................206 
 
4.2.1 Serotype specific Differences in Clinical Outcome ........................................206 
 
8 
 4.2.2 Phylogeny of the 2005 Singaporean Dengue Outbreak ..................................209 
 
4.2.2.1 Isolated Serotype 1 and Serotype 3 Viruses show different phylogenetic 
Tree Structures suggesting evolutionary Differences ............................................. 209 
 
4.2.2.2 Serotype 3 Clades show Differences with regard to viral Load and Platelet 
Count ….. .......................................................................................................... 211 
 
4.2.3 Concluding Remarks and Outlook..................................................................212 
5 Bibliography ...................................................................................................................214 
6 Appendix .........................................................................................................................228 
6.1 Sequencing Report and Optimization......................................................................229 
 
6.1.1 Virus Propagation ...........................................................................................229 
 
6.1.2 RNA Extraction ..............................................................................................229 
 
6.1.3 RT-PCR of DENV RNA.................................................................................230 
 
6.1.3.1 RT of DENV RNA ............................................................................. 230 
 
6.1.3.2 PCR of DENV cDNA ......................................................................... 231 
 
6.1.3.3 Gel Electrophoresis............................................................................. 233 
 
6.1.3.4 Gel Extraction of DNA ....................................................................... 233 
 
6.1.4 Results (or Method validation) .......................................................................234 
 
6.1.4.1 Optimization of Ramp Speed............................................................... 234 
 
6.1.4.2 Typical RT-PCR results ...................................................................... 236 
 
6.1.4.3 Typical gel purification results ............................................................ 237 
 




In Singapore, resurgence of dengue cases peaked with 14,209 laboratory confirmed 
cases in 2005. Interestingly, dengue epidemiology in Singapore presents itself with 
striking differences to other South-East Asian countries, where the main burden is 
considered to be among children. In Singapore, however, young adults are at the 
highest risk which exacerbates the implementation of the WHO classification scheme 
which is exclusively based on data from children. Thus, it is evident that these WHO 
guidelines on dengue diagnosis and case management have to be reassessed to 
accommodate the adult dengue cases as well. To address this goal the Early Dengue 
(EDEN) study has been launched in 2005 by a joint effort between Tan Tock Seng 
Hospital (TTSH), the Genome Institute of Singapore (GIS), the Novartis Institute for 
Tropical Diseases (NITD), the Environmental Health Institute (EHI), the Singapore 
Tissue Network (STN), DSO National Laboratories (DSO) and the NHG Polyclinic 
Group. EDEN aims at finding early host and viral markers that contribute to dengue 
pathogenesis and the present thesis was part of this effort. 
 
Firstly, this work harnessed patients clinical and immunological data collected during 
the 2005 Singaporean dengue outbreak in an attempt to distinguish dengue fever from 
other febrile illnesses. This resulting clinical model showed a sensitivity of 82%. The 
integration of immunological data improved the sensitivity to 90%. It identified a low 
white blood cell count (<=4800 cells/mm3) along with lower number of lymphocytes 
(<=500cells/mm3) as clinical indicators for dengue infection. Generally, lower serum 
levels of IL-2, decreased levels of TNF-α but, increased IP-10 and IL-10 levels were 
immunological markers that were predictive for dengue infection in an early stage of 
10 
 disease. Secondly, we aimed at finding an accurate prediction of disease severity in 
adult infections. Classification of severe patients based on a low platelet count 
(<=50,000/mm3) between days five and seven of illness resulted in a model that 
predicted severity within 72 hours of fever onset. It showed a sensitivity of 81% and 
integrated viral load along with secondary infection into one predictive model. 
Furthermore, we identified IP-10, IL-8 and IL-10 as possible severity markers for 
dengue pathogenesis in an early stage of disease. 
 
Thirdly, 94 full length genomes of dengue viruses (54 DENV-1 & 40 DENV-3) 
isolated during the 2005 Singaporean dengue outbreak were analyzed. Phylogenetic 
analysis revealed high levels of similarity between strains within a serotype. Dengue 
serotype 3 viruses were possibly maintained by silent maintenance since 2003 before 
the large 2005 Singaporean dengue outbreak. Further investigations of identified 
clades within the two serotypes did not result in the finding of severity related genomic 
differences but were able to detect IFN-α, IL-8 and viral load as serotype specific 
differences that might have a share in disease severity. We concluded that serotype 1 
was more likely to cause severe disease than serotype 3. 
 
Taken together, this work contributes to the understanding of the course of disease in 
relation to genotype patterns. The performed studies suggest new predictive models for 
distinguishing dengue fever from other febrile illnesses and for determining disease 
severity. 
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1. Introduction Investigating the 2005 Singaporean Dengue Outbreak
 
1.1 Epidemiology of Dengue 
 
1.1.1 The Global Emergence of Dengue 
 
Dengue is an old and the most important arthropod-borne viral disease affecting 
humans in terms of morbidity. There are reports in the medical literature about 
epidemics caused by an illness comparable to dengue that reach back to the late 17th 
century. The Chinese, however, described similar symptoms even earlier, more 
precisely during the Chin Dynasty (265 to 420 A.D.) (Gubler, 1998).  
 
Sporadic and widespread outbreaks of dengue caused a major burden on public health 
between the 17th and the 20th century (Gubler, 2004). Nowadays, over 2.5 billion 
people live in risk areas (Figure 1.1) and 50 to 100 million people suffer from dengue 
fever (DF) every year. The World Health Organization (WHO) estimates that 500,000 
cases of Dengue Hemorrhagic Fever / Dengue Shock Syndrome (DHF/DSS) and more 
than 20,000 deaths occur per year (WHO, 2002). In the last 25 years of the 20th 
century, dengue has emerged as a major public health problem and epidemics have a 
tremendous impact on social as well as economic structures of society especially in 
developing countries of the tropics (Gubler, 2002). 
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Figure 1.1: Countries and areas at risk of dengue transmission. Yellow color indicates dengue infested 
areas and countries that experienced new dengue epidemics between 2000-2006 are colored in red 
(WHO, 2006). 
 
1.1.1.1 Situation in the Americas 
 
In the Americas, major epidemics started to occur periodically in the early 17th century 
and the USA was confronted with a last major dengue outbreak in 1945 (Ehrenkranz et 
al., 1971; Gubler, 2004). Epidemics normally had their origin in one country 
subsequently spreading all over the region and were caused by only one serotype that 
disappeared after several months. Infections affected thousands of people and were 
characterised by self-limited classical DF (Gubler, 2004). In the 1900s, 
implementation of preventive measures and of control programs for subduing Aedes 
Aegypti (Ae. Aegypti) mosquitoes as the vector of yellow fever virus also had a highly 
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acceptable effect on combating dengue fever. It resulted in the declining or even 
disappearance of DF throughout the region (Graham et al., 1999; Gubler, 2004).  
 
1.1.1.2 Situation in the Asia/Pacific  
 
However, in the Asia/Pacific region, DF was a common occurrence in the first 50 
years of the 20th century. There was an epidemic every 10 to 40 years depending on the 
introduction of a new virus (Gubler, 2004). Various reports from this time show that 
dengue virus was endemic during this period but the exact distribution of all four 
serotypes was unknown. The isolation of all four serotypes in the 1940s (DENV-1 and 
DENV-2) and 1950’s (DENV-3 and DENV-4) finally suggested that dengue virus was 
already present earlier and was maintained by a monkey-mosquito-monkey cycle 
(Mackenzie et al., 2004; Weaver and Barrett, 2004). But after and during World War 
II, the epidemiology of dengue dramatically changed, causing major epidemics and the 
spread of dengue virus into new geographic areas. The reasons for this change are not 
completely understood but it is thought that the insertion of hundreds of thousands 
soldiers, increased population density, troop movement and shipment of war material 
played a crucial role in causing Asia to become hyperendemic with the co-circulation 
of multiple dengue virus serotypes (Gubler, 2004). This resulted in an increased 
transmission of multiple serotypes and in the sequential emergence of dengue 
hemorrhagic fever (DHF) in the 1950s with a first outbreak in Manila, Philippines. 
Singapore experienced its first DHF epidemic in the early 1960s (Gubler, 2004). 
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1.1.1.3 Reasons for the Global Emergence of Dengue 
 
The fledgling stages of the pandemic emergence of dengue originated in the social as 
well as economic disruptions caused by World War II, that created ideal conditions for 
mosquito-borne diseases (Gubler, 1998; Gubler, 2002; Gubler, 2004; Mackenzie et al., 
2004). Due to the hyperendemic situation in the Asia/Pacific, a newly described 
disease emerged in the form of DHF in 1960. It spread throughout South-East Asia and 
by the mid 1970s, DHF had became a major burden among children in this region 
(Gubler, 2004). On the other hand, the Americas faced dramatic epidemiological 
changes after discontinuing Ae. Aegypti eradication programs in the early 1970s. By 
the end of the 1990s, Ae. Aegypti mosquitoes had nearly regained the geographic 
distribution leading to major dengue outbreaks in countries that were known to be 
nonendemic or hypoendemic. From 1981 and 1997, the first DHF cases were reported 
in the Americas suggesting the same emergence of DHF as it happened 25 years before 
in the Asia/Pacific (Gubler, 2004).  
 
In summary, we can specify five factors that have been playing a crucial role in the 
emergence of dengue. Unprecedented population growth combined with unplanned 
and uncontrolled urbanization led to an increased transmission of arboviral diseases in 
tropical countries. Additionally, the lack of mosquito control and modern 
transportation introduced new virus strains and serotypes into new geographic regions 
that have been regained by the mosquito vector. The last factor of equal importance is 
represented by the decay of public health infrastructures and the changes in public 
health policies causing inappropriate outbreak and disease management (Gubler, 2002; 
Gubler, 2004; Mackenzie et al., 2004). 
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1.1.2 Public Health, Social & Economic Impacts of Dengue 
 
1.1.2.1 Impact on Public Health 
 
Due to poor dengue surveillance and due to great similarities in disease manifestation 
to other tropical diseases such us malaria and chikungunya fever (Rigau-Perez et al., 
1998), the early stages of dengue outbreaks are mostly not detected and thus, dengue 
cases are underreported (Gubler, 2002). This results in an unwanted impact on disease 
management because it is suggested that dengue patients have to be treated as early as 
possible to prevent the transition from DF to DHF. Furthermore, the case fatality rate 
(CFR) of DHF varies among countries between <1% to 15% depending on disease 
surveillance, disposal and condition of health facilities as well as on trained and 
capable health care worker (Gubler, 2002). Later on in an epidemic, more precisely 
when transmission peaks, the disease gets recognized and ironically gets over reported. 
The sequentially implemented emergency mosquito control is often too late and 
highlights the lack of public health planning and the poor preparedness for future 
outbreaks. 
 
1.1.2.2 Impact on Society 
 
The social impact of DF/DHF on community must not be underestimated. The 
complacency that originated between the 1950s and 1960s when the mosquito control 
programs in the Americas were highly successful resulted in the decrease of public 
awareness. The global spread of dengue disease was mainly ignored by public health 
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officials and hence, the people had to tolerate the interruption of their daily life by 
epidemics occurring every few years (Gubler, 2002). Especially, the insufficient 
surveillance and case management for DF/DHF in developing countries have a share in 
the overloading of primary health care centres, resulting in overworked staff and in the 
sub-standard treatment of life-threatening conditions of DHF and dengue shock 
syndrome (DSS) as well as in the increasing mortality. These circumstances led to 
chaos and have forced the governments to attempt preventive measures being mostly 
insufficient and delivering a false feeling of security (Gubler, 2002). 
 
1.1.2.3 Impact on Economy 
 
In 2002, the WHO estimated a global burden of dengue in the range of 612,000 
Disability Adjusted Life Years (DALYs) and 87% of them were represented by 
children younger than fifteen years of age (WHO, 2002). At first glance, this number 
seems to be fairly low compared to other infectious diseases such as tuberculosis and 
malaria. But a study performed a few years ago investigating the burden of DF and 
DHF in Puerto Rico between 1984-1994, showed that the magnitude of DALYs lies in 
the range of malaria and tuberculosis (Meltzer et al., 1998). This suggests that, in 
addition to the epidemic periods, there is a considerable disease burden during inter-
epidemic periods. Mainly, lost productivity and time away from work or school are 
indirect underreported costs that have a huge impact in third world settings where 
absence of work can easily be the start to the vicious cycle of poverty (Gubler, 2002; 
Meltzer et al., 1998). Therefore, dengue has to be considered as a major public health 
burden and more attention has to be paid in terms of research and prevention.  
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1.1.3 Epidemiological Situation in Singapore 
 
1.1.3.1 Dengue Epidemiology in Singapore 
 
In Singapore, dengue has been successfully prevented through a highly effective vector 
control program implemented between the 1970s and the 1980s but despite that, 
dengue cases have resurged since 1990 (Ooi et al., 2006). In 2005, dengue resurgence 
peaked with 14,209 laboratory confirmed cases (Figure 1.2), an increase of more than 
50% compared to 2004. Most cases were reported between June and October, but the 
month of September reported a weekly incidence of over 700 cases (Ministry of 
Health, 2006). Studies performed to investigate the seroepidemiology in the 
Singaporean population showed a completely different picture than observed in other 
South-East Asian countries where the main burden of dengue usually affects children 
and female adults (Wilder-Smith et al., 2004). This typical transmission picture is 
mainly influenced by the highly domesticated lifecycle of the vector Ae. Aegypti (Ooi 
et al., 2006). 
 
 
Figure 1.2: Weekly distribution of DF/DHF cases in Singapore between 2004-2005. In 2005, Singapore 
reported an increase of more than 50% cases compared to 2004 (MOH, 2006). 
 
31 
1. Introduction Investigating the 2005 Singaporean Dengue Outbreak
 
In Singapore, however, young male adults have the highest risk of being infected with 
dengue virus (Ooi et al., 2003; Ooi et al., 2006; Wilder-Smith et al., 2004). In 2005, 
the male to female ratio was 1.4:1 with the highest incidence found in the age group of 
15 to 24 year olds (Ministry of Health, 2006). A study performed in 2004 showed that 
the odds ratio of dengue seroprevalence increases by 4.13 for every 10 years increase 
in age (Wilder-Smith et al., 2004). The factors involved are not fully understood and 
several studies revealed lowered herd immunity, increased virus transmission outside 
the home and shift in the surveillance emphasis of the vector control program as the 
responsible players (Ooi et al., 2006). In addition, adults suffer more often from 
symptomatic infections than children and therefore more cases are reported. 
Furthermore, adults are at lower risk to develop DHF/DSS than are children due to 
age-dependent differences in vascular permeability. The switch from epidemics 
causing DHF/DSS to epidemics of classical DF can be nicely observed over the years. 
Before implementation of the effective mosquito control programs, the disease had a 
higher prevalence in children and therefore, more cases of DHF/DSS were reported. 
Nowadays, even though the overall occurrence of cases is much higher, manifestations 
of classical DF are much more likely to occur than DHF/DSS as a consequence of 
adult infections (Ooi et al., 2006).  
 
The low incidence rate of the more severe forms of dengue hint towards the 
unsuitability of the WHO classification scheme (Introduction; Page 37) in Singapore. 
The scheme is based on clinical data from children and probably does not reflect the 
present situation in Singapore. It is evident that these guidelines on dengue diagnosis 
and case management have to be reassessed and improved formulations suitable for 
adult dengue cases have to be found.  
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1.1.3.2 The Early DENgue (EDEN) Study 
 
To address this goal, a longitudinal study has been implemented by a joint effort 
between the Tan Tock Seng Hospital (TTSH), the Genome Institute of Singapore 
(GIS), the Novartis Institute for Tropical Diseases (NITD), the Environmental Health 
Institute (EHI), the Singapore Tissue Network (STN), DSO National Laboratories 
(DSO) and the NHG Polyclinic Group (Low et al., 2006). The six specific goals of the 
EDEN study are as following:(1) Identify early markers of the disease that are 
predictive of outcomes such as DF and DHF, (2) Identify pathways that lead to severe 
disease that may be amenable to therapeutic intervention, (3) Study the 
epidemiological features of adult infection, (4) Develop robust molecular tools for 
epidemiological investigation, (5) Correlate virus virulence with their sequences and 
their replication properties and (6) Refine early dengue clinical and laboratory 
diagnostic tools (Low et al., 2006). The study has been launched in 2005 and during 
the 2005 Singaporean dengue outbreak, 455 patients were enrolled and 133 of them 
were PCR confirmed dengue positive cases.  An initial blood and saliva sample is 
taken on the first visit (1 to 3 fever days) and consequently on the second visit (4 to 7 
fever days). Finally, a third sample during convalescence is taken 3 to 4 weeks after 
the first visit. Afterwards, a full blood count is performed on the samples and the data 
is analyzed in respect to disease outcome (Materials & Methods; Page 66). The study 
is expected to be completed by February 2007 (Low et al., 2006). 
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1.2 Classical Dengue Fever, Dengue Haemorrhagic Fever & Dengue 
Shock Syndrome 
 
1.2.1 Clinical Manifestations of Dengue 
 
1.2.1.1 Classical Dengue Fever 
 
Dengue is a mosquito-borne viral disease and has an incubation period of 3 to 14 days. 
The disease can be asymptomatic or lead to a large range of clinical symptoms. 
Classical DF is usually an acute flu-like febrile illness including fever, frontal 
headache, myalgias and frequently arthralgias, nausea, vomiting and rash (Rigau-Perez 
et al., 1998; WHO, 1997). This classical form of DF normally occurs in older children 
and adults whereas younger children are mostly asymptomatic or minimally 
symptomatic (Burke et al., 1988). The disease lasts five to seven days and the virus 
disappears after an average of five days at the starting point of defervescence. Dengue 
fever may be followed by a convalescence of several weeks presenting a major impact 
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1.2.1.2 Dengue Hemorrhagic Fever and Dengue Shock Syndrome 
 
In rare cases, dengue virus infections can lead to a more severe form called DHF/DSS. 
This vascular leakage syndrome is observed in all age groups but it is still considered 
the main burden among children. DHF/DSS starts with a sudden onset of temperature 
and similar symptoms found in classical DF (Gubler, 1998). The fever period is 
accompanied by high temperatures and endures for 2 to 7 days with minor or major 
bleeding. It is believed that an immune mediated mechanism commencing with the 
infection of cells of the monocytic lineage, which secrete cytokines and other chemical 
mediators, ultimately leads to the DHF/DSS typical increased vascular permeability or 
leakage (Fink et al., 2006; Green and Rothman, 2006). If not properly treated, this 
condition can lead to death. Viral and host factors suggested to be involved in 
triggering this immunological cascade include previous infection by a heterotypic 
dengue virus, virus strain, age as well as immunological and genetic background of the 
patient (Gubler, 1998; Mackenzie et al., 2004; Rigau-Perez et al., 1998).  
 
There are some few reports about other severe manifestations caused by dengue virus 
infections such as massive haemorrhage, organ failure, cardiomyopathy and 
neurological diseases in form of encephalitis (Nimmannitya et al., 1987; Rigau-Perez 
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1.2.2 Dengue Diagnosis and Discussion of the WHO Classification Scheme 
 
1.2.2.1 Important Laboratory Tests for Dengue Diagnosis 
 
Besides the description of clinical symptoms, there are also clinical laboratory tests 
that are useful in the diagnosis of dengue. These clinical tests include a complete blood 
cell count (CBC), especially the white blood cell count (WBC), platelet count and 
haematocrit levels. The other useful tools for diagnosis are albumin, liver function and 
urine tests (CDC, 2005).  
 
Confirmation of suspected dengue infections is commonly done with basic serologic 
and dengue specific tests (Gubler, 1998). An acute-phase blood sample should always 
be taken as soon as possible after the onset of suspected illness. Optimally, there 
should be a second blood sample taken after 2 to 3 weeks to affirm the disappearance 
of dengue virus from the blood. The follow up of non-hospitalized cases is difficult 
and laborious. Therefore, it is suggested to take a second blood sample of hospitalized 
cases before hospital discharge. Direct virus isolation is helpful in detecting the 
serotype of the infecting virus by RT-PCR and is performed by either using mosquito 
cell cultures or by mosquito inoculation. The IgM ELISA is the basic serologic test 
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1.2.2.2 WHO Classification Scheme 
 
The WHO scheme for dengue diagnosis consists of the above mentioned dengue case 
definition (having dengue or non-having dengue) and dengue case classification 
(classification of disease manifestations into DF/DHF/DSS and other forms)  
(Bandyopadhyay et al., 2006; WHO, 1997). Dengue case classification has been 
widely discussed by researchers and resulted in the demand for reassessment of the 
WHO guidelines. According to WHO guidelines, DHF must fulfill all of the following 
four criteria: (1) Fever or history of acute fever lasting 2 to 7 days, (2) hemorrhagic 
tendencies evidenced by at least one of the following: a positive tourniquet test, 
petechia, purpura, ecchymoses, bleeding from mucosa, gastrointestinal tract, injection 
sites or other location, haematemesis, melena, (3) thrombocytopenia (<=100,000 
platelets/μl) or (4) =>20% rise of hematocrit value relative to the normal baseline or 
evidence of plasma leakage (e.g. pleural effusion or ascites) (Bandyopadhyay et al., 
2006; WHO, 1997).  
 
DHF is further classified into four grades of severity (I-IV). DHF I is only defined by a 
positive tourniquet test whereas patients suffering from DHF II show spontaneous 
bleeding in the skin, through the nose or in the internal organs. DHF III is manifested 
in the form of hypotension, narrow pulse pressure, restlessness as well as rapid weak 
pulse and DHF IV is accompanied by profound shock with undetectable blood 
pressure or pulse. DHF grades III and IV constitute dengue shock syndrome (DSS) 
(Bandyopadhyay et al., 2006; WHO, 1997). 
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The description of severity was originally established in 1974 and was based on the 
data of a clinical study of Thai children performed in 1964 (Cohen and Halstead, 
1966). Even though, the resulting recommendations for case management resulted in 
the decrease of the case fatality rate (CFR), it is stringent that an improved and 
globally used classification scheme is introduced (Deen et al., 2006; Rigau-Perez, 
2006). Due to the global expansion and due to the changing epidemiology of dengue 
disease, several investigators face difficulties in using the old WHO guidelines. As a 
result, the terms “dengue fever with signs associated with unusual haemorrhage” and 
“dengue with signs associated with shock” have been introduced to try to find the 
correct definitions for atypical severe dengue cases (Deen et al., 2006). Using the 
WHO guidelines, DHF/DSS is only fulfilled when the four above discussed 
manifestations are present, but in a lot of severe cases only one manifestation is 
observed. Comparisons of cases classified by the WHO scheme to classification by 
expert clinicians, resulted in a sensitivity of 82% (Rigau-Perez, 2006). Additionally, 
the WHO classification scheme is often misquoted and requires different and repeated 
clinical tests which might be a serious challenge for countries with limited resources 
(Rigau-Perez, 2006).  
 
Therefore, it has been suggested that the WHO guidelines have to be reassessed 
employing the following three criteria (Deen et al., 2006): First, there is much overlap 
between DF, DHF and DSS and the guidelines do not treat this fact appropriately, but 
rigorously distinguish the three different disease manifestations. Second, not all of the 
severe cases fulfil the four criteria for DHF/DSS and finally, the term dengue 
haemorrhagic fever can be misleading because plasma leakage is the life-threatening 
condition to look-out for.  
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1.2.3 Prevention and Treatment of Dengue 
 
1.2.3.1 Vector Control 
 
In the Americas, first attempts to eradicate the vector Ae. Aegypti were successful in 
the beginnings of the 20th century and prevention of mosquito to human transmission 
was possible (Gubler, 2004). Today, implementations of mosquito control programs 
face major difficulties due to insufficient knowledge, compliance issues and lack of 
resources. It is also intriguing, that the use of ultra-low volume (ULV) concentrates of 
insecticides have become a routine during pre- and post-epidemic periods. They were 
originally supposed to be an emergency response during epidemics and they have very 
limited impact on adult as well as immature stages of the mosquito (Gubler, 2002; 
Newton and Reiter, 1992; Rigau-Perez et al., 1998). Therefore, dengue has to be 
promoted as a priority among health officials and the general public to achieve a 
common sense of responsibility for prevention of mosquito to human transmission. 
 
1.2.3.2 Dengue Vaccines 
 
To date, there is no dengue specific drug on the market and ongoing research has 
mostly been focused on the development of vaccines. A live attenuated vaccine seems 
to be the most promising at the moment and several candidates are in phase I or phase 
II clinical trials. Chimeric virus, DNA, inactivated and subunit recombinant vaccines 
are also of interest but they are still in the preclinical development (Chaturvedi et al., 
2005). It is estimated that an approved vaccine is not likely to be available for the next 
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5 to 7 years because of the complex immune reactions that are involved in dengue 
pathogenesis (Ooi et al., 2006).  
 
1.2.3.3 Drugs against Dengue 
 
Since 2002, the Novartis Institute for Tropical Diseases (NITD) funded by the 
Singapore Economic Board and by the Novartis Foundation has been the first 
institution putting immediate effort into R&D of a dengue specific chemotherapy with 
a strong vision to launch a widely available drug by the end of 2012. The main targets 
that are followed up are the E Glycoprotein, the NS3 protease, the NS3 helicase and 
the NS5 RNA dependent polymerase.  
 
1.2.3.4 Current Treatment of DF and DHF/DSS 
 
Currently, treatment of classical DF requires rest, oral fluids to compensate 
dehydration via diarrhea or vomiting and analgesics (Gubler, 1998; Rigau-Perez et al., 
1998). Antipyretics such as paracetamol are given for pain relief but aspirin and non-
steroidal anti-inflammatory drugs have to be avoided due to risk of impairment of 
platelet function (CDC, 2005; Gubler, 1998; Rigau-Perez et al., 1998; WHO, 1997). In 
suspicion of severe illness, fluids should be provided intravenously dependent on the 
patient’s blood pressure, haematocrit levels, platelet counts, haemorrhagic 
manifestations, urinary output and on patient’s level of consciousness. Isotonoic 
solutions and plasma expanders are additionally administered to deal with plasma loss 
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caused by increased vascular permeability (CDC, 2005; Gubler, 1998; Rigau-Perez et 
al., 1998; WHO, 1997). 
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Dengue virus belongs to the genus Flavivirus (family: Flaviviridae) which consists of 
more than 70 viruses (Kuno et al., 1998; Mackenzie et al., 2004). Based on the NS5 
gene sequence, the flaviviruses are clustered into three distinct groups which nicely 
correlate with the mode of transmission (mosquito-borne, tick-borne, unknown vector) 
(Kuno et al., 1998).  Dengue virus, Japanese encephalitis virus (JEV), West Nile virus 
(WNV) and yellow fever virus (YFV) are the most important members of the genus 
and cause every year large epidemics in many parts of the world. 
 
It is believed that dengue virus (Figure 1.3; 47) evolved from a common ancestor 
1,000 years ago and that human transmission started between 125 and 325 years ago 
(Mackenzie et al., 2004; Twiddy et al., 2003). It is still not clear whether the virus 
originated from Africa or from Asia but dengue transmission was first maintained in a 
sylvatic lifecycle with Aedes species (Holmes and Twiddy, 2003). Sporadic outbreaks 
first occurred in predomestic regions due to transmission by Aedes albopictus and 
showed similar dynamics as are now observed during yellow fever epidemics. As 
discussed above, adaptation of Aedes species, mainly Aedes aegypti, to urban and 
densely inhabited areas created optimal conditions for human transmission resulting in 




1. Introduction Investigating the 2005 Singaporean Dengue Outbreak
 
It is intriguing that the four serotypes are phylogenetically different to an extent as 
observed between different flaviviruses (Figure 1.3; Page 47) which, in turn, highlights 
their independent zoonotic transfer and their separate evolutionary development 
(Holmes and Twiddy, 2003). Thus, it is suggested that the phenomenon of antibody 
dependent enhancement (ADE) is not the driving force of genetic diversity but might 
be the result of recent contact between the four separately evolved viruses showing 
antigenic dissimilarities (Holmes and Twiddy, 2003). Evidence showing correlation 
between secondary infections and disease outcomes as well as the hyperendemic 
situation with the co-circulation of multiple serotypes additionally support this 
independent evolution hypothesis. A first study to determine intra-serotype variation 
was performed by Rico-Hesse using the junction between the E/NS1 genes of DENV-1 
and DENV-2 (Rico-Hesse, 1990). Nowadays, it is more common to use the entire 
sequence of the E-protein (1485nt) and recent phylogenetic studies revealed that three 
to five human genotypes could be found within a serotype (Holmes and Twiddy, 2003; 
Rico-Hesse, 2003). 
 
1.3.1.1 Dengue Serotype 1 (Figure 1.3; Page 47) 
 
According to Rico-Hesse, DENV-1 can be subdivided into five genotypes representing 
different geographic locations (Americas/Africa, South Pacific, Asia Thailand) and 
different host characteristics (human/sylvatic) (Rico-Hesse, 2003). By contrast, a more 
recent study using 177 DENV-1 E gene sequences grouped serotype 1 into 3 
genotypes but reflection of the geographical distribution was still maintained (A et al., 
2004). Genotype I consists of viruses from two different clades (Africa/Asia and 
Asia/Oceania) connected by short branch lengths and therefore suggesting that viruses 
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of this genotype are mixed regardless of their location. On the other hand, the picture 
of genotype II (viruses from Asia and Oceania) is very different representing clusters 
that are nicely defined by their geographic occurrence. Finally, branch interpretation of 
genotype III composed of three smaller clades (Asia, Africa, Latin America) is more 
difficult due to lack of resolution. Nevertheless, it has been postulated that genotype III 
viruses isolated in Latin America had earlier been introduced from Asia (Holmes and 
Twiddy, 2003; Rico-Hesse, 2003).  
1.3.1.2 Dengue Serotype 2 (Figure 1.3; Page 47) 
 
Phylogeny of DENV-2 is the best studied due to an abundance of sequence data. 
Earlier studies suggested that five genotypes (Malaysia/Indian Subcontinent, South-
East Asia, Americas, West Africa, sylvatic) would be present (Rico-Hesse, 2003). 
However, calculations using the current DENV-2 sample results in a slightly different 
picture detecting six possible genotypes (Cosmopolitan, Asian 2, Asian 1, 
American/Asian, American) (Holmes and Twiddy, 2003). Strikingly, genotypes found 
in both studies are representing different geographic distributions and state that 
sylvatic DENV-2 strains will have little epidemiological impact on human populations. 
Furthermore, both studies recognized the potential of DENV-2 genotypes to spread 
into various distinct geographic locations which has possibly been the cause of the 
introduction of the South-East Asian genotype into the Americas (Holmes and Twiddy, 
2003; Rico-Hesse, 2003). It was shown that this introduction correlated with the 
occurrence of DHF/DSS (Rico-Hesse et al., 1997) and later experiments underlined the 
early replicative advantage of the South-East Asian genotype (Cologna et al., 2005).  
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1.3.1.3 Dengue Serotype 3 (Figure 1.3; Page 47) 
 
DENV-3 consists of 4 or 5 distinct subtypes depending on the analysis performed 
(Messer et al., 2003; Rico-Hesse, 2003). Subtype I includes viruses from South-East 
Asia and the Pacific, whereas subtype II is only represented by viruses from Thailand. 
Subtype III was isolated in the Indian Subcontinent as well as Africa and subtype IV is 
comprised of viruses from Puerto Rico and Tahiti (Messer et al., 2003). Subtype III 
shows interesting patterns in terms of evolutionary and clinical aspects. Further 
clustering of this subtype into smaller clades (clade A (pre-DHF emergence) and clade 
B (post-DHF emergence)) revealed correlations with DHF (Messer et al., 2003). In Sri 
Lanka, regular outbreaks causing DHF only occurred after 1988 and it was proven that 
neither increased transmission nor introduction of a new serotype were the determining 
factors (Messer et al., 2002). Messer and collaborators showed that DENV-3 isolated 
before 1988 clustered into clade A whereas DENV-3 isolates after 1989 belonged to 
clade B. Possible explanations for this emergence might be (1) the introduction of 
group B viruses from East Africa or India and/or (2) a selective force favouring group 
B viruses after 1989 (Messer et al., 2003; Messer et al., 2002). A similar picture was 
also observed in the Americas and it was suggested that the group B subtype III 
variants spread from the Indian subcontinent to East Africa and subsequently to Latin 
America (Messer et al., 2003). This might be an additional reason for the emergence of 
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1.3.1.4 Dengue Serotype 4 (Figure 1.3; Page 47) 
 
There is still not much data available for DENV-4 which is the first to separate from 
the phylogenetic tree (Rico-Hesse, 2003). Considering DENV-4 to be the most 
divergent of all four serotypes, it was suggested that strain migration of DENV-4 in the 
Americas was influenced by different patterns in host immunity (Carrington et al., 
2005). Upon introduction, DENV-4 introduced from Asia was first isolated in 1981 
and showed a tremendous increase in genetic diversity reflecting rapid transmission 
throughout the region. After that, genetic diversity was retained reflecting the low 
mutation rate and reports of DENV-4 activity declined which is underlined by 
decreased transmission and rare occurrence in dengue outbreaks (Carrington et al., 
2005). Rico-Hesse suggested that there are currently the Malaysia, South-East Asia 
and Indonesia genotypes (Rico-Hesse, 2003) but further studies are essential to get a 
better picture of DENV-4 evolution.  
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Figure 1.3: Phylogenetic Tree based on 120 E gene sequences (1485 bp) representing the genetic 
diversity in dengue virus. Within each serotype, the corresponding genotypes are indicated and at each 
tree node, the approximate divergence times are shown. Claculated bootstrap values are shown below 
the selected nodes (Holmes and Twiddy, 2003). 
 
 
1.3.1.5 Serotype Switch & Clade Replacement 
 
Circulation of multiple serotypes in highly endemic regions leads to serotype switch 
and intraserotypic clade replacement which are commonly observed phenomena that 
play a crucial role in shaping transmission dynamics. It was observed that 
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intraserotypic clade replacement increased the overall abundance of a first serotype but 
simultaneously decreased the population of the second serotype due to mutations 
affecting viral fitness. In turn, the later decline of the prevalence of the first serotype 
was associated with the increase in prevalence of the second serotype (Zhang et al., 
2005). Finally, it was suggested that still existing clades belonging to the first serotype 
were antigenically more distinct to the second serotype than the clades that did not 
survive the period of the second serotype. This clearly hints towards an active role of 
cross-protection in serotype switch but does not completely explain the phenomenon 
(Zhang et al., 2005) and in contrast, other studies proposed stochastic explanations for 
clade replacement as well as serotype switch (Myat Thu et al., 2005). Therefore, 
further studies are required to determine the complex interactions of selective and 
stochastic forces that shape DENV-evolution and determine genotypic diversity. 
 
1.3.2 Dengue Virus Lifecycle 
 
1.3.2.1 Structure of Dengue Virions (Figure 1.4; Page 49) 
 
The mature dengue virions have a diameter of approximately 500 Ǻ and consist of a 
viral genome of around 10.8kb packed by the dimeric capsid proteins. The resulting 
nucleocapsid is enclosed by a host-derived lipid bilayer surrounded by 180 copies of 
the E and M protein that form an icosahedral symmetry (T=3) during the fusion 
process (Kuhn et al., 2002). The viral genome is comprised of a (+)-stranded RNA 
encoding three structural (C, prM and E-Protein) and seven non-structural proteins 
(NS1, NS2a, NS2b, NS3, NS4a, NS4b and NS5). The RNA genome is the only viral 
48 
1. Introduction Investigating the 2005 Singaporean Dengue Outbreak
 
mRNA encoding a single open reading frame and is transcribed as a polyprotein. 
Further processing and cleavage of the polyprotein by the viral serine-protease NS3, 
host signalases and furin lead to the final ten products that play an important role in 
viral assembly (C, prM and E proteins), viral maturation (conversion of prM to M) and 




Figure 1.4: Structure of dengue virions. (a) The immature particle is less smooth than the mature form 
and has 60 ptotein ‘spikes’ that stick out. (b) The structure of the mature dengue virus is unusually 
smooth. The membrane is completely enclosed by a protein shell consisting of 30 rafts of three parallel 
dimers of the E protein (red: domain I; yellow: domain II; blue: domain III and green: fusion peptide) 








Figure 1.5: Overview of the dengue polyprotein. Further processing and cleavage of the polyprotein by 
the viral serine-protease NS3, host signalases and furin lead to the final ten products that play an 
important role during viral lifecycle. C=capsid protein; prM=pre M protein; E=envelope protein; NS1-
5=non-structural proteins 1-5; Prot=protease; Hel=helicase; MTase=methyl transferase; RdRp=RNA 
dependent polymerase (NITD, 2005). 
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1.3.2.2 Viral Entry 
 
Dengue virus enters host cells including dendritic cells, monocytes/macrophages, B 
cells, T cells, endothelial cells, hepatocytes, and neuronal cells by receptor-mediated 
endocytosis (Clyde et al., 2006) (Figure 1.6; Page 55). Despite some few reports 
suggesting other entry mechanisms of dengue virus, the receptor-mediated endocytosis 
is generally accepted as the mode of entry. The primary receptors for this mechanism 
are DC-SIGN, GRP78/BiP and CD14-associated molecules (Chen et al., 1999; 
Jindadamrongwech et al., 2004; Navarro-Sanchez et al., 2003; Tassaneetrithep et al., 
2003). The interaction between DC-SIGN and the E glycoprotein was recently solved 
by Pokidysheva and collaborators (Pokidysheva et al., 2006). They have clearly shown 
that the carbohydrate recognition domain (CRD) of DC-SIGN interacts with the N-
glycosylated carbohydrate moieties of the E protein. They propose that this interaction 
represents a mechanism for avoiding an immune response. In previous studies it was 
suggested that the carbohydrate moieties on the virus surface might modulate 
specificity of receptor binding. There is only a ~40% amino acid identity among all the 
flaviviruses and the number and position of N-glycosylated residues is not conserved 
among different strains of the same virus.  A comparative study of two dengue strains 
showing differences in infectivity revealed a unique amino acid in the E-protein 
leading to the loss of a N-linked glycosylation site and therefore to a decreased 
infectivity (Ishak et al., 2001).  Another study with the New York strain of West Nile 
virus (WNV) suggested that E protein glycosylation is a molecular determinant of 
neuroinvasiveness (Shirato et al., 2004). Finally, Hanna and collaborators concluded 
from their experiments that the glycosylation of WNV prM and E proteins can affect 
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the efficiency of virus release and infection in a cell specific manner (Hanna et al., 
2005).   
 
The acidification in the endosome leads to a trimerization of the dimeric E 
glycoprotein followed by the release of viral RNA due to the class II fusion process 
(Figure 1.6; Page 55). The E Protein consists of three ectodomains (domains I-III) with 
a fusion peptide at the tip of domain II. The pH induced conformational change 
exposes the fusion peptide which then inserts into the host membrane to facilitate the 
class II fusion steps (Mukhopadhyay et al., 2005).  An interesting finding during 
structural studies of the E protein revealed that the detergent molecule N-octyl-β-D-
glucoside can occupy a pocket that forms the hinge region and is positioned at the 
interface of domains I and II (Modis et al., 2003; Modis et al., 2004). This pocket is 
essential for membrane fusion and it is thought that the hinge region controls the class 
II fusion process due to its flexibility. This finding is pertinent for drug discovery since 
blocking the pocket in the hinge region may prevent membrane fusion and thereby 
prevent the multiplication of the virus.  
 
1.3.2.3 Viral Replication, Assembly and Exocytosis 
 
Once the genome is released into the host cell, the positive sense RNA is transcribed 
into the polyprotein at the surface of the endoplasmatic reticulum (ER) (Figure 1.6; 
Page 55). During the process of translation the structural proteins are translocated and 
anchored into the endoplasmatic reticulum by membrane anchor sequences. The prM 
protein, the E protein and the non-structural proteins are found in the lumen of the 
endoplasmatic reticulum (ER) meanwhile the capsid protein is anchored on the outer 
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membrane of the ER (Mukhopadhyay et al., 2005). A study showed that translation of 
the m7G-capped, nonployadenylated positive-sense RNA genome is controlled by the 
3’UTR region in a similar way to cap-dependent and IRES-mediated initiation. 
Furthermore, the 3’stem loop (3’SL) region contributes significantly to 3’UTR-
mediated translation after recognition of the 5’cap structure by cellular proteins 
(Holden and Harris, 2004). In a later study of dengue virus translation using luciferase 
reporter mRNA’s transfected into Vero cells, it was found that the 3’UTR has 
translational properties similar to a poly(A) tail (Chiu et al., 2005).   
 
Soon after successful translation of the viral RNA, the virus starts synthesizing viral 
RNA. Replication of the viral RNA takes place in complexes composed of viral RNA 
as well as non-structural proteins (Figure 1.6; Page 55). The process is catalyzed by the 
RNA dependent RNA polymerase (RdRp) represented by the NS5 protein in the viral 
genome and the replication complexes are associated with intracellular membranes. 
Furthermore, involvement of interactions of flaviviral specific host proteins and other 
viral factors with the 3’ stem loop of the virus genome have been reported (Blackwell 
and Brinton, 1995). The 3’ non coding region contains adjacent, thermodynamically 
stable, conserved short and long stem-and-loop structures, formed by the 3’-terminal 
~100 nucleotides. It has been shown that the nucleotide sequences in different virus 
strains are quite variable whereas the secondary structure of the stem-loops stays 
conserved (Zeng et al., 1998). The 3’ stem loop of the viral RNA is preceded by a 
cyclization sequence 3’ CS. This sequence is complementary to the 5’ CS leading to a 
direct RNA-RNA interaction and finally to the cyclization of the viral RNA. This 
conformation is essential for initiation of replication and plays an additional role in 
translational control. Studies using atomic force microscopy revealed the RNA 
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circularization in vitro and showed that the presence of the CS regions is not sufficient 
by itself. An element of 16 nucleotides present at the 3’ and 5’ UTR is an additional, 
important determinant for RNA-RNA association (Alvarez et al., 2005). Generally, the 
proposed mechanism for minus-strand RNA synthesis includes the binding of the viral 
polymerase to the stem loop A (SLA) at the 5’ end of the genome. This results in the 
translocation of the RdRp to the site of initiation at the 3’end via long-range RNA-
RNA interactions (Filomatori et al., 2006). In addition, the SLA serves as a promoter 
element enhancing replication, meanwhile competence of replication is maintained by 
bulges and their topological location within the long stem of the 3’ stem loop (Yu and 
Markoff, 2005). 
 
One of the earliest events in virus assembly (Figure 1.6; Page 55) is the formation of a 
nucleocapsid (NC), which consists of one copy of the genomic RNA and multiple 
copies of the capsid protein. The assembled nucleocapsid (NC) then buds as a complex 
into the lumen of the ER which results in the immature virion with a host-derived lipid 
bilayer including the prM and E proteins. This process is highly coordinated by the 
membrane-associated capsid protein and the prM-E heterodimer in the ER. Then the 
immature virion will be transported through the trans-Golgi network where the prM 
protein is cleaved by the protease furin producing mature, infectious particles that are 
subsequently released by exocytosis. 
 
1.3.2.4 Extrinsic versus Intrinsic Lifecycle (Figure 1.7; Page 55) 
 
When the mosquito feeds on an infected human being, the virus gets taken up into the 
mosquito and starts replicating in the mosquito gut cells. This extrinsic period of the 
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lifecycle lasts for 10 to 14 days. With the next blood meal, the virus gets transmitted to 
humans in the mosquito saliva and starts infecting its target cells. Viruses can be 
detected after an incubation period of 3 to 14 days and normally for the first 3 days of 
fever. This part is called the intrinsic lifecycle. 
 
Dengue viruses are the only known arboviruses that have lost the need for an enzootic 
lifecycle for maintenance. They are fully adapted to humans and are transmitted by the 
highly domesticated Ae. Aegypti mosquito. It is thought that there is still rare 
maintenance of the virus through a sylvatic cycle with other Aedes species as the 
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Figure 1.6: Overview of dengue virus lifecycle. (1) Dengue virions bind to target receptors and (2) enter 
the cell by receptor-mediated endocytosis. (3) Acidification of the late endosome triggers the class II 
fusion process and the viral nucleocapsid gets released into the cytoplasm. (4) The viral RNA is 
translated in association with the ER into the polyrotein and further processing results in 3 structural and 
7 non-structural proteins. (5) After successful translation, viral replication takes place on intracellular 
membranes and (6) final assembly of the virions occurs in the ER. (7) The assembled viral particles 




Figure 1.7: Extrinsic versus intrinsic lifecycle of dengue virus. The extrinsic incubation time of the 
lifecycle lasts for approximately 10 to 14 days. With the next blood meal, the mosquitoes transmit 
dengue to the human host where the virus starts its replication. The virus can be detected after an 
intrinsic incubation period of 3 to 14 days (CDC, 2002). 
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1.4 Immunology of Dengue Virus Infections 
 
1.4.1 Dengue Pathogenesis and Host Immune Response 
 
1.4.1.1 Early Events in the Host after Infection 
 
Inoculation of dengue virus into the skin leads to DC-SIGN mediated infection of 
dendritic cells (DC) (Tassaneetrithep et al., 2003) and subsequent viral replication 
within the first 24 hours. It was shown that DCs are much more permissive than either 
macrophages or monocytic cells which are also considered as a main target of dengue 
virus infection (Wu et al., 2000). Additionally, the absolute number of lymphocytes is 
decreased during dengue infection which can be a result of infected or apoptosing cells 
(Azeredo et al., 2001). The infection of DCs is accompanied by the activation and 
maturation of the infected as well as neighbouring cells which finally results in the 
secretion of TNF-α, IFN-α and IL-10 (Green and Rothman, 2006). The antiviral 
response is mediated by RIG-I that recognizes double-stranded RNA and activates 
type I interferon signalling/secretion, especially IFN-α (Chang et al., 2006; Green and 
Rothman, 2006). Dengue virus is able to counteract this immediate antiviral response 
by downregulation of interferon signalling (I. Umareddy, unpublished data). 
Furthermore, infected dendritic cells migrate to the lymph nodes but are impaired in 
their ability to stimulate T-cells. Therefore, only neighbouring DCs undergo 
appropriate maturation and play a crucial role in the activation of the adaptive immune 
response (Green and Rothman, 2006). 
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1.4.1.2 Important Mediators of Innate Immunity during Infection 
 
Natural killer (NK) cells, basophiles, neutrophiles, macrophages and complement are 
other important mediators of innate immunity during dengue virus infection. NK cells 
can clear virally infected cells either by direct cytotoxicity or via antibody-dependent 
cell mediated cytotoxicity (ADCC) (Navarro-Sanchez et al., 2005). They are 
controlled by cytokines and chemokines released by DCs and macrophages in an early 
stage of infection. Basophil mast cells and neutrophiles are considered to be involved 
in dengue virus clearance. Their exact role has yet to be elucidated especially their 
interaction with endothelial cells, which might explain neutropenia and 
thrombocytopenia in DHF patients (Navarro-Sanchez et al., 2005). IFN-γ activated 
macrophages produce nitric oxid (NO) which has recently been shown to inhibit 
dengue replication in vitro (Charnsilpa et al., 2005). In addition, it has been suggested 
that overproduction of NO may enhance vascular permeability. Furthermore, TNF-α as 
well as IFN-α increase complement activation and the production of C3a and C5a 
which may have a significant impact on vascular permeability and therefore on disease 
outcome (Lei et al., 2001; Navarro-Sanchez et al., 2005). 
 
1.4.1.3 Antibody-Dependent Enhancement (ADE) 
 
Infection of one dengue serotype results in a life-long immunity to that serotype but 
not to heterologous serotypes. It is suggested that the cross-protective immunity 
against other serotypes is only active in the first several months after infection. This 
temporary cross-protection has recently been revealed as a major factor to explain 
currently observed transmission dynamics of dengue epidemics (Wearing and Rohani, 
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2006). By contrast, ADE has only a minor role in such transmission dynamics but it is 
still considered as an important immunological mechanism involved in disease 
outcome of secondary infections (Halstead, 2003) . 
 
ADE is caused by cross-reactive antibodies that are specific for the serotype of the 
primary infection, but are unable to neutralize the serotype of the secondary infection. 
Upon primary infection, neutralizing antibodies are mainly directed against the E 
glycoprotein (Kaufman et al., 1987) which is the main antigenic determinant but also 
prM (Kaufman et al., 1989) and NS1 epitopes (Wu et al., 2003) have been identified 
(Clyde et al., 2006). Following a secondary boost of the immune system, B-cells 
selected during a primary infection get activated and secrete cross-reactive antibodies. 
These non-neutralizing antibodies have still the ability to bind to the virus and allow 
rapid uptake of the virus by Fc-receptor bearing cells (Littaua et al., 1990). It is 
thought that ADE supports faster viral replication, resulting in greater viremia in an 
early stage of infection. 
 
1.4.1.4 Differences in Secondary T-Cell Responses 
 
The differences in T-cell responses during secondary infections may have an 
additional impact on viral clearance and immunopathogenesis. T-cell responses are 
predominately directed against NS3, NS1, NS2a and E protein. C and NS5 may also 
boost a T-cell response (Fink et al., 2006). Low affinity memory T-cells from a 
primary infection need small amounts of interferon to be stimulated and respond much 
faster than naïve T-cells. Their low-affinity is underlined by higher levels of TNF-α 
(increased inflammatory response) and lower levels of IFN-γ (impaired activation of 
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high-affinity T-cells) secreted by CD4 cells during heterologous infection (Green and 
Rothman, 2006). Furthermore, it was shown that CD8 T-cells boosted by a 
heterologous serotype are only able to induce lysis of the target cell but not to 
stimulate cytokine production (Zivny et al., 1999). This subsequently allows the 
infection to become established and leads to the apoptosis of high-affinity T-cells via 
the process of activation-induced cell death (AICD) (Fink et al., 2006; Mongkolsapaya 
et al., 2003). In summary, small numbers of T-cells at an early stage of infection may 
lead to survival of the virus and therefore to a higher viral load. Finally, the activated 
low-affinity T-cells have a share in cytokine release and tissue damage. It is suggested 
that dengue-mediated inhibition of interferon signalling may actively influence T-cell 
activity (Fink et al., 2006).  
 
ADE and the inadequate immune response caused by low affinity T-cells point 
towards a crucial role of the ‘original antigenic sin’ in disease outcome 
(Mongkolsapaya et al., 2003). One reported study states a clear association of high 
viremia titers peaking two days before defervescence with progression to DHF 
(Vaughn et al., 2000). A contradictory study implicates involvement of previous 
subclinical infection and not viral load in DHF progression (Yeh et al., 2006).  
However, only 4% of patients experience more severe manifestations during a 
secondary infection, making clear that additional factors including nutritional status, 
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1.4.1.5 Important Cytokines during Infection 
 
Not only interferon production is induced during dengue virus infection but a broad 
range of cytokines, mediators and soluble receptors (Fink et al., 2006; Green and 
Rothman, 2006). By way of example, it was shown that, in a first instance, peripheral 
blood monocytic cells (PBMC) release IFN-γ, TNF-α, IL-2 and IL-6 followed later on 
by the secretion of IL-4, IL-10 and IL-5 (Pacsa et al., 2000).  This points towards a 
switch of TH1 to TH2 response and leads to an imbalanced T-cell response and may 
enhance cytophatic effects. In general, a TH1 response mediates activation of infected 
monocytes enabling them to destroy intracellular pathogens whereas TH2 responses 
stimulate secretion of antibodies and are not sufficient for viral clearance. 
 
1.4.1.6 DHF/DSS: An Immune-Mediated Machanism 
 
A hallmark of DHF/DSS is vascular leakage and its appearance after significant 
reduction of viremia hints towards an immune-mediated mechanism (Green and 
Rothman, 2006). Vascular permeability is induced by various cytokines, e.g. TNF-α 
that may lead to permeability via cyclooxygenase (COX) and the release of 
prostanoids underlining the risk of using aspirin as a treatment (Fink et al., 2006).  
Furthermore, plasma leakage is accompanied by a marked thrombocytopenia. The 
mechanisms involved in platelet reduction are not fully understood but it is suggested 
that either anti-NS1 IgM antibodies can cross-react with platelets leading to their 
clearance in the presence of cytokines and complement (Lin et al., 2006) or that 
haematopoiesis is suppressed in the course of an infection (Murgue et al., 1998). 
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The discussed immunological response is complex and more studies are required to 
elucidate epidemiological, virological as well as immunological factors involved in 
dengue pathogenesis. This, in turn, will have a major contribution towards the ultimate 
goal of finding either a drug and/or a vaccine against dengue and towards a better 
understanding of the biology of dengue pathogenesis. 
 
1.4.1.7 Viral Determinants and Disease Outcome 
 
Besides host factors involved in disease pathogenesis, several studies suggest an active 
role of viral factors determining disease severity (Messer et al., 2002; Pandey and 
Igarashi, 2000; Rico-Hesse et al., 1997). Both different serotypes and mutational 
variations in strains are able to interfere with disease outcome, but clear correlations 
could not be shown (Balmaseda et al., 2006; Clyde et al., 2006; Vaughn et al., 2000). 
Differences in replication fitness based on sequence variation between serotypes and 
strains are thought to be a crucial factor leading to more severe disease (Holmes and 
Twiddy, 2003) which is underlined by the clear association of high viremia titers 
peaking two days before defervescence with progression to DHF (Vaughn et al., 
2000).  
 
A cross-sectional study recently compared DENV-1 to DENV-2 outbreak periods in 
Nicaragua and pointed out that DENV-1 outbreaks were associated with increased 
vascular permeability whereas DENV-2 infections resulted in more shock and internal 
haemorrhage (Balmaseda et al., 2006). Earlier studies indicated associations of certain 
genotypes of DENV-2 and DENV-3 to DHF versus DF. Firstly, it was shown that the 
Asian genotype of DENV-2 correlates with high virulence. This is underlined by 
61 
1. Introduction Investigating the 2005 Singaporean Dengue Outbreak
 
mutagenic studies of N390 of the E-protein  as well as exchange of 5’ and 3’ UTRs 
between Asian and American genotypes and shows an early replicative advantage of 
the Asian genotype in the host (Cologna et al., 2005; Leitmeyer et al., 1999). Secondly, 
Messer and collaborators identified a variant of DENV-3 genotype III as a possible 
factor in the emergence of DHF in Sri Lanka (Messer et al., 2003; Messer et al., 2002) 
 
It is clear that mutations in the 3’UTR have a major impact on viral fitness (Holmes 
and Twiddy, 2003), and existing directed repeats (DR) could affect virus transmission 
(Gritsun and Gould, 2006), but their impact on disease outcome is contradictory. 
Earlier studies mainly performed on DENV-2 suggested that specific mutations either 
resulting in altered secondary structures of 3’UTRs or in amino acid changes might be 
directly correlated to disease severity (Clyde et al., 2006; Leitmeyer et al., 1999; 
Pandey and Igarashi, 2000). However, recent evidence hints towards the activity of 
multiple gene loci involved in clinical outcome, and different 3’UTRs show only weak 
associations with viral virulence (Zhou et al., 2006). Therefore, it is unlikely that the 
3’UTR by itself represents the ultimate determinant of disease severity. This fact is 
further highlighted by a recent study investigating the 2004 Indonesian dengue 
outbreak. The analysis revealed high levels of genetic similarities to severe strains 
from Sumatra when looking at the whole genome rather than single mutations (M. 
Schreiber, personal communication). 
 
Therefore, it is evident that only complex host-pathogen interactions dependent on host 
and viral backgrounds are able to explain disease outcome. This synergy is also 
emphasized by results showing that some strains have the ability to inhibit interferon 
signalling (Chang et al., 2006). Recent observations suggest differences in ER stress 
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mediated response (Yu et al., 2006) and that, in general, flaviviral infections may lead 
to a lipid-raft mediated interference of the PI3K/AKT pathway, thus inhibiting 
apoptosis in an early stage of infection (Lee et al., 2005).   
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1.5 Aims of the Studies 
 
The overall purpose of this study was to investigate clinical parameters in dengue 
infection that would be useful in distinguishing dengue fever from other febrile 
illnesses and in predicting the extent of disease severity in an early stage of infection. 
Furthermore, we aimed at obtaining the full genome sequences of dengue virus isolates 
from the 2005 Singaporean outbreak to analyze them with regard to their phylogeny 
and to disease severity. 
 
More specifically we pursued the following four goals: 
 
• Finding of an appropriate model that distinguishes dengue fever from other 
febrile illnesses in an early stage of disease. 
 
• Identifying early clinical and immunological markers that would predict 
disease severity in dengue infections. 
 
• Sequencing of dengue viruses isolated during the 2005 Singaporean dengue 
outbreak and investigate them with regard to their phylogeny. 
 
• Characterizing of identified clades with regard to important markers 
established by the predictive model for dengue severity. 
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2.1 Analysis of Clinical Data 
 
2.1.1 Collection and Preprocessing of Clinical Data 
 
Clinical Data was collected during the 2005 Singaporean outbreak as part of the EDEN 
study. Briefly, 455 patients were enrolled into the study and a first blood and saliva 
sample was collected within 72 hours of illness (1st visit) (Figure 2.1). From the 133 
dengue positive patients, another sample on day four to seven of illness was collected 
on the 2nd visit and finally, a third sample was collected three to four weeks after onset 
of fever on the 3rd visit. The samples were analyzed using standard laboratory 
methods. For a more detailed description of the collection procedure please refer to the 
EDEN report (Low et al., 2006). 
 
 
Figure 2.1: Flowchart showing the sequence of events during the EDEN study (Low et al., 2006).  
 
The collected parameters included personal data, symptoms, clinical data as well as 
many more parameters of all the 455 patients recruited in the EDEN study and were 
summarized in one datasheet (CRF3) which was inconvenient for our analysis. 
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Furthermore, for hospitalized dengue patients (72 patients submitted to general 
hospitals and not private hospitals), more data was collected every day in hospital 
which was summarized in a separate datasheet (CRF4). The third raw datasheet 
represented the immunological information of 291 patients (95 dengue patients and 
196 cases with other febrile illnesses). Specific information used such as 
hospitalization status, viral load and additional immunological information was 
distributed over three other datasheets. For the purpose of analysis, it was necessary to 
sort, join and clean up the datasheets. Preprocessing of tables and replacement of 
missing values was performed using the program Inforsense (InforSense Ltd., London, 




Figure 2.2: Example of Inforsense (InforSense Ltd., London, UK), workflow used for data pre-
processing. 
 
2.1.1.1 Clinical Data used for Analyses 
 
For our analyses, we used 25 clinical parameters from the 1st visit, 24 clinical 
parameters from the 2nd visit along with 19 clinical parameters from the 3rd visit (Table 
2.3). In a first step, two main tables were generated including the clinical parameters 
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along with the identification number, serotype of the causative dengue virus, 
hospitalization status of the patient as well as our defined severity classification (see 
below): One table (EDEN_TOTAL) included the 1st visit data of 453 patients (2 
patients were excluded due to no follow up or were unlikely to have dengue fever) 
comprised of 133 dengue positive patients and 320 patients suffering from other febrile 
illnesses. The second table (DENGUE_TOTAL) included the 1st, 2nd and 3rd visit 
information of only the 133 dengue positive cases. In both tables, missing values were 
replaced by null values (Table 2.1). 
 
2.1.1.2 Clinical Data used for Severity Modeling 
 
From the created main table including the 133 dengue positive patients 
(EDEN_TOTAL), we generated a specific table for severity modeling. For this 
purpose, we categorized the patients into severe (low) and mild (high) cases based on a 
low platelet count using a threshold of <=50,000platelets/mm3 on either day five, six 
or seven of illness. The categorization was based on the hospitalized cases whereas the 
non-hospitalized patients were considered as mild cases and were directly classified as 
high. Seven patients of the hospitalized cases were excluded from the analysis because 
no samples were collected during hospital stay and one patient from the 72 patients 
with hospital information was excluded from the analysis due to no data on fever day 
five, six and seven. This resulted in a dataset (SEVERITY_TOTAL) including 125 
patients and was used for severity modeling. Missing values in the table were replaced 
by null values (Table 2.1). 
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2.1.1.3 Immunological and Clinical Data used for Analyses 
 
Three tables were generated including immunological (Table 2.2) as well as clinical 
data. From the 453 patients, immunological data was available for 291 enrolled 
patients (95 dengue positive cases and 196 patients suffering from other febrile 
illnesses). 162 patients were excluded from immunological modeling because no 
immunological data was measured. 
 
The first table (EDEN_IMMUN_TOTAL) joined the immunological information 
along with the clinical data into one table including all the 291 patients. A second table 
(DENGUE_IMMUN_TOTAL) included only the 95 dengue positive patients and the 
third table (SEVERITY_IMMUN_TOTAL) created from the severity table (125 cases) 
represented only 89 dengue patients (36 patients were excluded because there was no 
immunological information available) (Table 2.1). In all three tables, missing values 
were replaced with null values. 
 
It is important to note, that the read out of the standard test for the measurement of 
immunological parameters was the optical density. The different optical densities were 
then converted by the software to pg/ml cytokine, based on a series of optical densities 
from known human cytokine standards which provided a standard curve. A total of 8 
different concentrations was used in each run. Samples that were beyond the detection 
minimum resulted in a test value indicated as <low>. These <low> values were 
replaced by using the minimum value for each run and measured cytokine, thus not all 
<low> had the same values. The datasheet with all the <low> values replaced was used 
for further analysis (Eng Eong Ooi, personal communication). 
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2.1.1.4 Summary of Clinical and Immunological Data used for Analyses 
 
Table 2.1: Overview of generated tables which were eventually used for analyses. 1=1st visit; 2=2nd 
visit; 3=3rd visit. 
Table Name Cases Information included Description 
EDEN_TOTAL 453 Clinical Data 1  
DENGUE_TOTAL 133 Clinical Data 1, 2, 3  
SEVERITY_TOTAL 125 Clinical Data 1, 2, 3 PLT_CLASS (low/high) 
EDEN_IMMUN_TOTAL 291 Clinical & Cytokine Data 1  
DENGUE_IMMUN_TOTAL 95 Clinical & Cytokine Data 1, 2, 3  
SEVERITY_IMMUN_TOTAL 89 Clinical & Cytokine Data 1, 2, 3 PLT_CLASS (low/high) 
 
Table 2.2: Overview and explanation of the immunological parameters used for analyses. 1=1st visit; 
2=2nd visit; 3=3rd visit. 
Abbreviation Unit Explanation 
IP_10 1,2,3 [pg/ml] Interferon γ inducible protein 10 (IP-10) 
I_TAC 1,2,3 [pg/ml] Interferon inducible T cell α chemoattarctant (I-TAC) 
IFN_ALPHA 1,2,3 [pg/ml] Interferon α (IFN-α) 
GM_CSF 1,2,3 [pg/ml] Granulocyte macrophage colony-stimulating factor (GM-CSF) 
IFN_GAMMA 1,2,3 [pg/ml] Interferon-γ (IFN- γ) 
IL_1 1,2,3 [pg/ml] Interleukin-1 (IL-1) 
IL_10 1,2,3 [pg/ml] Interleukin-10 (IL-10) 
IL_12 1,2,3 [pg/ml] Interleukin-12 (IL-12) 
IL_2 1,2,3 [pg/ml] Interleukin-2 (IL-2) 
IL_4 1,2,3 [pg/ml] Interleukin-4 (IL-4) 
IL_6 1,2,3 [pg/ml] Interleukin-6 (IL-6) 
IL_8 1,2,3 [pg/ml] Interleukin-8 (IL-8) 
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Table 2.3: Overview and explanation of the clinical parameters used for analyses. 1=1st visit; 2=2nd 
visit; 3=3rd visit (NIH, 2007). 
Abbreviation Unit Explanation 
ID None Sample identification number 
TEMP 1,2 °C Body temperature 
PULSERATE 1,2 Beats per minute Pulse rate 
SYSTOLICBP 1,2 mmHg Systolic blood pressure 
DIASTOLICBP 1,2 mmHg Diastolic blood pressure 
WBC 1,2,3 Cells/microliter [x103] 
White blood cell count. It is almost always part of the CBC 
(complete blood count); Normal count is between 4,500-
10,000 white blood cells/µl. 
RBC 1,2,3 Cells/microliter [x106] 
Red Blood Cell count (varies with altitude): 
Male: 4.7 to 6.1 million cells/µl; Female: 4.2 to 5.4 million 
cells/µl 
HGB 1,2,3 Grams/deciliter Hemoglobin (varies with altitude): Male: 13.8 to 17.2 g/dL; Female: 12.1 to 15.1 g/dL 
HCT 1,2,3 Percentage [%] 
The hematocrit is the percent of whole blood that is 
composed of red blood cells. The hematocrit is a measure 
of both the number of red blood cells and the size of red 
blood cells; (varies with altitude): 
Male: 40.7 to 50.3 %; Female: 36.1 to 44.3 % 
MCV 1,2,3 Femtoliter MCV is the mean corpuscular volume or the average size of the red blood cells: Normal MCV: 80 to 100 femtoliter. 
MCH 1,2,3 Picograms/cell 
MCH is the mean corpuscular hemoglobin or the 
hemoglobin amount per red blood cell (MCH = 
HGB/RBC). 
Normal MCH: MCH: 27 to 31 picograms/cell 
MCHC 1,2,3 Grams/deciliter 
MCHC is the mean corpuscular hemoglobin concentration 
or the hemoglobin concentration (hemoglobin amount 
relative to the size of the cell) per red blood cell 
(HGB/HCT). 
Normal MCHC: 32 to 36 grams/deciliter 
PLT 1,2,3 Number/microliter [x103] 
PLT is the Platelet count or thrombocyte count. 
Normal PLT: 150,000 to 400,000/µl 
LYMPH_PCT 1,2,3 Percentage [%] The percentage of the WBC belonging to lymphocytes. Normal LYMPH_PCT: 20% to 40% of the WBC 
MXD_PCT 1,2,3 Percentage [%] 
The percentage of the WBC belonging to monocytes, 
eosinophiles & basophiles. 
Monocytes: 2%-8%; Eosinophils: 1%-4%; Basophils: 
0.5%-1% 
NEUT_PCT 1,2,3 Percentage [%] The percentage of the WBC belonging to neutrophiles. Normal NEUT_PCT: 40% to 60% of the WBC 
LYMPH_NO 1,2,3 Cells/microliter [x103] 
The absolute number of lymphocytes calculated by 
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Table 2.3 (continued): Overview and explanation of the clinical parameters used. 1=1st visit; 2=2nd 
visit; 3=3rd visit. 
Abbreviation Unit Explanation 
MXD_NO 1,2,3 Cells/microliter [x103] 
The absolute number of monocytes, eosinophiles & 
basophiles calculated by multiplying MXD_PCT with 
WBC. (MXD_PCT x WBC) 
NEUT_NO 1,2,3 Cells/microliter [x103] 
The absolute number of neutrophiles calculated by 
multiplying NEUT_PCT with WBC. (NEUT_PCT x 
WBC) 
RDW_CV 1,2,3 Percentage [%] 
Red blood cell distribution width is a measure of the 
variation of red blood cell volume that is reported as part 
of a standard complete blood count. Usually red blood 
cells are a standard size. It’s a coeffiecient of variation 
((Standard deviation of red cell volume/mean cell volume) 
× 100); Normal range: 11.5-14.5% 
RDW_SD 1,2,3 Percentage [%] Standard deviation of RDW_CV. 
PDW 1,2,3 Femtoliter Platelet distribution width. 
MPV 1,2,3 Femtoliter Mean platelet volume is a machine calculated measurement of the average size of the platelets. 
P_LCR_PCT 1,2,3 Percentage [%] Platelet Large Cell Ratio 
DV_PCR 1 None Detection of dengue Virus by PCR. (positive/negative) 
DV_IG_G 1 None Detection of dengue virus antibodies: marker for secondary infection. (positive=secondary/negative=primary) 
CT_COLLECTION 1 Number of cycles 
The Ct-value is the number of cycles used to reach a 
specific threshold in the RT-PCR. High Ct-value means a 
low amount of template and a low Ct-value represents a 
large amount of template. 
HOSPITALIZATION None Hospitalization status of dengue positive patients (yes/no). 
PLT_CLASS None 
Severity classification of patients defined with regard to 











2. Materials & Methods Investigating the 2005 Singaporean Dengue Outbreak 
 
2.1.2 Statistical Analyses used for the Description of Clinical and 
Immunological Data 
 
2.1.2.1 Univariate Analyses 
 
Shapiro-Wilk normality test was used to check for non-normally distributed parameters 
whereby a p value < 0.05 indicated that the parameter was unlikely to originate from a 
normal distribution. Non-normally distributed parameters were log-transformed and 
rechecked for normality. Cases with missing values were excluded from the analysis 
and thus, the number of cases used for calculations varied between different covariates. 
All calculations were performed using Systat® for Windows® (SYSTAT Software Inc., 
2004). 
 
If the log-transformation still resulted in non-normal distribution, non-parametric 
Kruskal-Willis test was used for continuous variables whereas Student’s t test was 
exploited for normally distributed continuous variables. For dichotomous variables, 
Chi-square test was used in case of expected frequencies that were higher than 5, 
whereas Fisher’s exact test was performed when the expected table values were 
smaller than 5. A two-tailed p value < 0.05 was considered as statistically significant. 
Cases with missing values were excluded from the analysis and thus, the number of 
cases used for calculations varied between different covariates. All statistical 
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Overall significant differences in clinical manifestations between identified viral 
clades were assessed by one-way ANOVA (analysis of variance). The Tukey post hoc 
test was used to calculate the pairwise probabilities between the clades and to finally 
identify the pairs that showed the highest level of significance. Cases with missing 
values were excluded from the analysis and thus, the number of cases used for 
calculations varied between different covariates. All statistical computations were 
performed using Systat® for Windows® (SYSTAT Software Inc., 2004). 
 
2.1.2.2 Multivariate Analyses 
 
Significant differences found by univariate analyses were further entered into 
multivariate analysis using a logistic regression model to identify genuine risk factors. 
The complete algorithm was chosen because we aimed at assessing the independent 
risk for all the entered variables. By contrast, the using of stepwise algorithms results 
in a model that includes only the most significant covariates. A two-tailed p value < 
0.05 was considered as statistical significant. Cases with missing values were excluded 
from the analysis. All statistical computations were performed using Systat® for 
Windows® (SYSTAT Software Inc., 2004). 
 
2.1.3 Decision Tree Analyses for Disease Modeling 
 
The thesis exploited decision trees as predictive models to either distinguish dengue 
from other febrile illnesses or to find an appropriate classification for dengue severity. 
Decision trees predicting categorical variables are normally referred as classification 
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trees whereas trees predicting continuous variables are called regression trees 
(TwoCrowsCorporation, 2005).  
 
Decision trees represent a powerful supervised learning tool commonly used in 
datamining and are used in medical decision analysis (Peters et al., 2006), in gene 
expression profiling (Schramm et al., 2005) as well as in molecular biology (Han et al., 
2006; Rhee et al., 2006). The top-down induction of decision trees is a simple and 
potent method of deducing classification rules from a set of labeled data (Quinlan, 
1993). At each node a decision rule is implemented that splits the data into two or 
more partitions. New nodes are created to handle each of the partitions and a node is 
considered terminal or a leaf node based on a stopping criterium. The advantages of 
using decision trees in knowledge discovery mainly lie in the simplicity as well as the 
ability to handle categorical and numerical values at the same time (Kothari and Dong, 
2000) 
 
There are several algorithms that are used for tree induction (Holsheimer and Siebes, 
1993; Kothari and Dong, 2000). In our case, calculations of classification trees were 
performed by using the efficient machine learning algorithm C4.5 which is an 
extension of the ID3 algorithm (Quinlan, 1993). ID3 stands for induction of decision 
trees and was developed in the first half of the eighties by Quinlan (Holsheimer and 
Siebes, 1993). It uses an information gain based node splitting where the attribute that 
minimizes the information needed in the resulting subtrees to classify the elements is 
selected. In other words, the algorithm takes the parameter as a splitting criterium 
which has the highest information gain and which reduces the existing data entropy the 
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most. The algorithm uses a greedy search meaning it chooses the best attribute at the 
moment and never looks back to reconsider earlier choices. 
 
Another interesting aspect of the C4.5 system is the integration of an extension that is 
able to handle missing values. Briefly, when coming across a missing attribute which 
is used for further splitting, the algorithm explores all the possible branches at this 
point and estimates the probability that this is the correct choice. Finally, the result of 
the classification is the class with the highest probability (Holsheimer and Siebes, 
1993; Quinlan, 1993). The ability to handle missing values represented another 
advantage of the used algorithm because during pre-processing of clinical and 
immunological data we encountered a substantial number of missing values. The C4.5 
system permitted us to make use of all the cases and thus, we did not have to exclude 
cases with missing values which is a common problem in multivariate analyses such us 
logistic regression and discriminant analysis (Acuna and Rodriguez, 2004). Decision 
tree modeling was performed in Inforsense (InforSense Ltd., London, UK) and the 
typical workflow used is shown  in Figure 2.3. 
 
 
Figure 2.3: Example of Inforsense (InforSense Ltd., London, UK) workflow used for the calculation of 
decision tree models. Briefly, the data was entered into the model node for decision tree induction. 
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2.1.3.1 Classifier Modeling 
 
Pre-processed data was entered into the model node for decision tree induction. We 
aimed at finding a decision tree that is simple to understand and that includes only the 
most important parameters for the addressed prediction task. For this purpose, we had 
to select both the variables which would serve as predictors and the target class. 
Furthermore, important tree parameters such as the splitting stopping criterium 
(minimal cases) and the parameter used for tree simplification (pruning confidence) 
had to be defined. 
 
In decision tree modeling, pruning of trees is used to remove branches that are not 
relevant for the generalization of the model and that are more likely to come from data 
overfitting. In Inforsense (InforSense Ltd., London, UK), the pruning confidence can 
be adjusted. For all the decision tree calculations the standard pruning confidence of 
25% was used meaning that branches were removed when the algorithm was 25% or 
less confident that the specific branch is not representative for generalization. The 
higher the pruning confidence is set, the lesser pruning is performed. 
 
The parameter ‘minimal cases’ represents a stopping criterium for the further partition 
of data at a specific decision node. Tree growing at a specific decision node is stopped 
when at least one class includes equal or less cases as the tree parameter ‘minimal 
cases’. This parameter is used to overcome noisy data and a higher value indicates a 
smaller tree resulting in the inclusion of probably the more important parameters and 
thus, the risk of data overfitting can be reduced. Choosing an appropriate value for 
‘missing cases’ was done using k-fold cross validation (see below). Briefly, various 
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decision trees with different ‘minimal cases’ were calculated and the value resulting in 
the tree with the best performance was chosen. 
 
2.1.3.2 Classifier Evaluation 
 
The calculated models were validated by using the approach of k-fold cross validation. 
The fold value was set to the standard k=10 and it was ensured that the order of data 
instances presented to the cross validation was class and data independent as well as 
ideally randomized. This was done by picking the standard options stratify and sort in 
the cross validation node. 
 
K-fold cross validation is considered to be a powerful methodology to overcome data 
overfitting and a study recommended using stratified ten-fold cross validation for 
model selection (Kohavi, 1995). Briefly, the original sample is divided into k 
subsamples. Each subsample is put aside as evaluation data for testing a model, and the 
remaining k-1 subsamples are used for training the model. The cross-validation 
process is repeated k times (folds) and each of the k subsamples is used once as the 
validation data. The k results obtained from the k folds can then be averaged to 
produce a single estimation of model performance (Moore, 2007) 
 
In Inforsense (InforSense Ltd., London, UK), the output of k-fold cross validation was 
a report including an overall evaluation of the ten folds as well as the exact details of 
every fold (Table 2.4). Moreover an averaged receiver operating characteristic curve 
(ROC curve) was constructed which is a commonly used tool to graphically evaluate 
classifier performance (Figure 2.4). Briefly, a decision tree is a probabilistic classifier 
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and for each classification made, a confidence value or a probability associated to the 
decision is obtained. By choosing a specific threshold, the cases are classified as 
positive in case the confidence value is greater than the threshold and negative if the 
confidence value is below the threshold. By varying this threshold, it is possible to 
compute the true positive rate (sensitivity) and the false negative rate for each of these 
thresholds which finally results in a ROC curve. ROC curves can then be used to judge 
the discrimination power of a calculated classification model. The area under the curve 
(AUC) represents a good indicator for the overall performance of a specific classifier 
(Fawcett, 2003; Hanley and McNeil, 1982). It is worthwhile mentioning, that not only 
AUCs can be used to choose the best classifier but depending on the situation, other 
calculated parameters such as profit of the model or the misclassification rate are better 
to use. However, we chose our classification trees based on the overall performance as 
well as on the sensitivity. The classifier which had the highest sensitivity along with a 
high AUC was selected. Furthermore, it was also important to have a classifier with a 
good discriminative power which was indicated by a low overall error rate and by a 
higher profit. By way of example, a model was considered inappropriate in case of 
having a high AUC but, in turn, a low sensitivity. The AUCs  of the chosen models 
were further investigated by calculating their confidence intervals which was based on 
the method described by Hanley and McNeil (Hanley and McNeil, 1982; McNeil and 
Hanley, 1984). The overall performance was considered not to be significantly 
different from the worst classifier when the confidence interval included 0.5. 
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Table 2.4: Explanation of the overall evaluation report obtained after k-fold cross-validation. 
Attribute Explanation Confusion Matrix 
Total 
misclassifications 
Number of misclassified 
cases after cross validation   Predicted Class 
Overall error rate Overall error rate of the model after cross validation   negative positive 
SE of error rate Estimated standard error of the overall error rate 









SE of profit Estimated standard error of the profit 
AUC negative 
Area under the curve of 
averaged ROC curve for the 

















Area under the curve of 
averaged ROC curve for the 
classification of positive 
cases 
 




Figure 2.4: A simplified receiver operating characteristic curve obtained by threshold averaging after k-
fold cross validation. The table at right shows twenty data and the score assigned to each by a scoring 
classifier. The black graph at left shows the corresponding ROC curve with each point labeled by the 
threshold that produces it. The green line indicates the ROC curve of an optimal classifier (100%), the 
red line represents the ROC curve for the worst classifier (50%) and the blue line shows a typical ROC 
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2.1.3.3 Epidemiological Analyses of Parameters included into the Models 
 
 
Finally, it was important to evaluate the chosen classifier with regard to their 
epidemiological values. This would give us a more realistic picture of which 
parameters included in the classification trees might represent genuine risks. For this 
purpose the odds ratio (OR) along with their confidence intervals and the relative risk 
(RR) for the chosen parameters with the defined threshold were calculated on the 
whole dataset as well as on the specific subgroups defined by the obtained decision 
rules. Statistical significance was assessed by using either Chi square test (for expected 
frequencies > 5) or Fisher’s exact test (for expected frequencies < 5). Cases with 
missing values were excluded from the analysis. All statistical computations were 
performed using Systat® for Windows® (SYSTAT Software Inc., 2004). 
 
The odds ratio (OR) is defined as the ratio of the odds of an event occurring in the 
exposed group to the odds of it occurring in the non-exposed group. An OR of 1 
indicates that the event is evenly likely to occur in both groups. An odds ratio OR > 1 
indicates that the event is more likely to occur in the exposed group and an OR < 1 
indicates that the event is more likely to occur in the non-exposed group (Rothman and 
Greenland, 1998).  
 
The relative risk (RR) is the risk of an event relative to exposure. RR is a ratio of the 
probability of the event occurring in the exposed group versus the probability of the 
event in the non-exposed group. A relative risk of 1 means that there is no risk 
difference between the two groups. A RR of < 1 indicates that the event is less likely to 
occur in the exposed group than in the non-exposed.  On the other hand, a RR of > 1 
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indicates the event is more likely to occur in the exposed group than in the non-
exposed group (Rothman and Greenland, 1998). 
 
2.1.3.4 Summary of generated Models included in the Thesis 
 
Table 2.5: Overview of calculated classification tree models. Model names were used throughout the 
results  and discussion sections. Namea: DENPRE=dengue prediction; HOSP=hospitalization 
prediction; SEVERE=severity prediction; SEVHOSP=severity prediction of hospitalized patients; 
EXCYT=excluding cytokine data; INCYTA=including cytokine data; INCYT=including cytokine data 
but excluding IFN-α; CYTOA=only including cytokine data; CYTO=only including cytokine data but 
excluding IFN-α. Datab: See Table 2.1; Prec=predictor: clin=clinical data; cyto=cytokine data. Targetd: 
denpcr=dengue PCR positive/negative; hosp=hospitalization yes/no; pltclass= platelet class low/high. 
Mine: tree parameter ‘minimum cases’.1=1st visit data; 2=2nd visit data. 
Namea & Number of Cases  Datab Prec Targetd Pruning Mine  
DENPRE_TOTAL_453 EDEN_TOTAL clin1 denpcr 25% 19 
DENPRE_EXCYT_291 EDEN_IMMUN_TOTAL clin1 denpcr 25% 9 
DENPRE_INCYTA_291 EDEN_IMMUN_TOTAL clin, cyto1 denpcr 25% 8 
DENPRE_INCYT_291 EDEN_IMMUN_TOTAL clin, cyto1 denpcr 25% 8 
DENPRE_CYTOA_291 EDEN_IMMUN_TOTAL cyto1 denpcr 25% 15 
DENPRE_CYTO_291 EDEN_IMMUN_TOTAL cyto1 denpcr 25% 14 
HOSP_TOTAL_133 DENGUE_TOTAL clin1,2 hosp 25% 12 
HOSP_EXCYT_95 DENGUE_IMMUN_TOTAL clin1,2 hosp 25% 5 
HOSP_CYTO_95 DENGUE_IMMUN_TOTAL clin, cyto1,2 hosp 25% 10 
SEVERE_TOTAL_125 SEVERITY_TOTAL clin1 pltclass 25% 16 
SEVERE_EXCYT_89 SEVERITY_IMMUN_TOTAL clin1 pltclass 25% 10 
SEVERE_INCYTA_89 SEVERITY_IMMUN_TOTAL clin, cyto1 pltclass 25% 10 
SEVERE_CYTOA_89 SEVERITY_IMMUN_TOTAL cyto1 pltclass 25% 23 
SEVHOSP_TOTAL_71 SEVERITY_TOTAL clin1 pltclass 25% 4 
SEVHOSP_EXCYT_52 SEVERITY_IMMUN_TOTAL clin1 pltclass 25% 4 
SEVHOSP_INCYTA_52 SEVERITY_IMMUN_TOTAL clin, cyto1 pltclass 25% 10 
SEVHOSP_CYTOA_52 SEVERITY_IMMUN_TOTAL cyto1 pltclass 25% 4 
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2.2 Full Length Genome Sequencing of Dengue Virus Isolates 
 
2.2.1 Preparative RT-PCR Step 
 
The process of sequencing was divided into several steps undertaken in collaboration 
with the respective research institutes (Figure 2.5) First, dengue virus isolated from 
RT-PCR positive samples was quantified by immuno fluorescence (IF) and propagated 
at the Environmental Health Institute (EHI). Secondly, virus was further passaged up 
to a titer of 105pfu/ml at the Novartis Institute for Tropical Diseases (NITD) followed 
by RNA extraction and the preparative RT-PCR step. Finally, amplified cDNA was 
sent to the Genome Institute of Singapore (GIS) for sequencing and concluding 
sequence analysis was performed at NITD as well as GIS. 
 
 
Figure 2.5: Flowchart of the EDEN sequencing project. Green represents the virus work at the 
Environmental Health Institute (EHI). Yellow indicates the virus work performed at the Novartis 
Institute for Tropical Diseases (NITD) followed by the RT-PCR step (dark yellow). Orange stands for 
the sequencing process at the Genome institute of Singapore which is followed by the sequence analysis 
at NITD and GIS (blue). The turquoise part is the in vitro validation of identified patterns. 
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2.2.1.1 Propagation of Virus 
 
Virus isolates received from EHI were propagated in C6/36 mosquito gut cells. Firstly, 
virus was inoculated onto C6/36 cells (MOI=0.01) that were split and seeded 24h 
before in RPMI1640 culture medium (10% fetal bovine serum and 1% penicillin-
streptomycin mixture). The cells used were estimated to be 5x107 in number. The virus 
was incubated with the cells in RPMI1640 medium (5% fetal bovine serum) for an 
hour at 28°C. The viral infection medium was removed and fresh medium RPMI1640 
culture medium (5% fetal bovine serum) was added. After an incubation of five days at 
28°C, the supernatant was harvested and 0.2 ml was used for the quantification of the 
virus titer by plaque assay. The rest of the supernatant was stored at -80°C. Isolates 
were propagated till a virus titer of >105pfu/ml and used for viral RNA extraction. 
 
2.2.1.2 Quantification of Virus by Plaque Assay 
 
Two hundred microliters of viral supernatants were inoculated onto 2x105 BHK21 cells 
seeded to each well of a 24 well-plate (RPMI1640 medium with 10% fetal bovine 
serum and 1% penicillin-streptomycin mixture). Virus and cells were incubated for an 
hour at 37°C. Afterwards, the inoculums were removed and wells were overlaid with 
0.8% methyl-cellulose in RPMI1640 medium containing 2% fetal bovine serum. After 
an incubation of four to six days at 37°C, 10% formaldehyde was added to each well. 
The contents of the wells were removed by gentle agitation of the wells and followed 
by addition of 1ml of 10% formaldehyde for 20 minutes at room temperature. Then, 
the well contents were removed and stained with 0.2 ml crystal violet for 20 minutes at 
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room temperature. Subsequently, the wells were washed with running water and dried 
at 70°C. 
2.2.1.3 Extraction of viral RNA and cDNA Synthesis 
 
RNA extraction was performed using the QIAamp Viral RNA Mini Kit (Qiagen Inc., 
CA, US). Isolated viral RNA was reverse transcribed into five overlapping fragments 
using serotype specific anti sense primers and Superscript III (Invitrogen Co., CA, US) 
as the reverse transcriptase. The reactions were performed on the GeneAMP® PCR 
System 9700 (Applied Biosystems, CA, US). Briefly, 6μl of isolated viral RNA was 
mixed with 1μl of 10mM dNTP and 1μl of 10μM serotype specific primers. The 
mixture was done depending on the fragment as well as the serotype and was filled up 
with RNAse free water to a volume of 13μl. The reaction mixture was incubated at 65 
°C for five minutes to denature the RNA secondary structure followed by the 
immediate shock reaction on ice for at least 1 min. After that, a second mixture of 4μl 
5x first strand buffer (Invitrogen), 1μl DTT (Invitrogen), 1μl RNAsin (Promega Co., 
VA, USA) and 1 μl Superscript III (Invitrogen) was added. The final reaction volume 
of 20μl was first heated up to 25 °C for five minutes and afterwards to 42°C for an 
hour allowing cDNA synthesis. Finally, the reaction was inactivated at 70 °C for 15 
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Table 2.6: Overview of RT-Conditions for cDNA synthesis of DENV-1 & DENV-3. 
Serotype Fragment RT Conditions 



































































Table 2.7: Overview of RT-Primers for cDNA synthesis of DENV-1 & DENV-3. 
Serotype Fragment Primer Sequence Nucleotide Position 
DENV-1 F1 d1a17 5'-CCAATGGCYGCTGAYAGTCT 2540-2559 
 F2 d1a13a 5’-CCTACTTGGGACCTGCCCA 4611-4629 
  d1a13b 5’-GGGACCTGCCCAACAGTCCT 4603-4622 
  d1a13c 5’-TGCCCAACAGTCCTCTCTGC 4597-4616 
 F3 d1a9 5'-CCAGTYARCACAGCTATCAAAGC 6551-6573 
 F4 d1a4 5'-CACTCCACTGAGTGAATTCTCTCT 9068-9091 
 F5 d1a23 5'-AGAACCTGTTGATTCAACAG 10716-10735 
DENV-3 F1 d3a18 5'-GATTCCTATCGCAATGCATG 2361-2380 
 F2 d3a14 5'-ACTGTGATCATTAARTTGTGGGA 4334-4356 
 F3 d3a10 5'-GCYGCAAARTCCTTGAATTCCT 6339-6360 
 F4 d3a6 5'-GCATTRACATGTCGRGTTCC 8342-8361 
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2.2.1.4 Amplification of cDNA by Polymerase Chain Reaction 
 
Polymerase chain reaction was performed using the GeneAMP® PCR System 9700 
(Applied Biosystems). The cDNA of the five fragments was amplified by PCR using 
pfu Turbo polymerase (Stratagene, CA, US) and 10 serotype specific primers. Briefly, 
2μl of cDNA was mixed together with 39μl of water, 5μl 10x pfu buffer (Stratagene), 
1 μl of 10mM dNTP as well as with either 1μl (fragments 1, 2, 3 & 4 for DENV-1 and 
DENV-3), 1μl (fragment 5 for DENV-3) or 10μl (fragment 5 for DENV-1) serotype 
specific sense as well as serotype specific anti sense primers. Finally, 1μl of pfu Turbo 
polymerase (Stratagene) was added to amplify the overlapping fragments under 
fragment specific conditions. The ramp speed [°C/s] was set to the maximum, except 
the amplification of fragment 5 of DENV-1 used 9600 as the ramp speed (Table 2.8; 
Table 2.9). The PCR products were analyzed on a 1% agarose gel and the correct 
bands were cut out, gel purified using the QIAquick Gel Extraction Kit (Quiagen) 
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Table 2.8: Overview of PCR conditions for the amplification of DENV-1 & DENV-3; Shading 
indicates the PCR cycles. 
Serotype Fragment PCR Conditions 
DENV-1 F1 35 cycles 
95°C 95°C 55°C 
2 min 30 sec 1 min 
72°C 





 F2 35 cycles 
95°C 95°C 58°C 
2 min 30 sec 1 min 
72°C 





 F3 35 cycles 
95°C 95°C 55°C 
2 min 30 sec 1 min 
72°C 





 F4 35 cycles 
95°C 95°C 58°C 
2 min 30 sec 1 min 
72°C 





 F5 40 cycles 
95°C 95°C 55°C 







DENV-3 F1 45 cycles 
95°C 95°C 55°C 
2 min 30 sec 1 min 
72°C 





 F2 45 cycles 
95°C 95°C 55°C 
2 min 30 sec 1 min 
72°C 





 F3 45 cycles 
95°C 95°C 63.1°C 
2 min 30 sec 1 min 
72°C 





 F4 45 cycles 
95°C 95°C 55°C 
2 min 30 sec 1 min 
72°C 





 F5 45 cycles 
95°C 95°C 55°C 
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Table 2.9: Overview of PCR Primers for the amplification of DENV-1 & DENV-3. 
Serotype Fragment Primer Sequence Nucleotide Position 
DENV-1 F1 d1a17 5'-CCAATGGCYGCTGAYAGTCT 2540-2559 
  d1s22 5’-AGTTGTTAGTCTACGTGGAC 1-20 
 F2 d1a13 5'-TTCCACTTCYGGAGGGCT 4544-4561 
  d1s6 5'-GGYTCTATAGGAGGRGTGTTCAC 2201-2223 
 F3 d1a9 5'-CCAGTYARCACAGCTATCAAAGC 6551-6573 
  d1s10 5'-RGCYGGSCCACTAATAGCT 4213-4231 
 F4 d1a4 5'-CACTCCACTGAGTGAATTCTCTCT 9068-9091 
  d1s14 5'-ATGGRGAAAGGAACAACCAG 6216-6235 
 F5 d1a23 5'-AGAACCTGTTGATTCAACAG 10716-10735 
  d1s18c 5’-GGTGAGTCCTCTCCAAACCC 8015-8034 
DENV-3 F1 d3a18 5'-GATTCCTATCGCAATGCATG 2361-2380 
  d3s23 5’-AGTTGTTAGTCTACGTGGAC 1-20 
 F2 d3a14 5'-ACTGTGATCATTAARTTGTGGGA 4334-4356 
  d3s5 5'-TGAACCTCCTTTTGGGGAA 2035-2053 
 F3 d3a10 5'-GCYGCAAARTCCTTGAATTCCT 6339-6360 
  d3s9 5'-GAAAACAGATTGGCTCCCAA 4030-4049 
 F4 d3a6 5'-GCATTRACATGTCGRGTTCC 8342-8361 
  d3s13 5'-CCAGCTCTCTTTGAACCAGAAA 6032-6053 
 F5 d3a23 5’-AGAACCTGTTGATTCAACAG 10688-10707 
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2.2.2 Phylogenetic Analyses of Dengue Virus Genomes 
 
2.2.2.1 Sequencing Process, Assembly and Quality Control 
 
The sequencing of the amplified cDNA products were performed at GIS. Sequencing 
of PCR products were carried out using the BigDye Terminator Cycle Sequencing 
Ready Reaction Kit (Applied Biosystems). Briefly, for every sequencing reaction, 
approximately 40 ng of purified PCR product and 3.2 pmol of primers were added into 
a BigDye Terminator v3.1 master mix. The mixture was then subjected to multiple 
cycles of PCR in the Eppendorf Mastercycler ep real-time PCR system and cleaned 
with CleanSEQ (Agencourt Bioscience, MA, US) before being analyzed with an 
Applied Biosystems 3730xl DNA Analyzer. The sequences were assembled and edited 
using SeqScape® version 2.5 from Applied Biosystem. 
 
2.2.2.2 Sequence Alignment and Phylogentic Analyses 
 
The nucleotide sequences were aligned with ClustalW-MPI (Li, 2003). Phylogenetic 
trees were inferred via the Minimum Evolution method and the Tamura-Nei genetic 
distance (Tamura and Nei, 1993) implemented within MEGA 3.1 (Kumar et al., 2004). 
Branch topology was verified by generating 1000 bootstraps from the sample 
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3.1 Decision Tree Analyses of Clinical Data 
 
3.1.1 Distinguishing Dengue Fever from other febrile Illnesses 
 
Data were collected as part of the EDEN study during the 2005 Singaporean Dengue 
Outbreak. In total, 455 patients showing manifestations of febrile illness were recruited 
and 133 of them were PCR confirmed dengue positive cases (Low et al., 2006). 
Dengue patients showed significant differences to the control group regarding a lower 
platelet count, a decreased white blood cell count and lower absolute number of 
lymphocytes as well as of neutrophiles. Seventy-nine (59.4 %) of the dengue positive 
patients were hospitalized whereas only four (1.2%) amongst the controls needed 
hospital care. From the 133 dengue positive cases, there were fifty-seven (42.9%) who 
experienced a secondary infection which was indicated by a positive result for IgG 
antibodies at the first visit. There was no significant difference between secondary and 
primary infections in terms of hospitalization (49.4% versus 50.6%) but logistic 
regression identified smaller absolute numbers of lymphocytes, decreased platelet 
count and a higher viral load as genuine risk factors for hospitalization. 
 
3.1.1.1 Dengue Prediction based on Clinical Data 
 
The first results of decision tree modeling were based on the rationale of identifying 
markers that indicate dengue infection in an early stage of disease. For this purpose, 
we aimed at predicting a dengue PCR positive result by using clinical data collected on 
the 1st visit (average length of illness at around 42 hours) which finally resulted in a 
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dataset including the information of 453 patients. Two patients were excluded because 
of either a false positive PCR result or because the patient was unlikely to have dengue 
fever. Missing values were replaced by null, pruning confidence was set to the 
standard 25% and the tree parameter “minimum cases” was set to 19. The calculated 
tree (DENPRE_TOTAL_453) (Figure 3.1) used WBC_1<=4.8 (OR: 25.84; 95%CI: 
24.14, 27.54), LYMPH_NO_1<=0.8 (OR: 16; 95%CI: 13.30, 18.70), 
LYMPH_NO_1<=0.5 (OR: 26.88; 95%CI: 24.39, 29.37) and finally TEMP_1>38.5 
(OR: 8.23; 95%CI: 4.44, 12.01)1 as splitting criteria to identify dengue positive cases 
(Table 3.1; Table 3.2). The tree correctly classified 400 (88%) of the patients with a 
sensitivity of 82% and a specificity of 91% (Table 3.3; Figure 3.2). The overall error 
rate estimated after k-fold cross validation (k=10) was 12%. The ROC curve had an 
area under the curve (AUC) of 0.90 for positive (95%CI: 0.86, 0.94) as well as 
negative (95%CI: 0.87, 0.93) cases. The optimal classifier at a defined threshold for 
negative and positive cases had an average profit of 0.766.  
 
In addition, we checked for the influence of symptoms on the classifier performance 
especially to investigate whether one would be able to define dengue disease by only 
characterizing the patients in terms of symptoms. Using symptoms alone was not at all 
predictive and resulted in a poor classifier performance (data not shown). We further 
observed that, when we included symptoms and clinical data for dengue prediction, the 
tree did not take into account any symptoms and the calculated tree was identical to the 
tree exclusively based on clinical data (data not shown). 
 
 
                                                 
1 WBC=white blood cell count; LYMPH_NO=absolute number of lymphocytes; TEMP=body 
temperature; 1=1st visit data; OR=odds ratio; CI=confidence interval 
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ROOT
133 positives / 320 NEGATIVES
WBC_1 <= 4.8
104 POSITIVES / 39 negatives
WBC_1 > 4.8
29 positives / 281 NEGATIVES
LYMPH_NO_1 <= 0.5
21 positives / 25 NEGATIVES
LYMPH_NO_1 > 0.5
8 positives / 256 NEGATIVES
LYMPH_NO_1 <= 0.8
96.80 POSITIVES / 18 negatives
LYMPH_NO_1 > 0.8
7.20 positives / 21 NEGATIVES
TEMP_1 <= 38.5
5 positives / 18 NEGATIVES
TEMP_1 > 38.5
16 POSITIVES / 7 negatives
 
Figure 3.1: DENPRE_TOTAL_453: Decision tree for dengue prediction calculated on 453 patients 
excluding cytokine data. WBC=white blood cell count; LYMPH_NO=absolute numbers of lymphocytes; 
TEMP=body temperature; 1=1st visit data. 
 
Table 3.1: DENPRE_TOTAL_453: Decision tree for dengue prediction calculated on 453 patients 
excluding cytokine data. Statistical analysis of splitting criteria performed on the whole dataset; 
WBC=white blood cell count; LYMPH_NO=absolute numbers of lymphocytes; TEMP=body 
temperature; 1=1st visit data; RR=relative risk; OR=odds ratio; CI=confidence interval.  
Decision Node Feature RR OR 95% CI (OR) p value 
WBC_1 [*1000 cells/mm3] 
Cut-off  value <= 4.8 7.77 25.84 24.14, 27.54 < 0.001 
LYMPH_NO_1 [*1000 cells/mm3] 
Cut-off value <= 0.8 12.27 28.55 26.65, 30.46 < 0.001 
LYMPH_NO_1 [*1000 cells/mm3] 
Cut-off value <= 0.5 5.00 14.73 13.08, 16.38 < 0.001 
TEMP_1 [°C] 
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Table 3.2: DENPRE_TOTAL_453: Decision tree for dengue prediction calculated on 453 patients 
excluding cytokine data. Statistical analysis of splitting criteria performed on each subgroup at the 
decision nodes. WBC=white blood cell count; LYMPH_NO=absolute numbers of lymphocytes; 
TEMP=body temperature; 1=1st visit data; RR=relative risk; OR=odds ratio; CI=confidence interval. 
Decision Node Feature RR OR 95% CI (OR) p value 
WBC_1 [*1000 cells/mm3] 
Cut-off  value <= 4.8 7.77 25.84 24.14, 27.54 < 0.001 
LYMPH_NO_1 [*1000 cells/mm3] 
Cut-off value <= 0.8 3.37 16 13.30, 18.70 < 0.001 
LYMPH_NO_1 [*1000 cells/mm3] 
Cut-off value <= 0.5 15.07 26.88 24.39, 29.37 < 0.001 
TEMP_1 [°C] 
Cut-off value > 38.5 3.20 8.23 4.44, 12.01 0.003 
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Table 3.3: DENPRE_TOTAL_453: Summary of K-fold (k=10) cross validation for dengue prediction 
based on 453 patients excluding cytokine data.  
Overall Evaluation Value (n=453) Confusion Matrix 
Total 
misclassifications 53.0    Predicted Class 
Overall error rate 11.691%    neg pos 
SE of error rate 8.247  






SE of profit 0.165  













AUC positive 0.9013 95%CI: 0.86, 0.94 
 
    
 
 
Figure 3.2: DENPRE_TOTAL_453: Receiver operating characteristics (ROC) curve for dengue 
prediction calculated on 453 patients excluding cytokine data. 
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3.1.1.2 Dengue Prediction based on Cytokine and Clinical Data 
 
In a second attempt we examined whether we would be able to improve the 
classification tree by including available cytokine data represented by IP_10_1, 
IFN_ALPHA_1, I_TAC_1, GM_CSF_1, IL_1_1, IL_10_1, IL_12_1, IL_2_1, IL_4_1, 
IL_6_1, IL_8_1 and TNF_12. For this analysis, only 291 patients (p(positive)=0.36; 
p(negative)=0.64) were included due to lack of required information in the remaining 
162 patients. As a comparison, a tree excluding the cytokine data was first constructed 
by using a pruning confidence of 25% and 9 as the “minimum cases”. The resulting 
tree (DENPRE_EXCYT_291) (Figure 3.3) used the same splitting criteria as the first 
tree constructed on the whole dataset of 453 patients. Besides WBC_1<=4.8 (OR: 
26.24; 95%CI: 24.33, 28.16), LYMPH_NO_1<=0.8 (OR: 19.44; 95%CI: 15.27, 
23.62), LYMPH_NO_1<=0.5 (OR: 42.12; 95%CI: 38.96, 45.25) and TEMP_1>38.5 
(OR: 9.33; 95%CI: 1.51, 17.15), the tree additionally included LYMPH_NO_1<=0.3 
(OR: 4.89; 95%CI: -1.06, 10.83) as a splitting criteria for dengue cases (Table 3.4; 
Table 3.5)3. It correctly classified 252 (85%) of the patients with a sensitivity of 79% 
and a specificity of 90% (Table 3.6; Figure 3.4). The AUC of the ROC curve was 0.91 
and was equal regarding the classification accuracy for positive (95%CI: 0.87, 0.95) 
and negative (95%CI: 0.88, 0.94) cases. K-fold cross validation (k=10) resulted in an 
average profit of the model of 0.731.  
 
 
                                                 
2 IP_10=interferon-inducible protein 10; IFN_ALPHA=interferon-α; I_TAC=interferon-inducible T cell 
α chemoattractant; GM_CSF=granulocyte macrophage colony-stimulating factor; IL_1=interleukin-1; 
IL_10=interleukin-10; IL_12=interleukin-12; IL_2=interleukin-2; IL_4=interleukin-4; 
IL_6_1=interleukin-6; IL_8=interleukin-8; TNF=tumor necrosis factor α; 1=1st visit data 
3 WBC=white blood cell count; LYMPH_NO=absolute numbers of lymphocytes; TEMP=body 
temperature; 1=1st visit data; OR=odds ratio; CI=confidence interval. 
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ROOT
95 positives / 196 NEGATIVES
WBC_1 <= 4.8
73 POSITIVES / 22 negatives
WBC_1 > 4.8
22 positives / 174 NEGATIVES
LYMPH_NO_1 <= 0.5
17 POSITIVES / 13 negatives
LYMPH_NO_1 > 0.5
5 positives / 161 NEGATIVES
LYMPH_NO_1 <= 0.8
70 POSITIVES / 12 negatives
LYMPH_NO_1 > 0.8
3 positives / 10 NEGATIVES
LYMPH_NO_1 > 0.3
9 positives / 11 NEGATIVES
LYMPH_NO_1 <= 0.3
8 POSITIVES / 2 negatives
TEMP_1 <= 38.5
2 positives / 8 NEGATIVES
TEMP_1 > 38.5
7 POSITIVES / 3 negatives
 
 
Figure 3.3: DENPRE_EXCYT_291: Decision tree for dengue prediction calculated on 291 patients 
excluding cytokine data. WBC=white blood cell count; LYMPH_NO=absolute numbers of lymphocytes; 
TEMP=body temperature; 1=1st visit data. 
 
Table 3.4: DENPRE_EXCYT_291: Decision tree for dengue prediction calculated on 291 patients 
excluding cytokine data. Statistical analysis of splitting criteria performed on the whole dataset. 
WBC=white blood cell count; LYMPH_NO=absolute numbers of lymphocytes; TEMP=body 
temperature; 1=1st visit data; RR=relative risk; OR=odds ratio; CI=confidence interval. 
Decision Node Feature RR OR 95% CI (OR) p value 
WBC_1 [*1000 cells/mm3] 
Cut-off  value <= 4.8 6.85 26.24 24.33, 28.16 < 0.001 
LYMPH_NO_1 [*1000 cells/mm3] 
Cut-off value <= 0.8 16.00 42.17 39.75, 44.60 < 0.001 
LYMPH_NO_1 [*1000 cells/mm3] 
Cut-off value <= 0.5 5.61 21.06 19.16, 22.95 < 0.001 
LYMPH_NO_1 [*1000 cells/mm3] 
Cut-off value <= 0.3 3.72 32.7 29.30, 36.05 < 0.001 
TEMP_1 [°C] 
Cut-off value > 38.5 2.26 2.26 2.03, 5.45 < 0.001 
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Table 3.5: DENPRE_EXCYT_291: Decision tree for dengue prediction calculated on 291 patients 
excluding cytokine data. Statistical analysis of splitting criteria performed on each subgroup at the 
decision nodes. WBC=white blood cell count; LYMPH_NO=absolute numbers of lymphocytes; 
TEMP=body temperature; 1=1st visit data; RR=relative risk; OR=odds ratio; CI=confidence interval. 
Decision Node Feature RR OR 95% CI (OR) p value 
WBC_1 [*1000 cells/mm3] 
Cut-off  value <= 4.8 6.85 26.24 24.33, 28.16 < 0.001 
LYMPH_NO_1 [*1000 cells/mm3] 
Cut-off value <= 0.8 3.70 19.44 15.27, 23.62 < 0.001 
LYMPH_NO_1 [*1000 cells/mm3] 
Cut-off value <= 0.5 18.81 42.12 38.96, 45.25 < 0.001 
LYMPH_NO_1 [*1000 cells/mm3] 
Cut-off value <= 0.3 1.78 4.89 -1.06, 10.83 0.119 
TEMP_1 [°C] 
Cut-off value > 38.5 3.50 9.33 1.51, 17.15 0.07 
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Table 3.6: DENPRE_EXCYT_291: Summary of K-fold (k=10) cross validation for dengue prediction 
based on 291 patients excluding cytokine data.  
Overall Evaluation Value (n=291) Confusion Matrix 
Total 
misclassifications 39.0    Predicted Class 
Overall error rate 13.437%    neg pos 
SE of error rate 8.054  






SE of profit 0.161  













AUC positive 0.9088 95%CI: 0.87, 0.95 
 
    
 
 
Figure 3.4: DENPRE_EXCYT_291: Receiver operating characteristics (ROC) curve for dengue 
prediction calculated on 291 patients excluding cytokine data. 
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Finally, a tree constructed including the cytokine data (DENPRE_INCYTA_291) 
(Figure 3.5) used IFN_ALPHA_1>389.21 (OR: 79.54; 95%CI: 76.61, 82.48), 
IL_2_1<=2.24 (OR: 131.59; 95%CI: 123.65, 139.53), WBC<=4.1 (OR: 109.2; 95%CI: 
105.23, 113.17) and IL_1_1>2.62 (OR: 45.0; 95%CI: 33.87, 56.13)4 as splitting 
criteria (Table 3.7; Table 3.8) and had an overall error rate of 7.9%. Tree parameters 
such as pruning confidence were left at 25% and “minimum cases” was set to 8. It 
showed a sensitivity of 84% respectively a specificity of 96% and the AUC was 0.92 
for positive (95%CI: 0.89, 0.96) as well as negative (95%CI: 0.90, 0.95) cases, with an 
average profit of 0.842 (Table 3.9; Figure 3.6).  
ROOT
95 positives / 196 NEGATIVES
IFN_ALPHA_1 > 389.21
58.43 POSITIVES / 4 negatives
IFN_ALPHA_1 <= 389.21
36.57 positives / 192 NEGATIVES
IL_2_1 >  2.24
22.57 positives / 192 NEGATIVES
IL_2_1 <= 2.24
14 POSITIVES / 0 negative
WBC_1 <= 4.1
18.79 POSITIVES / 10 negatives
WBC_1 > 4.1
3.79 positives / 182 NEGATIVES
IL_1_1 <= 2.62
3 positives / 9 NEGATIVES
IL_1_1 > 2.62
15.79 POSITIVES / 1 negative
 Figure 3.5: DENPRE_INCYTA_291: Decision tree for dengue prediction calculated on 291 patients 
including cytokine and clinical data. IFN_ALPHA=interferon-α; IL_2=interleukin-2; WBC=white blood 
cell count; IL_1=interleukin-1; 1=1st visit data. 
                                                 
4 IFN_ALPHA=interferon-α; IL_2=interleukin-2; WBC=white blood cell count; IL_1=interleukin-1; 
1=1st visit data; OR=odds ratio; CI=confidence interval. 
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Table 3.7: DENPRE_INCYTA_291: Decision tree calculated on 291 patients including cytokine and 
clinical data. Statistical analysis of splitting criteria performed on the whole dataset. In case of 0 values 
in the original contingency table, OR calculations were adjusted by adding 1 to each table value +1. 
IFN_ALPHA=interferon-α; IL_2=interleukin-2; WBC=white blood cell count; IL_1=interleukin-1; 
1=1st visit data; RR=relative risk; OR=odds ratio; CI=confidence interval. 
Decision Node Feature RR OR 95% CI (OR) p value 
IFN_ALPHA_1 [pg/ml] 
Cut-off value > 389.21 6.07 79.54 76.61, 82.47 < 0.001 
IL_2_1[pg/ml] +1 
Cut-off value <= 2.24 3.77 84.01 76.53, 91.50 < 0.001 
WBC_1 [*1000 cells/mm3] 
Cut-off value <= 4.1 5.51 28.81 26.75, 30.86 < 0.001 
IL_1_1 [pg/ml] 
Cut-off value > 2.62 4.30 7.28 5.36, 9.19 < 0.001 
 
Table 3.8: DENPRE_INCYTA_291: Decision tree calculated on 291 patients including cytokine and 
clinical data. Statistical analysis of splitting criteria performed on each subgroup at the decision nodes. 
In case of 0 values in the original contingency table, OR calculations were adjusted by adding 1 to each 
table value+1. IFN_ALPHA=interferon-α; IL_2=interleukin-2; WBC=white blood cell count; 
IL_1=interleukin-1; 1=1st visit data; RR=relative risk; OR=odds ratio; CI=confidence interval. 
Decision Node Feature RR OR 95% CI (OR) p value 
IFN_ALPHA_1 [pg/ml] 
Cut-off value > 389.21 6.07 79.54 76.61, 82.47 < 0.001 
IL_2_1 [pg/ml] +1 
Cut-off value <= 2.24 9.16 131.59 123.65, 139.53 < 0.001 
WBC_1 [*1000 cells/mm3] 
Cut-off value <= 4.1 39.64 109.20 105.23, 113.17 < 0.001 
IL_1_1 [pg/ml] 
Cut-off value > 2.62 3.75 45.00 33.87, 56.13 < 0.001 
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Table 3.9: DENPRE_INCYTA_291: Summary of K-fold (k=10) cross validation for dengue prediction 
based on 291 patients including cytokine and clinical data.  
Overall Evaluation Value (n=291) Confusion Matrix 
Total 
misclassifications 23.0    Predicted Class 
Overall error rate 7.908%    neg pos 
SE of error rate 4.323  






SE of profit 0.086  













AUC positive 0.9245 95%CI: 0.89, 0.96 
 
    
 
 
Figure 3.6: DENPRE_INCYTA_291: Receiver operating characteristics (ROC) curve for dengue 
prediction calculated on 291 patients including cytokine and clinical data. 
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Considering the fact that interferon-α levels are a general indicator of RNA virus 
infections we aimed at getting a more detailed picture by excluding this parameter 
from the decision tree analysis. Interestingly, the resulting classifier (pruning 
confidence was left at 25% and minimum cases was set to 8) (DENPRE_INCYT_291) 
(Figure 3.7) was able to correctly classify 270 (92.78%) of the patients with a 
sensitivity of 90%, a specificity of 94% and an overall error rate of 7.2% (Table 3.12; 
Figure 3.8). The first split was represented by IL_2_1<=2.54 and patients below this 
threshold were very likely to be dengue positive (OR: 88.21; 95%CI: 80.73, 95.68). 
The other arm of the tree which was represented by higher levels of IL_2_1 was 
further separated by WBC_1<=4.8 (OR: 29.38; 95%CI: 27.28, 31.47) into dengue 
positive cases which were additionally categorized by using LYMPH_NO_1<=0.8 
(OR: 20.83; 95%CI: 15.66, 26.01), IFN_GAMMA_1>9.33 (OR: 26.25; 95%CI: 20.80, 
31.70) and WBC_1<=3.2 (OR: 63.0; 95%CI: 44.04, 81.96) as characteristics for 
positive cases5 (Table 3.10; Table 3.11). Patients showing WBC>4.8 were further split 
into dengue positive cases by using IP_10_1>1490 (OR: 68.57; 95%CI: 63.65, 73.49) 
and TNF_1<=4.08 (OR: 36.0; 95%CI: 25.69, 46.31) as cut off values. The overall 
classifier performance was 0.94 for positive (95%CI: 0.91, 0.98) as well as negative 
cases (95%CI: 0.92, 0.97) and the overall profit averaged 0.856. 
                                                 
5 IL_2=interleukin-2; WBC_1=white blood cell count; LYMPH_NO=absolute number of lymphocytes; 
IFN_GAMMA=interferon-γ; IP_10=interferon-inducible protein 10; TNF=tumor necrosis factor α; 
1=1st visit data; OR=odds ratio; CI=confidence interval. 
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ROOT
95 positives / 196 NEGATIVES
IL_2_1 <= 2.54
29 POSITIVES / 0 negative
IL_2_1 >  2.54
66 positives / 196 NEGATIVES
WBC_1 <= 4.8
52 POSITIVES / 22 negatives
WBC_1 > 4.8
14 positives / 174 NEGATIVES
LYMPH_NO_1 <=0.8
50 POSITIVES / 12 negatives
LYMPH_NO_1 > 0.8
2 positives / 10 NEGATIVES
IFN_GAMMA_1 > 9.33
42 POSITIVES / 2 negatives
IFN_GAMMA <= 9.33
8 positives / 10 NEGATIVES
IP_10_1 > 1490.0
12 positives / 14 NEGATIVES
IP_10_1 <= 1490.0
2 positives / 160 NEGATIVES
TNF_1 <= 4.8
12 POSITIVES / 3 negatives
TNF_1 > 4.8
0 positive / 11 NEGATIVES
WBC_1 <= 3.2
7 POSITIVES / 1 negative
WBC_1 > 3.2
1 positive / 9 NEGATIVES
 
Figure 3.7: DENPRE_INCYT_291: Decision tree for dengue prediction calculated on 291 patients 
including cytokine (excl. IFN_ALPHA_1) and clinical data. IL_2=interleukin-2; WBC_1=white blood 
cell count; LYMPH_NO=absolute number of lymphocytes; IFN_GAMMA=interferon-γ; 
IP_10=interferon-inducible protein 10; TNF=tumor necrosis factor α; 1=1st visit data. 
 
Table 3.10: DENPRE_INCYT_291: Decision tree for dengue prediction calculated on 291 patients 
including cytokine (excl. IFN_ALPHA_1) and clinical data. Statistical analysis of splitting criteria 
performed on the whole dataset. In case of 0 values in the original contingency table, OR calculations 
were adjusted by adding 1 to each table value+1. IL_2=interleukin-2; WBC_1=white blood cell count; 
LYMPH_NO=absolute number of lymphocytes; IFN_GAMMA=interferon-γ; IP_10=interferon-
inducible protein 10; TNF=tumor necrosis factor α; 1=1st visit data; RR=relative risk; OR=odds ratio; 
CI=confidence interval. 
Decision Node Feature RR OR 95% CI (OR) p value 
IL_2_1[pg/ml] +1 
Cut-off value <= 2.54 3.81 88.21 80.73, 95.68 < 0.001 
WBC_1 [*1000 cells/mm3] 
Cut-off value <= 4.8 6.85 26.24 24.33, 28.16 < 0.001 
WBC_1 [*1000 cells/mm3] 
Cut-off value <= 3.2 4.60 83.69 79.42, 87.95 < 0.001 
LYMPH_NO_1 [*1000 cells/mm3] 
Cut-off value <= 0.8 16.00 42.17 39.75, 44.60 < 0.001 
IFN_GAMMA_1 [pg/ml] 
Cut-off value > 9.33 1.58 1.94 0.27, 3.61 0.011 
IP_10_1 [pg/ml] 
Cut-off value > 1490.0 5.19 20.73 18.05, 22.65 < 0.001 
TNF_1 [pg/ml] 
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Table 3.11: DENPRE_INCYT_291: Decision tree calculated on 291 patients excluding including 
cytokine (excl. IFN_ALPHA_1) and clinical data. Statistical analysis of splitting criteria performed on 
each subgroup at the decision nodes. In case of 0 values in the original contingency table, OR 
calculations were adjusted by adding 1 to each table value+1. IL_2=interleukin-2; WBC_1=white blood 
cell count; LYMPH_NO=absolute number of lymphocytes; IFN_GAMMA=interferon-γ; 
IP_10=interferon-inducible protein 10; TNF=tumor necrosis factor α; 1=1st visit data; RR=relative risk; 
OR=odds ratio; CI=confidence interval. 
Decision Node Feature RR OR 95% CI (OR) p value 
IL_2_1[pg/ml] +1 
Cut-off value <= 2.54 3.81 88.21 80.73, 95.68 < 0.001 
WBC_1 [*1000 cells/mm3] 
Cut-off value <= 4.8 9.44 29.38 27.28, 31.47 < 0.001 
WBC_1 [*1000 cells/mm3] 
Cut-off value <= 3.2 8.75 63.00 44.04, 81.96 0.003 
LYMPH_NO_1 [*1000 cells/mm3] 
Cut-off value <= 0.8 4.84 20.83 15.66, 26.01 < 0.001 
IFN_GAMMA_1 [pg/ml] 
Cut-off value > 9.33 2.15 26.25 20.80, 31.70 < 0.001 
IP_10_1 [pg/ml] 
Cut-off value > 1490.0 37.38 68.57 63.65, 73.49 < 0.001 
TNF_1 [pg/ml] +1 
Cut-off value <= 4.8 9.75 36.00 25.69, 46.31 < 0.001 
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Table 3.12: DENPRE_INCYT_291: Summary of K-fold (k=10) cross validation for dengue prediction 
based on 291 patients including cytokine and clinical data (excl. IFN_ALPHA_1).  
Overall Evaluation Value (n=291) Confusion Matrix 
Total 
misclassifications 21.0    Predicted Class 
Overall error rate 7.207%    neg pos 
SE of error rate 3.765  






SE of profit 0.075  













AUC positive 0.9442 95%CI: 0.91, 0.98 
 
    
 
 
Figure 3.8: DENPRE_INCYT_291: Receiver operating characteristics (ROC) curve for dengue 
prediction calculated on 291 patients including cytokine (excl. IFN_ALPHA_1) and clinical data. 
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3.1.1.3 Dengue Prediction based on Cytokine Data 
 
We also addressed the question whether it would be possible to classify dengue 
patients by only using the cytokine data. The first constructed tree 
(DENPRE_CYTOA_291) (Figure 3.9) showed a sensitivity of 84% and a specificity of 
94% which resulted in an overall error rate of 9.28% (27 cases). The average profit of 
the model was 0.814 and the positive AUC was 0.92 (95%CI: 0.88, 0.96). The 
negative AUC had also a value of 0.92 (95%CI: 0.89, 0.95) (Table 3.15; Figure 3.10). 
The first split of the tree was represented by IFN_ALPHA_1>389.21 (OR: 79.54; 
95%CI: 76.61, 82.47) for dengue positive cases. Patients showing lower levels of 
IFN_ALPHA_1 were further sub divided by IL_2_1<=2.72 (OR: 63.33; 95%CI: 58.63, 
68.03) which represented a higher risk for patients to be dengue positive. Classification 
of cases having IL_2_1>2.72 additionally needed IL_10_1>9.14 (OR: 16.10; 95%CI: 
13.34, 18.85) as well as TNF_1<=4.33 (OR: 32.5; 95%CI: 23.07, 41.93) as splitting 
criteria 6 (Table 3.13; Table 3.14). 
ROOT
95 positives / 196 NEGATIVES
IFN_ALPHA_1 > 389.21
58.43 POSITIVES / 4 negatives
IFN_ALPHA_1 <= 389.21
36.57 positives / 192 NEGATIVES
IL_2_1 >  2.72
20.57 positives / 190 NEGATIVES
IL_2_1 <= 2.72
16 POSITIVES / 2 negatives
IL_10_1 > 9.14
14.57 positives / 21 NEGATIVES
IL_10_1 <= 9.14
6 positives / 169 NEGATIVES
TNF_1 <= 4.33
13.57 POSITIVES / 6 negatives
TNF_1 > 4.33
1 positive / 15 NEGATIVES
 
Figure 3.9: DENPRE_CYTOA_291: Decision tree for dengue prediction calculated on 291 patients 
only using cytokine data. IFN_ALPHA=interferon-α; IL_10=interleukin-10; IL_2=interleukin-2; 
TNF=tumor necrosis factor α; 1=1st visit data. 
                                                 
6 IFN_ALPHA=interferon-α; IL_10=interleukin-10; IL_2=interleukin-2; TNF=tumor necrosis factor α; 
1=1st visit data; OR=odds ratio; CI=confidence interval. 
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Table 3.13: DENPRE_CYTOA_291: Decision tree for dengue prediction calculated on 291 patients 
only including cytokine data. Statistical analysis of splitting criteria performed on the whole dataset. 
IFN_ALPHA=interferon-α; IL_10=interleukin-10; IL_2=interleukin-2; TNF=tumor necrosis factor α; 
1=1st visit data; RR=relative risk; OR=odds ratio; CI=confidence interval. 
Decision Node Feature RR OR 95% CI (OR) p value 
IFN_ALPHA_1 [pg/ml] 
Cut-off value > 389.21 6.07 79.54 76.61, 82.47 < 0.001 
IL_2_1 [pg/ml]  
Cut-off value <= 2.72 3.69 42.62 38.32, 46.93 < 0.001 
IL_10_1 [pg/ml]  
Cut-off value > 9.14 2.80 6.33 4.49, 8.16 < 0.001 
TNF_1 [pg/ml] 
Cut-off value <= 4.33 11.49 23.93 21.53, 26.33 < 0.001 
 
Table 3.14: DENPRE_CYTOA_291: Decision tree for dengue prediction calculated on 291 patients 
only including cytokine data. Statistical analysis of splitting criteria performed on each subgroup at the 
decision nodes. IFN_ALPHA=interferon-α; IL_10=interleukin-10; IL_2=interleukin-2; TNF=tumor 
necrosis factor α; 1=1st visit data; RR=relative risk; OR=odds ratio; CI=confidence interval. 
Decision Node Feature RR OR 95% CI (OR) p value 
IFN_ALPHA_1 [pg/ml] 
Cut-off value > 389.21 6.07 79.54 76.61, 82.47 < 0.001 
IL_2_1 [pg/ml] 
Cut-off value <= 2.72 8.79 63.33 58.63, 68.03 < 0.001 
IL_10_1 [pg/ml] 
Cut-off value > 9.14 10.06 16.10 13.34, 18.85 < 0.001 
TNF_1  
Cut-off value <= 4.33 10.95 32.50 23.07, 41.93 < 0.001 
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Table 3.15: DENPRE_CYTOA_291: Summary of K-fold (k=10) cross validation for dengue prediction 
based on 291 patients only including cytokine data.  
Overall Evaluation Value (n=291) Confusion Matrix 
Total 
misclassifications 27.0    Predicted Class 
Overall error rate 9.276%    neg pos 
SE of error rate 5.637  






SE of profit 0.113  













AUC positive 0.9193 95%CI: 0.88, 0.96 
 
    
 
 
Figure 3.10: DENPRE_CYTOA_291: Receiver operating characteristics (ROC) curve for dengue 
prediction calculated on 291 patients only including cytokine data. 
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Finally, we calculated a tree (minimum cases set to 14; pruning confidence set to 25%) 
based on only the cytokine data and excluding IFN_ALPHA_1 
(DENPRE_CYTO_291) (Figure 3.11). This resulted in a correct classification of 264 
(90.72%) of the cases with a sensitivity of 84% and a specificity 94% (Table 3.18; 
Figure 3.12). The overall performance of the tree was slightly worse compared to the 
inclusion of IFN_ALPHA_1 with an AUC for positive (95%CI: 0.87, 0.95) and 
negative (95%CI: 0.88, 0.94) cases of 0.91 but had the same average profit of 0.814. 
IL_2_1<=2.54 (OR: 88.21; 95%CI: 80.73, 95.68) was chosen as the first splitting 
criteria whereby cases below this threshold were more likely to have dengue. On the 
other hand, patients having higher levels of IL_2_1 were further classified into positive 
cases by taking IP_10_1>878.7 (OR: 29.12; 95%CI: 26.77, 31.46) and TNF_1<=4.29 
(OR: 25.75; 95%CI: 22.68, 28.82) as characteristics for dengue infections 7 (Table 
3.16; Table 3.17).    
ROOT
95 positives / 196 NEGATIVES
IL_2_1 <= 2.54
29 POSITIVES / 0 negative
IL_2_1 >  2.54
66 positives / 196 NEGATIVES
IP_10_1 <= 878.7
7 positives / 152 NEGATIVES
IP_10_1 > 878.7
59 POSITIVES / 44 negatives
TNF_1 > 4.29
5 positives / 31 NEGATIVES
TNF_1 <= 4.29
54 POSITIVES / 13 negatives
 
Figure 3.11: DENPRE_CYTO_291: Decision tree for dengue prediction calculated on 291 patients only 
including cytokine data (excl. IFN_ALPHA_1). IL_2=interleukin-2; IP_10=interferon-inducible protein 
10; TNF=tumor necrosis factor α; 1=1st visit data. 
                                                 
7 IL_2=interleukin-2; IP_10=interferon-inducible protein 10; TNF=tumor necrosis factor α; 1=1st visit 
data. OR=odds ratio; CI=confidence interval. 
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Table 3.16: DENPRE_CYTO_291: Decision tree for dengue prediction calculated on 291 patients only 
including cytokine data (excl. IFN_ALPHA_1). Statistical analysis of splitting criteria performed on the 
whole dataset. In case of 0 values in the original contingency table, OR calculations were adjusted by 
adding 1 to each table value +1. IL_2=interleukin-2; IP_10=interferon-inducible protein 10; TNF=tumor 
necrosis factor α; 1=1st visit data; RR=relative risk; OR=odds ratio; CI=confidence interval. 
Decision Node Feature RR OR 95% CI (OR) p value 
IL_2_1 [pg/ml] +1  
Cut-off value <= 2.54 3.81 88.21 80.73, 95.68 < 0.001 
IP_10_1 [pg/ml] 
Cut-off value > 878.7 10.67 29.36 27.28, 31.45 < 0.001 
TNF_1 [pg/ml] 
Cut-off value <= 4.29 11.65 24.45 22.05, 26.86 < 0.001 
 
Table 3.17: DENPRE_CYTO_291: Decision tree for dengue prediction calculated on 291 patients only 
including cytokine data (excl. IFN_ALPHA_1). Statistical analysis of splitting criteria performed on 
each subgroup at the decision nodes. In case of 0 values in the original contingency table, OR 
calculations were adjusted by adding 1 to each table value+1. IL_2=interleukin-2; IP_10=interferon-
inducible protein 10; TNF=tumor necrosis factor α; 1=1st visit data; RR=relative risk; OR=odds ratio; 
CI=confidence interval. 
Decision Node Feature RR OR 95% CI (OR) p value 
IL_2_1 [pg/ml] +1 
Cut-off value <= 2.54 3.81 88.21 80.73, 95.68 < 0.001 
IP_10_1 [pg/ml] 
Cut-off value > 878.7 13.01 29.12 26.77, 31.46 < 0.001 
TNF_1 [pg/ml] 
Cut-off value <= 4.29 5.80 25.75 22.68, 28.82 < 0.001 
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Table 3.18: DENPRE_CYTO_291: Summary of K-fold (k=10) cross validation for dengue prediction 
based on 291 patients only including cytokine data (excl. IFN_ALPHA_1).  
Overall Evaluation Value (n=291) Confusion Matrix 
Total 
misclassifications 27.0    Predicted Class 
Overall error rate 9.287%    neg pos 
SE of error rate 5.415  






SE of profit 0.108  













AUC positive 0.9132 95%CI: 0.87, 0.95 
 
    
 
 
Figure 3.12: DENPRE_CYTO_291: Receiver operating characteristics (ROC) curve for dengue 
prediction calculated on 291 patients only including cytokine data (excl. IFN_ALPHA_1). 
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3.1.2 Prediction of Disease Severity in Dengue Patients 
 
3.1.2.1 Prediction of Hospitalization based on Clinical Data 
 
Besides distinguishing between dengue and non-dengue patients, we also elucidated 
whether we can identify any severity related differences within the 133 dengue 
positive patients. In a first attempt, we tried to classify dengue patients by using 
hospitalization (yes/no) as the outcome. A first tree (HOSP_TOTAL_133) was 
calculated including the total dataset and missing values were replaced by null. The 
pruning confidence was set to the standard 25% whereas the “minimum cases” was 
defined to 12. Using PLT_2<=84.0 (OR: 75.87; 95%CI: 68.25, 83.49), 
LYMPH_NO_1<=0.7 (OR: 15.97; 95%CI: 8.00, 23.94) and TEMP_2<=37.0 (OR: 
11.73; 95%CI: 8.44, 15.02)8 as splitting criteria (Table 3.19; Table 3.20), the tree 
(Figure 3.13) correctly identified 107 (80.45%) of the cases which accounted for an 
overall error rate of 19.45% (Table 3.21; Figure 3.14). The tree had a higher sensitivity 
(85%) but, in turn, a lower specificity (74%) and the profit averaged 0.611. The overall 
accuracy of the tree was high with an AUC of 0.91 for the classification of yes 
(95%CI: 0.86, 0.96) and no (95%CI: 0.85, 0.97) cases. Due to our interest in finding 
early markers of severity of dengue infection we tried to predict hospitalization by 
only using data from the first visit, but the model did not result in a reliable prediction 
(data not shown). 
                                                 
8 PLT=platelet count; LYMPH_NO=absolute number of lymphocytes; TEMP=body temperature; 1=1st 
visit data; 2=2nd visit data; OR=odds ratio; CI=confidence interval. 
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ROOT
79 YES / 54 low
PLT_2 <= 84.0
47.75 YES / 2.26 no
PLT_2 > 84.0
31.25 yes / 51.74 NO
LYMPH_NO_1 <= 0.7
31.25 yes / 35.74 NO
LYMPH_NO_1 > 0.7
0 yes / 16 NO
TEMP_2 <= 37.0
7.64 yes / 26.93 NO
TEMP_2 > 37.0
23.60 YES / 8.81 no
 
Figure 3.13: HOSP_TOTAL_133: Decision tree for hospitalization calculated on 133 patients 
excluding cytokine data. PLT=platelet count; LYMPH_NO=absolute number of lymphocytes; 
TEMP=body temperature; 1=1st visit data; 2=2nd visit data. 
 
Table 3.19: HOSP_TOTAL_133: Decision tree for hospitalization calculated on 133 patients excluding 
cytokine data. Statistical analysis of splitting criteria performed on the whole dataset. PLT=platelet 
count; LYMPH_NO=absolute number of lymphocytes; TEMP=body temperature; 1=1st visit data; 2=2nd 
visit data; RR=relative risk; OR=odds ratio; CI=confidence interval. 
Decision Node Feature RR OR 95% CI (OR) p value 
PLT_2 [*1000/mm3] 
Cut-off  value <= 84 2.53 75.87 68.25, 83.49 < 0.001 
LYMPH_NO_1 [*1000 cells/mm3] +1 
Cut-off value <= 0.7 2.76 6.15 3.21, 9.09 0.001 
TEMP_2 [°C] 
Cut-off value > 37.0 1.61 3.60 1.44, 5.77 0.001 
 
Table 3.20: HOSP_TOTAL_133: Decision tree for hospitalization calculated on 133 patients excluding 
cytokine data. Statistical analysis of splitting criteria performed on each subgroup at the decision nodes. 
In case of 0 values in the original contingency table, OR calculations were adjusted by adding 1 to each 
table value +1. PLT=platelet count; LYMPH_NO=absolute number of lymphocytes; TEMP=body 
temperature; 1=1st visit data; 2=2nd visit data; RR=relative risk; OR=odds ratio; CI=confidence interval. 
Decision Node Feature RR OR 95% CI (OR) p value 
PLT_2 [*1000/mm3] +1 
Cut-off  value <= 84 2.53 75.87 68.25, 83.49 < 0.001 
LYMPH_NO_1 [*1000 cells/mm3] +1 
Cut-off value <= 0.7 8.72 15.97 8.00, 23.94 < 0.001 
TEMP_2 [°C] 
Cut-off value > 37.0 3.50 11.73 8.44, 15.02 < 0.001 
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Table 3.21: HOSP_TOTAL_133: Summary of K-fold (k=10) cross validation for prediction of 
hospitalization based on 133 patients excluding cytokine data. 
Overall Evaluation Value (n=133) Confusion Matrix 
Total 
misclassifications 26.0    Predicted Class 
Overall error rate 19.451%    no yes 
SE of error rate 10.962  






SE of profit 0.219  













AUC yes 0.9067 95%CI: 0.86, 0.96 
 
    
 
 
Figure 3.14: HOSP_TOTAL_133: Receiver operating characteristics (ROC) curve for prediction of 
hospitalization calculated on 133 patients excluding cytokine data. 
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3.1.2.2 Prediction of Hospitalization based on Cytokine and Clinical Data 
 
In a next step, we investigated the question whether using cytokine data can improve 
the model for hospitalization. Hence, we first calculated a tree (pruning confidence set 
to 25% and “minimum cases” set to 5) only using the information of 95 patients and 
excluding the cytokine data. This tree was the reference tree to investigate the effect of 
cytokines on the prediction of hospitalization. The remaining 38 patients were 
excluded from the analysis due to no available cytokine data. The resulting tree 
(HOSP_EXCYT_95) (Figure 3.15) showed a sensitivity of 81% and a specificity of 
70% with an overall error rate of 22.778% which reflected a correct classification of 73 
cases (Table 3.24; Figure 3.16). The overall performance was worse than the accuracy 
of the tree constructed on all the 133 dengue patients and the AUC of the ROC curve 
was 0.85 (95%CI: 0.76, 0.93) for classification of non-hospitalized cases and 0.85 
(95%CI: 0.77, 0.92) for the prediction of hospitalized cases. The probabilistic classifier 
had an average profit of 0.544. The tree chose different decision nodes and thresholds 
unlike the tree calculated on the total dataset of 133 patients (Figure 3.13). PLT_2 
(OR: 16.88; 95%CI: 14.04, 19.71) was still chosen as the first splitting criteria but with 
a slightly higher threshold of <=116 for hospitalized cases. Patients having a higher 
platelet count than the defined threshold were additionally divided by PULSERATE_1 
(OR: 26.00; 95%CI: 14.63, 37.37) whereby patients equal or below the threshold 75.00 
were more likely to be hospitalized 9 (Table 3.22; Table 3.23).  
                                                 
9 PLT=platelet count; PULSERATE=pulse rate; 1=1st visit data; 2=2nd visit data; OR=odds ratio; 
CI=confidence interval. 
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ROOT
58 YES / 37 no
PLT_2 <= 116
49.20 YES / 8 no
PLT_2 > 116
8.80 yes / 29 NO
PULSERATE_1 <= 75.0
4 YES / 1 no
PULSERATE > 75.0
4.80 yes / 28 NO
 
Figure 3.15: HOSP_EXCYT_95: Decision tree for hospitalization calculated on 95 patients excluding 
cytokine data. PLT=platelet count; PULSERATE=pulse rate; 1=1st visit data; 2=2nd visit data. 
 
Table 3.22: HOSP_EXCYT_95: Decision tree for hospitalization calculated on 95 patients excluding 
cytokine data. Statistical analysis of splitting criteria performed on the whole dataset. PLT=platelet 
count; PULSERATE=pulse rate; 1=1st visit data; 2=2nd visit data; RR=relative risk; OR=odds ratio; 
CI=confidence interval. 
Decision Node Feature RR OR 95% CI (OR) p value 
PLT_2 [*1000/mm3] 
Cut-off  value <= 116 3.65 16.88 14.04, 19.71 < 0.001 
PULSERATE_1 [beats/min] 
Cut-off value <= 75.0 1.40 3.21 -1.70, 8.13 0.193 
 
Table 3.23: HOSP_EXCYT_95: Decision tree calculated on 95 patients excluding cytokine data. 
Statistical analysis of splitting criteria performed on each subgroup at the decision nodes. PLT=platelet 
count; PULSERATE=pulse rate; 1=1st visit data; 2=2nd visit data; RR=relative risk; OR=odds ratio; 
CI=confidence interval. 
Decision Node Feature RR OR 95% CI (OR) p value 
PLT_2 [*1000/mm3] 
Cut-off  value <= 116 3.65 16.88 14.04, 19.71 < 0.001 
PULSERATE_1 [beats/min] 
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Table 3.24: HOSP_EXCYT_95: Summary of K-fold (k=10) cross validation for prediction of 
hospitalization based on 95 patients excluding cytokine data. 
Overall Evaluation Value (n=95) Confusion Matrix 
Total 
misclassifications 22.0    Predicted Class 
Overall error rate 22.778%    no yes 
SE of error rate 11.139  






SE of profit 0.223  













AUC yes 0.8481 95%CI: 0.77, 0.92 
 
    
 
 
Figure 3.16: HOSP_EXCYT_95: Receiver operating characteristics (ROC) curve for prediction of 
hospitalization calculated on 95 patients excluding cytokine data. 
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In a second step, a tree using cytokine as well as clinical data was calculated. A small 
change in classifier performance (data not shown) could be observed but the splitting 
criteria remained the same. The tree had an overall performance of 0.86 for 
hospitalized (95%CI: 0.78, 0.93) as well as non-hospitalized (95%CI: 0.77, 0.94) cases 
with a higher sensitivity (83%) and a lower specificity (68%). The overall profit of the 
tree accounted for 0.542.  
 
3.1.2.3 Prediction of Hospitalization based on Cytokine Data 
 
The little improvement with the splitting criteria remaining the same, suggested a 
minor effect of the cytokine data that was worthwhile investigating. For this purpose, a 
second classification tree (pruning confidence was set to 25% and minimum cases was 
defined as 10) which was based only on cytokine data was constructed which turned 
out to be rather difficult. Nevertheless, a tree (HOSP_CYTO_95) (Figure 3.17)  
including IP_10_1<=1697.9 (OR: 7.09; 95%CI: 4.56, 9.61), IL_1_1<=7.06 (OR: 8.82; 
95%CI: 0.07, 17.58), TNF_1>1.68 (OR: 5.78; 95%CI: -0.08, 11.63) and IL_12_2>15.9 
(OR: 7.88; 95%CI: 0.75, 15.00)10 as splitting criteria (Table 3.25; Table 3.26) had the 
best overall performance and an AUC of 0.69 for hospitalized (95%CI: 0.58, 0.79) as 
well as non-hospitalized (95%CI: 0.57, 0.80) cases. It showed an error rate of 26.1% 
with a sensitivity of 81% plus a specificity of 63% and the model accounted for an 
average profit of 0.478 (Table 3.27; Figure 3.18).  
 
 
                                                 
10 IP_10=interferon-inducible protein 10; IL_1=interleukin-10; TNF=tumor necrosis factor α; 
IL_12=interleukin-12; 1=1st visit data; 2=2nd visit data; OR=odds ratio; CI=confidence interval. 
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ROOT
58 YES / 37 no
IP_10_1 > 1697.9
42 YES / 10 no
IP_10_1 <= 1697.9
16 yes / 27 NO
IL_1_1 <= 7.06
15 yes / 17 NO
IL_1_1 > 7.06
1 yes / 10 NO
TNF_1 <= 1.68
2 yes / 8 NO
TNF_1 > 1.68
13 YES / 9 no
IL_12_2 <= 15.9
4 yes / 7 NO
IL_12_2 > 15.9
9 YES / 2 no
Figure 3.17: HOSP_CYTO_95: Decision tree for hospitalization calculated on 95 patients only 
including cytokine data. IP_10=interferon-inducible protein 10; IL_1=interleukin-10; TNF=tumor 
necrosis factor α; IL_12=interleukin-12; 1=1st visit data; 2=2nd visit data. 
 
Table 3.25: HOSP_CYTO_95: Decision tree for hospitalization calculated on 95 patients only including 
cytokine data. Statistical analysis of splitting criteria performed on the whole dataset. IP_10=interferon-
inducible protein 10; IL_1=interleukin-10; TNF=tumor necrosis factor α; IL_12=interleukin-12; 1=1st 
visit data; 2=2nd visit data; RR=relative risk; OR=odds ratio; CI=confidence interval. 
Decision Node Feature RR OR 95% CI (OR) p value 
IP_10_1 [pg/ml] 
Cut-off value > 1697.9 2.17 7.09 4.56, 9.61 < 0.001 
IL_1_1 [pg/ml] 
Cut-off value <= 7.06 1.45 2.30 -0.42, 5.02 0.098 
TNF_1 [pg/ml] 
Cut-off value > 1.68 1.18 1.52 -0.85, 3.88 0.343 
IL_12_2 [pg/ml] 
Cut-off value > 15.9 1.01 1.02 -1.37, 3.41 0.968 
 
Table 3.26: HOSP_CYTO_95: Decision tree for hospitalization calculated on 95 patients only including 
cytokine data. Statistical analysis of splitting criteria performed on each subgroup at the decision nodes. 
IP_10=interferon-inducible protein 10; IL_1=interleukin-10; TNF=tumor necrosis factor α; 
IL_12=interleukin-12; 1=1st visit data; 2=2nd visit data; RR=relative risk; OR=odds ratio; 
CI=confidence interval. 
Decision Node Feature RR OR 95% CI (OR) p value 
IP_10_1 [pg/ml] 
Cut-off value > 1697.9 2.17 7.09 4.56, 9.61 < 0.001 
IL_1_1 [pg/ml] 
Cut-off value <= 7.06 5.16 8.82 0.07, 17.58 0.033 
TNF_1 [pg/ml] 
Cut-off value > 1.68 2.95 5.78 -0.08, 11.63 0.060 
IL_12_2 [pg/ml] 
Cut-off value > 15.9 2.25 7.88 0.75, 15.00 0.080 
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Table 3.27: HOSP_CYTO_95: Summary of K-fold (k=10) cross validation for prediction of 
hospitalization based on 95 patients only including cytokine data. 
Overall Evaluation Value (n=95) Confusion Matrix 
Total 
misclassifications 25.0    Predicted Class 
Overall error rate 26.111%    no yes 
SE of error rate 10.776  






SE of profit 0.216  













AUC yes 0.6867 95%CI: 0.58, 0.79 
 
    
 
 
Figure 3.18: HOSP_CYTO_95: Receiver operating characteristics (ROC) curve for prediction of 
hospitalization calculated on 95 patients only including cytokine data. 
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3.1.2.4 Using a Platelet Count <=50,000/mm3 as a Marker of Severity 
 
Although we were able to classify the 133 patients into hospitalized and non-
hospitalized groups, we wanted to further investigate disease severity because of 
several reasons. First, parameters chosen by the calculated classifier included data 
collected on 2nd visit which corresponded to the day of hospitalization and the 
calculated trees excluding the cytokine data included parameters such as platelet count 
and body temperature which were probably used by the treating doctors to decide for 
hospitalization. Second, we aimed at having early markers of severity that are 
represented by data from the 1st collection. Both trees excluding the cytokine data only 
included either the absolute numbers of lymphocytes or the pulse rate as first visit data 
and strikingly, excluding the 2nd visit platelet count from the analysis was not at all 
predictive. On the other hand, the classification tree based only on cytokine data 
included three first visit parameters but did not result in a reliable classification 
meaning that the two groups were overlapping in terms of cytokines. Third, 
hospitalization is biased due to its dependency on the treating doctor as well as on the 
patient and therefore, it is not a good, indicative categorization for severity. This was 
underlined by the fact that the calculated trees showed different splitting and threshold 
criteria pointing towards instability of classifier performance. Fourth, we could 
naturally assume that hospitalized cases felt sicker but on the other hand, the chance to 
become hospitalized might be higher as soon as the patient did not feel well. Hence, 
hospitalization might also be considered as a safety measure. Fifth, the ratio of 
hospitalized to non-hospitalized cases was 1.46 and probably did not represent the real 
severity situation in the 2005 Singaporean dengue outbreak. 
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To address the above mentioned concerns arisen from hospitalization and to improve 
severity prediction, we decided to take the platelet count as a marker of severity. 
Therefore, we first analyzed the 133 dengue patients regarding their platelet count 
during the course of infection. From the 71 hospitalized patients that were submitted to 
general hospitals, blood count as well as other clinical parameters were daily measured 
and the average platelet count at each day was plotted regarding length of illness 
(Figure 3.19). The plot indicated a nadir of platelet counts at either day five 
(60,500/mm3), day six (54,400/mm3) or day seven (55,100/mm3) of illness. For that 
reason, we defined day five, six and seven as the time points for more severe disease 
and a platelet count <=50,000/mm3 was chosen as a severity marker. Using a threshold 
of <=50,000/mm3 as a severity marker was additionally supported by evidence of 
several studies (Balmaseda et al., 2006; Hammond et al., 2005; Malavige et al., 2006) 
showing clear associations with more severe disease manifestations. Hence, patients 
having a platelet count <=50,000/mm3 on either day five, six or seven were classified 
as more severe cases and named as ‘low’.  Eight hospitalized patients were excluded 
from the analysis due to either no clinical information during their hospital stay (seven 
patients) or due to no data on days five, six and seven (one patient). This resulted in a 
total of 125 patients that were included into severity modeling using the approach of 
decision trees. The hospitalized patients showing a platelet count > 50,000/mm3 as well 
as the non-hospitalized cases assumed to experience mild disease were categorized 
into the mild group named as ‘high’. 
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Figure 3.19: Platelet Counts [*1000/mm3] plotted as a function of days of illness. In total, 71 
hospitalized patients were included. Average for each time point was calculated with available 
information (missing values were excluded); error bars representing +/- standard error. 
 
The two severity groups along with hospitalization as a grouping criterium were 
compared regarding their clinical parameters that were measured on all of the three 
visits (Table 3.28; Table 3.29; Table 3.30). There were 42 (33.6%) of the patients in 
the low group and 83 (66.4%) of the patients belonged to the high group. The overall 
male-to-female ratio was 1.6 (1.31 in the high group and 2.5 in the low group). 
Multivariate analysis performed on first visit data revealed higher viral load (OR: 0.86; 
95%CI: 0.75, 0.98), increased body temperature (OR: 1.84; 95%CI: 1.00, 3.40), 
decreased platelet count (OR: 0.98; 95%CI: 0.97, 0.99) and a secondary infection (OR: 
4.49; 95%CI: 1.70, 12.40) as genuine risk factors for the development of low platelet 
counts whereas a higher body temperature (OR: 2.03; 95%CI: 1.05, 3.89) as well as a 
higher mean corpuscular haemoglobin concentration (MCHC) (OR: 1.74; 95%CI: 
1.01, 3.00) represented real risks at the second visit (Table 3.32). On the other hand, 
using hospitalization as a severity indicator, resulted in a slightly different but still 
overlapping picture in terms of possible risk factors. Higher viral load (OR: 0.86; 
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95%CI: 0.77, 0.97), a decreased platelet count (OR: 0.98; 95%CI: 0.97, 0.99) and a 
smaller absolute number of lymphocytes (OR: 0.06; 95%CI: 0.01, 0.48) represented 
real risks for hospitalization on the first visit while a higher body temperature (OR: 
10.21; 95%CI: 2.15, 48.63) along with low platelets (OR: 0.96; 95%CI: 0.93, 0.98) 
were identified as real significant differences between hospitalized and non-
hospitalized patients on the second visit (Table 3.31). It is intriguing that the cytokine 
patterns were strikingly different between hospitalization and platelet group 
classification with regard to univariate analyses (Table 3.33; Table 3.35; Table 3.38). 
We observed IP-10, I-TAC, IL-10 and IL-8 as significant differences on the first visit 
between the two platelet group whereas IP-10, IL-10 as well as IL-8 represented the 
main differences on the second visit. On the other hand, hospitalization as a categorical 
variable was able to only detect IP-10 on the first and IP-10 along with IL-10 on the 
second visit. However, logistic regression did only identify IP_10 as a independent risk 
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Table 3.28: Mean for normally a and median for non-normally b distributed clinical data collected on the 
first visit. Shapiro-Wilk normality test was performed to check for non-normally distributed parameters 
(p<0.05) which were first log-transformed c. If the log-transformation still resulted in a non-normal 
distribution then non-parametric Kruskal-Willis test was used whereas Student’s t test was considered in 
case of normally distributed data. Chi-square test d was used to assess for significance between 
secondary infections; absolute counts for negatives (neg) / positives (pos) are indicated below e. Cases 
with missing values were excluded and therefore, the number of cases for  p value calculations differed 
between covariates *. Shading indicates a significant p value < 0.05. 
Dengue positive cases (n=133) * 
Hospitalization 
Dengue positive cases (n=125) *    
Platelet Group Covariate (1st visit) 
yes SDyes no SDno p value low SDlow high SDhi p value
CT_1ST_COLLECTION  b 16.84  20.77  0.001 16.50  19.56  0.002 
TEMP_1 a 38.48 0.873 38.24 0.800 0.112 38.60 0.91 38.23 0.801 0.029 
PULSERATE_1 a 92.96 15.04 93.93 16.27 0.730 94.21 15.91 92.17 15.31 0.475 
SYSTOLICBP_1 a 114.5 15.92 112.9 13.88 0.548 116.6 15.81 113.0 14.36 0.215 
DIASTOLIC1 a 70.90 11.72 73.63 9.444 0.141 71.64 11.64 72.34 10.38 0.745 
WBC_1 c 0.508 0.215 0.582 0.178 0.034 0.509 0.241 0.551 0.186 0.319 
RBC_1 a 4.993 0.649 4.900 0.746 0.457 5.051 0.678 4.937 0.707 0.382 
HGB_1 a 14.75 1.879 14.25 2.209 0.175 15.16 1.957 14.35 2.018 0.032 
HCT_1 a 43.41 5.256 42.38 6.275 0.324 44.38 5.660 42.59 5.677 0.100 
MCV_1 b 87.80  87.00  0.561 87.70  87.45  0.736 
MCH_1 b 30.00  29.45  0.206 30.10  29.80  0.163 
MCHC_1 b 33.90  33.55  0.031 34.05  33.65  0.009 
PLT_1 b 133.0  188.5  0.001 112.5  168.5  0.001 
LYMPH_PCT_1 b 13.75  16.35  0.363 13.20  16.20  0.266 
MXD_PCT_1 b 5.700  5.350  0.865 5.100  5.500  0.820 
NEUT_PCT_1 b 82.30  77.95  0.326 82.40  78.70  0.476 
LYMPH_NO_1 b 0.450  0.550  0.001 0.400  0.500  0.005 
MXD_NO_1 b 0.200  0.200  0.754 0.200  0.200  0.642 
NEUT_NO_1 c 0.411 0.254 0.477 0.217 0.135 0.406 0.275 0.455 0.225 0.345 
RDW_CV_1 b 13.30  13.60  0.183 13.25  13.45  0.302 
RDW_SD_1 a 42.16 2.870 42.82 2.605 0.172 42.51 2.713 42.41 2.732 0.854 
PDW_1 c 1.086 0.072 1.062  0.041 1.091 0.079 1.070 0.063 0.141 
MPV_1 c 1.031 0.047 10.47  0.112 1.033 0.053 1.023 0.041 0.282 
P_LCR_PCT_1 c 1.467 0.144 1.431  0.123 1.474 0.162 1.443 0.121 0.284 
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Table 3.29: Mean for normally a and median for non-normally b distributed clinical data collected on the 
second visit. Shapiro-Wilk normality test was performed to check for non-normally distributed 
parameters (p<0.05) which were fist log-transformed c. If the log-transformation still resulted in a non-
normal distribution then non-parametric Kruskal-Willis test was used whereas Student’s t test was 
considered in case of normally distributed data. Cases with missing values were excluded and therefore, 
the number of cases for  p value calculations differed between covariates *. Shading indicates a 
significant p value < 0.05. 
Dengue positive cases (n=133) * 
Hospitalization 
Dengue positive cases (n=125) *    
Platelet Group Covariate (2nd visit) 
yes SDyes no SDno p value low SDlow high SDhi p value
CT_2ND_COLLECTION b 28.16  29.13  0.169 28.47  28.29  0.609 
TEMP_2 b 37.20  36.70  0.001 37.30  36.90  0.021 
PULSERATE_2 a  80.84 14.00 76.95 13.36 0.124 78.98 13.77 79.08 13.61 0.969 
SYSTOLICBP_2 a 108.3 16.56 109.0 15.93 0.800 111.4 17.17 108.5 15.25 0.374 
DIASTOLIC2 a 70.90 10.73 73.10 10.96 0.376 72.10 10.14 72.57 11.25 0.819 
WBC_2 c 0.398 0.222 0.523 0.202 0.002 0.423 0.239 0.472 0.214 0.271 
RBC_2 b 5.130  4.870  0.156 5.125  4.940  0.471 
HGB_2 b 15.10  14.30  0.058 15.25  14.40  0.064 
HCT_2 b 44.10  42.10  0.138 44.30  43.05  0.174 
MCV_2 b 87.20  87.00  0.883 86.65  87.35  0.993 
MCH_2 b 29.90  29.45  0.039 29.85  29.65  0.087 
MCHC_2 b 34.30  33.70  0.002 34.45  33.80  0.001 
PLT_2 b 67.00  149.5  0.001 44.50  126.0  0.001 
LYMPH_PCT_2 a 30.18 10.43 33.23 10.24 0.113 29.99 10.41 32.27 10.20 0.263 
MXD_PCT_2 b 7.400  9.100  0.726 6.500  8.900  0.839 
NEUT_PCT_2 b 65.20  54.25  0.107 65.90  59.20  0.142 
LYMPH_NO_2 c -0.13 0.287 0.020 0.271 0.003 -0.12 0.317 -0.04 0.273 0.150 
MXD_NO_2 b 0.200  0.350  0.054 0.200  0.300  0.107 
NEUT_NO_2 b 1.300  1.800  0.049 1.350  1.700  0.109 
RDW_CV_2 b 13.30  13.60  0.308 13.30  13.50  0.434 
RDW_SD_2 a 41.96 2.780 42.53 2.636 0.245 42.31 2.532 42.12 2.702 0.705 
PDW_2 c 1.127 0.079 1.085 0.064 0.003 1.130 0.090 1.099 0.069 0.114 
MPV_2 c 1.055 0.045 1.030 0.041 0.003 1.060 0.052 1.038 0.041 0.048 
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Table 3.30: Mean for normally a and median for non-normally b distributed clinical data collected on the 
third visit. Shapiro-Wilk normality test was performed to check for non-normally distributed parameters 
(p<0.05) which were first log-transformed c. If the log-transformation still resulted in a non-normal 
distribution then non-parametric Kruskal-Willis test was used whereas Student’s t test was considered in 
case of normally distributed data. Cases with missing values were excluded and therefore, the number of 
cases for  p value calculations differed between covariates *. Shading indicates a significant p value < 
0.05. 
Dengue positive cases (n=133) * 
Hospitalization 
Dengue positive cases (n=125) *    
Platelet Group Covariate (3rd visit) 
yes SDyes no SDno p value low SDlow high SDhi p value
WBC_3 b 6.100  6.200  0.532 6.200  6.100  0.788 
RBC_3 a 4.603 0.660 4.567 0.572 0.764 4.523 0.632 4.611 0.569 0.502 
HGB_3 c 1.131 0.065 1.117 0.063 0.275 1.132 0.071 1.123 0.059 0.523 
HCT_3 b 40.70  38.90  0.330 40.50  39.70  0.648 
MCV_3 b 88.80  88.35  0.514 89.10  88.35  0.089 
MCH_3 b 30.05  29.70  0.080 30.10  29.70  0.017 
MCHC_3 a 33.64 0.995 33.15 1.030 0.013 33.80 0.918 33.32 1.073 0.020 
PLT_3 b 318.0  318.5  0.508 314.0  319.5  0.879 
LYMPH_PCT_3 a 33.64 7.677 34.43 7.184 0.582 35.76 7.684 33.14 7.496 0.110 
MXD_PCT_3 a 9.320 3.949 8.912 3.751 0.632 9.448 4.592 8.845 3.536 0.553 
NEUT_PCT_3 a 57.29 9.091 56.24 7.942 0.575 54.70 9.269 58.08 8.341 0.118 
LYMPH_NO_3 c 0.304 0.142 0.329 0.103 0.289 0.339 0.147 0.311 0.109 0.335 
MXD_NO_3 b 0.500  0.600  0.914 0.500  0.600  0.743 
NEUT_NO_3 a 3.725 1.190 3.721 1.015 0.984 3.526 1.179 3.894 1.051 0.177 
RDW_CV_3 b 13.55  13.80  0.445 13.60  13.65  0.918 
RDW_SD_3 c 1.635 0.031 1.636 0.025 0.912 1.643 0.034 1.631 0.025 0.080 
PDW_3 b 10.70  10.70  0.972 11.10  10.60  0.557 
MPV_3 b 9.800  9.900  0.723 10.10  9.700  0.218 
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Table 3.31: Logistic regression results for the assessment of genuine risk factors of significant group 
differences which were found by univariate analysis on 1st visit as well as 2nd visit data. Cases with 
missing values were excluded and complete algorithm was used; table showing the risks for 
hospitalization (yes/no). Shading indicates a significant p value < 0.05. 
Covariate (1st visit) OR 95% CI (OR) p value (n=125) 
CT_1ST_COLLECTION 0.86 0.77, 0.97 0.012 
MCHC_1 1.12 0.64, 1.97 0.699 
PLT_1 0.98 0.97, 0.99 0.001 
WBC_1 1.21 0.88, 1.66 0.239 
LYMPH_NO_1 0.06 0.01, 0.48 0.008 
PDW_1 1.06 0.82, 1.37 0.633 
 
Covariate (2nd visit) OR 95% CI (OR) p value (n=80) 
TEMP_2 10.21 2.15, 48.63 0.004 
WBC_2 0.10 0.01, 1.86 0.124 
MCH_2 1.02 0.57, 1.81 0.954 
MCHC_2 2.36 0.89, 6.24 0.085 
PLT_2 0.96 0.93, 0.98 0.001 
NEUT_NO_2 4.22 0.24, 74.19 0.325 
MPV_2 26.84 0.39, 1867.08 0.129 
PDW_2 2.22 0.83, 5.91 0.111 
LYMPH_NO_2 35.66 0.48, 2645.61 0.104 
P_LCR_PCT_2 0.59 0.32, 1.12 0.105 
 
Table 3.32: Logistic regression results for the assessment of genuine risk factors of significant group 
differences which were found by univariate analysis on 1st visit as well as 2nd visit data (PLT_2 was 
excluded). Cases with missing values were excluded and complete algorithm was used; table showing 
the risks for platelet group (low/high). Shading indicates a significant p value < 0.05. 
Covariate (1st visit) OR 95% CI (OR) p value (n=124) 
CT_1ST_COLLECTION 0.86 0.75, 0.98 0.027 
TEMP_1 1.84 1.00, 3.40 0.050 
HGB_1 0.96 0.70, 1.28 0.784 
MCHC_1 1.54 0.85, 2.79 0.158 
PLT_1 0.98 0.97, 0.99 < 0.001 
LYMPH_NO_1 0.37 0.04, 3.78 0.398 
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Table 3.32 (continued): Logistic regression results for the assessment of genuine risk factors of 
significant group differences which were found by univariate analysis on 1st visit as well as 2nd visit data 
(PLT_2 was excluded). Cases with missing values were excluded and complete algorithm was used; 
table showing the risks for platelet group (low/high). Shading indicates a significant p value < 0.05. 
Covariate (2nd visit) OR 95% CI (OR) p value (n=100) 
TEMP_2 2.03 1.05, 3.89 0.036 
MCHC_2 1.74 1.01, 3.00 0.048 
MPV_2 0.70 0.09, 5.38 0.728 
P_LCR_PCT_2 1.11 0.87, 1.43 0.399 
 
Table 3.33: Mean for normally a and median for non-normally b distributed cytokine data collected on 
the first visit. Shapiro-Wilk normality test was performed to check for non-normally distributed 
parameters (p<0.05) which were first log-transformed c. If the log-transformation still resulted in a non-
normal distribution then non-parametric Kruskal-Willis test was used whereas Student’s t test was 
considered in case of normally distributed data. Cases with missing values were excluded and therefore, 
the number of cases for  p value calculations differed between covariates *. Shading indicates a 
significant p value < 0.05. 
Dengue positive cases (n=95) * 
Hospitalization 
Dengue positive cases (n=89) *    
Platelet Group Covariate (1st visit) 
no SD p low SD high SD pyes SDyes no value low hi  value
 bIP_10_1 2016  1508  0.001 2298  1614  0.001 
I_TAC_1 b 1226  1096  0.576 1456  1033  0.004 
IFN_ALPHA_1 b 859.1  798.4  0.329 855.8  798.5  0.149 
GM_CSF_1 b 4.365  6.32  0.196 4.57  6.18  0.313 
IFN_GAMMA_1 b 13.30  17.10  0.213 14.00  14.85  0.865 
IL_1_1 b 5.30  5.30  0.430 5.30  5.23  0.652 
IL_10_1 b 8.13  5.61  0.427 9.37  5.00  0.039 
IL_12_1 b 21.00  23.0  0.746 20.00  22.45  0.919 
IL_2_1 b 10.75  11.50  0.164 10.60  11.30  0.625 
IL_4_1 b 4.24  5.56  0.792 4.04  5.65  0.304 
IL_6_1 b 18.15  23.00  0.751 14.90  22.55  0.990 
IL_8_1 b 3.44  3.26  0.587 4.55  2.61  0.001 
TNF_1 b 1.80  1.87  0.765 1.87  1.80  0.746 
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Table 3.34: Logistic regression results for the assessment of genuine risk factors of significant group 
differences which were found by univariate analysis on 1st visit. Cases with missing values were 
excluded and complete algorithm was used; table showing the risks for platelet group (low/high). 
Shading indicates a significant p value < 0.05. 
Covariate (1st p value (n=56)  visit) OR 95% CI (OR) 
IP_10_1 1.001 1.000, 1.002 0.099 
I_TAC_1 1.000 1.000, 1.001 0.273 
IL_10_1 1.012 0.986, 1.039 0.369 
IL_8_1 1.151 0.885, 1.497 0.295 
 
aTable 3.35: Mean for normally  and median for non-normally b distributed cytokine data collected on 
the second visit. Shapiro-Wilk normality test was performed to check for non-normally distributed 
parameters (p<0.05) which were first log-transformed c. If the log-transformation still resulted in a non-
normal distribution then non-parametric Kruskal-Willis test was used whereas Student’s t test was 
considered in case of normally distributed data. Cases with missing values were excluded and therefore, 
the number of cases for  p value calculations differed between covariates *. Shading indicates a 
significant p value < 0.05. 
Dengue positive cases (n=95) * 
Hospitalization 
Dengue positive cases (n=89) *    
Platelet Group Covariate (2nd visit) 
no SD p low SD high SD pyes SDyes no  value low hi  value
IP_10_2 b 1502  949.4  0.005 1925  998.1  0.001 
I_TAC_2 b 1070  1184  0.903 1147  996.7  0.713 
IFN_ALPHA_2 b 499.6  458.2  0.870 295.7  503.0  0.113 
GM_CSF_2 b 4.97  12.65  0.057 4.15  8.75  0.150 
IFN_GAMMA_2 b 10.75  12.80  0.932 11.70  11.80  0.604 
IL_1_2 b 4.64  5.30  0.222 4.64  5.30  0.390 
IL_10_2 b 25.25  8.51  0.021 33.50  9.07  0.046 
IL_12_2 b 17.60  18.60  0.400 19.40  17.40  0.882 
IL_2_2 b 7.43  12.09  0.175 6.98  10.40  0.777 
IL_4_2 b 4.04  5.26  0.461 4.27  5.23  0.351 
IL_6_2 b 14.55  20.60  0.862 15.80  20.30  0.608 
IL_8_2 b 3.55  2.79  0.194 4.00  2.63  0.020 
TNF_2 b 1.80  1.87  0.398 1.80  1.80  0.969 
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Table 3.36: Logistic regression results for the assessment of genuine risk factors of significant group 
differences which were found by univariate analysis on 2nd visit. Cases with missing values were 
excluded and complete algorithm was used; table showing the risks for hospitalization (yes/no). Shading 
indicates a significant p value < 0.05. 
Covariate (2nd p value (n=87)  visit) OR 95% CI (OR) 
IP_10_2 1.001 1.000, 1.001 0.084 
IL_10_2 1.017 0.998, 1.037 0.085 
 
Table 3.37: Logistic regression results for the assessment of genuine risk factors of significant group 
differences which were found by univariate analysis on 2nd visit. Cases with missing values were 
excluded and complete algorithm was used; table showing the risks for platelet group (low/high). 
Shading indicates a significant p value < 0.05. 
Covariate (2nd p value (n=81)  visit) OR 95% CI (OR) 
IP_10_2 1.001 1.000, 1.001 0.031 
IL_10_2 1.010 0.997, 1.023 0.143 
IL_8_2 1.155 0.835, 1.597 0.384 
 
aTable 3.38: Mean for normally  and median for non-normally b distributed cytokine data collected on 
the third visit. Shapiro-Wilk normality test was performed to check for non-normally distributed 
parameters (p<0.05) which were first log-transformed c. If the log-transformation still resulted in a non-
normal distribution then non-parametric Kruskal-Willis test was used whereas Student’s t test was 
considered in case of normally distributed data. Cases with missing values were excluded and therefore, 
the number of cases for  p value calculations differed between covariates *. Shading indicates a 
significant p value < 0.05. 
Dengue positive cases (n=95) * 
Hospitalization 
Dengue positive cases (n=89) *    
Platelet Group Covariate (3rd visit) 
no SD p low SD high SD pyes SDyes no  value low hi  value
IP_10_3 b 153.9  145.3  0.753 198.4  143.6  0.062 
I_TAC_3 b NA  NA  NA NA  NA  NA 
IFN_ALPHA_3 b NA  NA  NA NA  NA  NA 
GM_CSF_3 b 5.20  8.67  0.360 5.19  7.64  0.336 
IFN_GAMMA_3 b 8.86  8.78  0.483 9.88  9.15  0.874 
IL_1_3 b 5.30  5.32  0.834 5.30  5.31  0.621 
IL_10_3 b 2.22  3.08  0.626 2.07  3.06  0.648 
IL_12_3 b 17.80  18.47  0.627 17.30  18.49  0.547 
IL_2_3 b 9.39  12.40  0.181 9.41  12.10  0.458 
IL_4_3 b 3.56  4.44  0.104 2.98  4.48  0.007 
IL_6_3 b 13.60  16.70  0.309 11.35  18.45  0.255 
IL_8_3 b 2.33  2.27  0.724 2.33  2.15  0.210 
TNF_3 b 1.80  1.80  0.727 1.80  1.80  0.812 
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3.1.2.5 Severity Prediction based on Clinical Data 
 
A first tree (SEVERE_TOTAL_125) (Figure 3.20) based on first visit data was 
calculated using inputs of 125 patients and the pruning confidence was set to 25% with 
“minimal cases” defined as 16. Missing values were treated as null and the tree was 
evaluated by k-fold cross validation (k=10). Excluding TEMP_1, this resulted in a 
correct classification of 103 (82.4%) cases with a sensitivity of 81% and a specificity 
of 83% (Table 3.41; Figure 3.21). The AUC of the low ROC curve was 0.83 (95%: 
0.74, 0.91) whereas the AUC of the high classification averaged 0.83 (95%CI: 0.76, 
0.90). The threshold for the optimal classifier was set to an average profit of 0.646. 
The tree took PLT_1 <= 108 (OR: 24.24; 95%CI: 20.57, 27.92) as a first decision node 
and patients classified under this threshold were mainly cases belonging to the low 
group. Patients that had higher platelet counts at the first decision node were further 
classified using CT_1ST_COLLECTION <= 20.9 (OR: 16.29; 95%CI: 8.53, 24.06) 
and DV_IG_G_1 = ‘positive’ (OR: 9.87; 95%CI: 6.65, 13.09) as splitting criteria 11 
(Table 3.39; Table 3.40). 
                                                 
11 PLT=platelet count; CT_1st_COLLECTION=viral load whereby a high Ct-value indicates a low viral 
load; DV_IG_G=indicator for primary/secondary infection whereby a positive result indicates a 
secondary infection; 1=1st visit data; OR=odds ratio; CI=confidence interval. 
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ROOT
42 low / 83 HIGH
PLT_1 <= 108
20 LOW / 3 high
PLT_1 > 108
22 lows / 80 HIGH
CT_1ST_COLLECTION <= 20.9
22 low / 47 HIGH
CT_1ST_COLLECTION > 20.9
0 low / 33 HIGH
DV_IG_G_1 = positive
16 LOW / 10 high
DV_IG_G_1 = negative
6 low / 37 HIGH
 
Figure 3.20: SEVERE_TOTAL_125: Decision tree for severity prediction calculated on 125 patients 
excluding cytokine data. PLT=platelet count; CT_1st_COLLECTION=viral load whereby a high Ct-
value indicates a low viral load; DV_IG_G=indicator for primary/secondary infection whereby a 
positive result indicates a secondary infection; 1=1st visit data. 
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Table 3.39: SEVERE_TOTAL_125: Decision tree for severity prediction calculated on 125 patients 
excluding cytokine data. Statistical analysis of splitting criteria performed on the whole dataset. 
PLT=platelet count; CT_1st_COLLECTION=viral load whereby a high Ct-value indicates a low viral 
load; DV_IG_G=indicator for primary/secondary infection whereby a positive result indicates a 
secondary infection; 1=1st visit data; RR=relative risk; OR=odds ratio; CI=confidence interval. 
p value Decision Node Feature RR OR 95% CI (OR) 
PLT_1 [*1000/mm3] 4.03 24.24 20.57, 27.92 < 0.001 Cut-off  value <= 108 
CT_1ST_COLLECTION 3.36 5.13 2.33, 7.94 0.001 Cut-off value <= 20.9 
DV_IG_G_1  2.29 3.54 1.36, 5.71 0.002 Cut-off value = positive 
 
Table 3.40: SEVERE_TOTAL_125: Decision tree for severity prediction calculated on 125 patients 
excluding cytokine data. Statistical analysis of splitting criteria performed on each subgroup at the 
decision nodes. In case of 0 values in the original contingency table, OR calculations were adjusted by 
adding 1 to each table value +1. PLT=platelet count; CT_1st_COLLECTION=viral load whereby a high 
Ct-value indicates a low viral load; DV_IG_G=indicator for primary/secondary infection whereby a 
positive result indicates a secondary infection; 1=1st visit data; RR=relative risk; OR=odds ratio; 
CI=confidence interval. 
p value Decision Node Feature RR OR 95% CI (OR) 
PLT_1 [*1000/mm3] 4.03 24.24 20.57, 27.92 < 0.001 Cut-off  value <= 108 
CT_1ST_COLLECTION +1 11.34 16.29 8.53, 24.06 < 0.001 Cut-off value <= 20.9 
DV_IG_G_1  4.41 9.87 6.65, 13.09 < 0.001 Cut-off value = positive 
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Table 3.41: SEVERE_TOTAL_125: Summary of K-fold (k=10) cross validation for severity prediction 
based on 125 patients excluding cytokine data. 
Overall Evaluation Value (n=125) Confusion Matrix 
Total 
misclassifications 22.0    Predicted Class 
Overall error rate 17.692%    high low 











 (83%) (17%) Average profit 0.646  






(19%) (81%) AUC high 0.8264 
95%CI: 0.74, 
0.91 AUC low 0.8262     
 
 
Figure 3.21: SEVERE_TOTAL_125: Receiver operating characteristics (ROC) curve for severity 
prediction calculated on 125 patients excluding cytokine data. 
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3.1.2.6 Severity Prediction based on Clinical Data and only using hospitalized Cases 
 
The second tree (SEVHOSP_TOTAL_71) was constructed by only including first visit 
data from hospitalized cases leading to a dataset of 71 samples. Pruning confidence 
was set to the standard of 25% and a value of 4 was given to “minimum cases”. The 
overall performance of the decision tree excluding the body temperature (TEMP_1) 
was slightly worse and resulted in a higher sensitivity (84%) but lower specificity 
(70%) (Table 3.44; Figure 3.23). The AUC of the ROC curve for more severe (95%CI: 
0.69, 0.90) as well as mild cases (95%CI: 0.69, 0.91) was 0.80. The classifier correctly 
predicted 55 cases with an overall misclassification rate of 22.7%. Interestingly, the 
tree (Figure 3.22) still used PLT_1 <= 108 (OR: 25.45; 95%CI: 17.41, 33.50) as the 
main decision criterium to detect the low cases. Patients that were found to have higher 
platelet counts were further separated in secondary/primary infections. DV_IG__1 = 
‘positive’ (OR: 5.63; 95%CI: 2.21, 9.05) patients were sub-grouped by first using 
CT_1st_COLLECTION <= 20.94 (OR: 29.75; 95%CI: 19.14, 40.36) as a criteria 
followed by MCHC_1 <= 34.5 (OR: 32.00; 95%CI: 18.00, 46.00) as a last decision 
node, both indicating classification into the low group. On the other hand, cases that 
were categorized as primary infections (DV_IG_G_1 = ‘negative’) were further 
grouped by using DIASTOLIC_BP_1 <= 67.0 (OR: 11.38; 95%CI: 1.67, 21.08) as a 
threshold for low cases. However, patients that had a higher diastolic blood pressure 
were separated into groups having either lower or higher systolic blood pressure and 
SYSTOLICBP_1<=119.0 (OR: 14.00; 95%CI: 1.67, 26.33) was an indicator for the 
more severe group low 12 (Table 3.42; Table 3.43). 
                                                 
12 PLT=platelet count; DV_IG_G=indicator for primary/secondary infection whereby a positive result 
indicates a secondary infection; CT_1st_COLLECTION=viral load whereby a high Ct-value indicates a 
low viral load; MCHC=mean corpuscular hemoglobin concentration; DIASTOLIC=diastolic blood 
pressure; SYSTOLICBP=systolic blood pressure; 1=1st visit data; OR=odds ratio; CI=confidence 
interval. 
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ROOT
42 LOW / 29 high
PLT_1 <= 108
20 LOW / 1 high
PLT_1 > 108
22 low / 28 HIGH
DV_IG_G_1 = positive
16 LOW / 9 high
DV_IG_G_1 = negative
6 low / 19 HIGH
CT_1ST_COLLECTION <= 20.94
16 LOW / 3 high
CT_1ST_COLLECTION > 20.94
0 low / 6 HIGH
DIASTOLIC1 <= 67.0
0 low / 12 HIGH
DIASTOLIC1 > 67.0
6 low / 7 HIGH
MCHC_1 <= 34.5
15 LOW / 0 high
MCHC_1 > 34.5
1 low / 3 HIGH
SYSTOLICBP_1 <= 119.0
6 LOW / 2 high
SYSTOLICBP_1 > 119.0
0 low / 5 HIGH
 
Figure 3.22: SEVHOSP_TOTAL_71: Decision tree for severity prediction calculated on 71 
hospitalized patients excluding cytokine data. PLT=platelet count; DV_IG_G=indicator for 
primary/secondary infection whereby a positive result indicates a secondary infection; 
CT_1st_COLLECTION=viral load whereby a high Ct-value indicates a low viral load; MCHC=mean 
corpuscular hemoglobin concentration; DIASTOLIC=diastolic blood pressure; SYSTOLICBP=systolic 
blood pressure; 1=1st visit data. 
 
Table 3.42: SEVHOSP_TOTAL_71: Decision tree for severity prediction calculated on 71 hospitalized 
patients excluding cytokine data. Statistical analysis of splitting criteria performed on the whole dataset. 
PLT=platelet count; DV_IG_G=indicator for primary/secondary infection whereby a positive result 
indicates a secondary infection; CT_1st_COLLECTION=viral load whereby a high Ct-value indicates a 
low viral load; MCHC=mean corpuscular hemoglobin concentration; DIASTOLIC=diastolic blood 
pressure; SYSTOLICBP=systolic blood pressure; 1=1st visit data; RR=relative risk; OR=odds ratio; 
CI=confidence interval. 
p value Decision Node Feature RR OR 95% CI (OR) 
PLT_1 [*1000/mm3] 2.16 25.45 17.41, 33.50 < 0.001 Cut-off  value <= 108 
DV_IG_G_1  1.65 3.42 0.72, 6.12 0.017 Cut-off value = positive 
CT_1ST_COLLECTION 1.74 3.02 -078, 6.83 0.11 Cut-off value <= 20.94 
MCHC_1 0.78 0.52 -2.71, 3.75 0.397 Cut-off value <= 34.5 
DIASTOLIC1 1.21 1.57 -1.1084, 4.26 0.451 Cut-off value > 67.0 
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Table 3.43: SEVHOSP_TOTAL_71: Decision tree for severity prediction calculated on 71 patients 
excluding cytokine data. Statistical analysis of splitting criteria performed on each subgroup at the 
decision nodes. In case of 0 values in the original contingency table, OR calculations were adjusted by 
adding 1 to each table value +1. PLT=platelet count; DV_IG_G=indicator for primary/secondary 
infection whereby a positive result indicates a secondary infection; CT_1st_COLLECTION=viral load 
whereby a high Ct-value indicates a low viral load; MCHC=mean corpuscular hemoglobin 
concentration; DIASTOLIC=diastolic blood pressure; SYSTOLICBP=systolic blood pressure; 1=1st 
visit data; RR=relative risk; OR=odds ratio; CI=confidence interval. 
p value Decision Node Feature RR OR 95% CI (OR) 
PLT_1 [*1000/mm3] 2.16 25.45 17.41, 33.50 < 0.001 Cut-off  value <= 108 
DV_IG_G_1  2.67 5.63 2.21, 9.05 0.01 Cut-off value = positive 
CT_1ST_COLLECTION +1 6.48 29.75 19.14, 40.36 < 0.001 Cut-off value <= 20.94 
MCHC_1 [g/dl] +1 2.82 32.00 18.00, 46.00 < 0.001 Cut-off value <= 34.5 
+1 DIASTOLIC1 [mmHg] 6.53 11.38 1.67, 21.08 0.015 Cut-off value > 67.0 
SYSTOLICBP_1 [mmHg] +1 1.28 14.00 1.67, 26.33 0.015 Cut-off value <= 119.0 
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Table 3.44: SEVHOSP_TOTAL_71: Summary of K-fold (k=10) cross validation for severity prediction 
based on 71 hospitalized patients excluding cytokine data. 
Overall Evaluation Value (n=71) Confusion Matrix 
Total 
misclassifications 16.0    Predicted Class 
Overall error rate 22.679%    high low 











 (70%) (30%) Average profit 0.546  






(17%) (83%) AUC high 0.7991 
95%CI: 0.69, 
0.90 AUC low 0.7962     
 
 
Figure 3.23: SEVHOSP_TOTAL_71: Receiver operating characteristics (ROC) curve for severity 
prediction calculated on 71 hospitalized patients excluding cytokine data. 
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3.1.2.7 Severity Prediction based on Cytokine and Clinical Data  
 
Furthermore, we checked for the influence of cytokines on the classifier performance 
especially to elucidate the possibility of using specific cytokines as a marker for more 
severe infections. For this kind of analysis, we calculated a decision tree based on 89 
dengue positive patients excluding the cytokine data to be able to compare the 
influence of cytokines on the overall classifier performance. The remaining 36 patients 
were excluded due to no cytokine data. The resulting tree (SEVERE_EXCYT_89) 
(Figure 3.24) (excluding TEMP_1), having a pruning confidence of 25% and 
“minimum cases” set to 10, was identical to the tree (Figure 3.20) calculated on the 
total of 133 dengue patients using PLT_1 <= 108 (OR: 40.53; 95%CI: 32.40, 48.65), 
CT_1ST_COLLECTION <= 20.9 (OR: 13.53; 95%CI: 5.55, 21.51) as well as 
DV_IG_G_1 = ‘positive’ (OR: 2.28; 95%CI: 6.04, 13.46)13 as the classification 
criteria for more severe infections (Table 3.45; Table 3.46). The tree had a 
misclassification rate of 20.28% with a sensitivity of 77% and a specificity of 83% 
(Table 3.47; Figure 3.25). The AUC of the high classification was minimally higher 
(95%CI: 0.70, 0.88) than the AUC for the low classification (95%CI: 0.69, 0.89) 
indicating similar overall performance of 0.79. The average profit of the chosen 
probabilistic classifier was 0.594.  
                                                 
13 TEMP=body temperature; PLT=platelet count; CT_1st_COLLECTION=viral load whereby a high 
Ct-value indicates a low viral load; DV_IG_G=indicator for primary/secondary infection whereby a 
positive result indicates a secondary infection; 1=1st visit data; OR=odds ratio; CI=confidence interval. 
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ROOT
33 low / 56 HIGH
PLT_1 <= 108
14 LOW / 1 high
PLT_1 > 108
19 lows / 55 HIGH
CT_1ST_COLLECTION <= 20.9
19 low / 33 HIGH
CT_1ST_COLLECTION > 20.9
0 low / 22 HIGH
DV_IG_G_1 = positive
13 LOW / 6 high
DV_IG_G_1 = negative
6 low / 27 HIGH
 
Figure 3.24: SEVERE_EXCYT_89: Decision tree for severity prediction calculated on 89 patients 
excluding cytokine data. PLT=platelet count; CT_1st_COLLECTION=viral load whereby a high Ct-
value indicates a low viral load; DV_IG_G=indicator for primary/secondary infection whereby a 
positive result indicates a secondary infection; 1=1st visit data. 
 
Table 3.45: SEVERE_EXCYT_89: Decision tree for severity prediction calculated on 89 patients 
excluding cytokine data. Statistical analysis of splitting criteria performed on the whole dataset. 
PLT=platelet count; CT_1st_COLLECTION=viral load whereby a high Ct-value indicates a low viral 
load; DV_IG_G=indicator for primary/secondary infection whereby a positive result indicates a 
secondary infection; 1=1st visit data; RR=relative risk; OR=odds ratio; CI=confidence interval. 
p value Decision Node Feature RR OR 95% CI (OR) 
PLT_1 [*1000/mm3] 3.64 40.53 32.40, 48.65 < 0.001 Cut-off  value <= 108 
CT_1ST_COLLECTION 6.05 10.80 6.20, 15.40 < 0.001 Cut-off value <= 20.9 
DV_IG_G_1  1.91 2.90 0.43, 5.30 0.026 Cut-off value = positive 
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Table 3.46: SEVERE_EXCYT_89: Decision tree for severity prediction calculated on 89 patients 
excluding cytokine data. Statistical analysis of splitting criteria performed on each subgroup at the 
decision nodes. In case of 0 values in the original contingency table, OR calculations were adjusted by 
adding 1 to each table value +1. PLT=platelet count; CT_1st_COLLECTION=viral load whereby a high 
Ct-value indicates a low viral load; DV_IG_G=indicator for primary/secondary infection whereby a 
positive result indicates a secondary infection; 1=1st visit data; RR=relative risk; OR=odds ratio; 
CI=confidence interval. 
p value Decision Node Feature RR OR 95% CI (OR) 
PLT_1 [*1000/mm3] 3.64 40.53 32.40, 48.65 < 0.001 Cut-off  value <= 108 
CT_1ST_COLLECTION +1 8.89 13.53 5.55, 21.51 < 0.001 Cut-off value <= 20.9 
DV_IG_G_1  3.76 2.28 6.04, 13.46 0.001 Cut-off value = positive 
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Table 3.47: SEVERE_EXCYT_89: Summary of K-fold (k=10) cross validation for severity prediction 
based on 89 patients excluding cytokine data. 
Overall Evaluation Value (n=89) Confusion Matrix 
Total 
misclassifications 18.0    Predicted Class 
Overall error rate 20.278%    high low 











 (83%) (17%) Average profit 0.594  






(23%) (77%) AUC high 0.7933 
95%CI: 0.69, 
0.89 AUC low 0.7901     
 
 
Figure 3.25: SEVERE_EXCYT_89: Receiver operating characteristics (ROC) curve for severity 
prediction calculated on 89 patients excluding cytokine data. 
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Including the cytokine data and leaving the technical tree parameters unchanged 
(minimum cases was set to 10 with a pruning confidence of 25%), no changes in the 
tree splitting criteria were observed but the overall performance of the tree decreased 
suggesting noisiness caused by interference of cytokine and clinical data.  
 
Therefore, we constructed a tree that excluded TEMP_1 and CT_1ST_COLLECTION. 
This resulted in a tree similar to the one calculated without the cytokine data 
(SEVERE_INCYTA_89) (Figure 3.24), with the split represented by 
CT_1ST 14_COLLECTION exchanged by IP_10_1 (OR: 12.75; 95%CI: 7.98, 17.52)  
(Table 3.48; Table 3.49). The chosen classifier (Figure 3.26) had a higher profit 
(0.617) with higher specificity (86%) but lower sensitivity (74%) and the resulting 
overall error rate was 19.17% (Table 3.50; Figure 3.27). The AUC for low and high 
classification was 0.79 but the two groups showed different confidence intervals (low 
95%CI: 0.68, 0.89; high 95%CI: 0.69, 0.88).  
 
 
                                                 
14 TEMP=body temperature; CT_1st_COLLECTION=viral load whereby a high Ct-value indicates a 
low viral load; PLT=platelet count; IP_10=interferon-inducible protein 10; DV_IG_G=indicator for 
primary/secondary infection whereby a positive result indicates a secondary infection; 1=1st visit data. 
OR=odds ratio; CI=confidence interval. 
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ROOT
33 low / 56 HIGH
PLT_1 <= 108
14 LOW / 1 high
PLT_1 > 108
19 lows / 55 HIGH
IP_10_1 > 1697.9
17 low / 22 HIGH
IP_10_1 <= 1697.9
2 low / 33 HIGH
DV_IG_G_1 = positive
12 LOW / 4 high
DV_IG_G_1 = negative
7 low / 18 HIGH
 
Figure 3.26: SEVERE_INCYTA_89: Decision tree for severity prediction calculated on 89 patients 
including cytokine data. PLT=platelet count; IP_10=interferon-inducible protein 10; 
DV_IG_G=indicator for primary/secondary infection whereby a positive result indicates a secondary 
infection; 1=1st visit data. 
 
Table 3.48: SEVERE_INCYTA_89: Decision tree for severity prediction calculated on 89 patients 
including cytokine data. Statistical analysis of splitting criteria performed on the whole dataset. 
PLT=platelet count; IP_10=interferon-inducible protein 10; DV_IG_G=indicator for 
primary/secondary infection whereby a positive result indicates a secondary infection; 1=1st visit data; 
RR=relative risk; OR=odds ratio; CI=confidence interval. 
p value Decision Node Feature RR OR 95% CI (OR) 
PLT_1 [*1000/mm3] 3.64 40.53 32.40, 48.65 < 0.001 Cut-off  value <= 108 
IP_10_1 [pg/ml] 5.40 11.20 7.97, 14.44 < 0.001 Cut-off value > 1697.9 
DV_IG_G_1  1.91 2.87 0.43, 5.30 0.026 Cut-off value = positive 
 
Table 3.49: SEVERE_INCYTA_89: Decision tree for severity prediction calculated on 89 patients 
including cytokine data. Statistical analysis of splitting criteria performed on each subgroup at the 
decision nodes. PLT=platelet count; IP_10=interferon-inducible protein 10; DV_IG_G=indicator for 
primary/secondary infection whereby a positive result indicates a secondary infection; 1=1st visit data; 
RR=relative risk; OR=odds ratio; CI=confidence interval. 
p value Decision Node Feature RR OR 95% CI (OR) 
PLT_1 [*1000/mm3] 3.64 40.53 32.40, 48.65 < 0.001 Cut-off  value <= 108 
IP_10_1 [pg/ml] 7.63 12.75 7.98, 17.52 < 0.001 Cut-off value <= 1697.9 
DV_IG_G_1  3.45 10.80 6.30, 15.30 0.003 Cut-off value = positive 
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Table 3.50: SEVERE_INCYTA_89: Summary of K-fold (k=10) cross validation for severity prediction 
based on 89 patients including cytokine data. 
Overall Evaluation Value (n=89) Confusion Matrix 
Total 
misclassifications 17.0    Predicted Class 
Overall error rate 19.167%    high low 











 (86%) (14%) Average profit 0.617  






(26%) (74%) AUC high 0.7865 
95%CI: 0.68, 
0.89 AUC low 0.7874     
 
 
Figure 3.27: SEVERE_INCYTA_89: Receiver operating characteristics (ROC) curve for severity 
prediction calculated on 89 patients including cytokine data. 
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3.1.2.8 Severity Prediction based on Cytokine Data 
 
It is known that cytokines are important factors in determining severity of disease and 
thus, a tree only including the cytokine data was constructed. This would provide us 
with a better picture of data interference and second, with a more detailed view of 
which cytokines could be important for disease pathogenesis. The following 
calculations revealed that classifier performance was strongly dependent on which 
cytokines were included into the tree. Therefore, we only picked the cytokines 
IP_10_1, IL_10_1 and IL_8_115 which showed the highest accuracy for severity 
prediction and this resulted in a good classifier performance of 0.75 for the prediction 
of ‘low’ (95%CI: 0.64, 0.86) as well as of ‘high’ (95%CI: 0.65, 0.85) cases (minimum 
cases was set to 23 with a pruning confidence of 25%). K-fold cross validation (k=10) 
determined an overall error rate of 29.028% with a sensitivity of 66% and a specificity 
of 76% (Table 3.53; Figure 3.30). The model (SEVERE_CYTOA_89_IL8) (Figure 
3.28) picked IP_10_1>1697.9 (OR: 11.20; 95%CI: 7.97, 14.44)  as the first and 
IL_8_1>3.34 (OR: 5.93; 95%CI: 2.52, 9.33) as the second splitting criterium (Table 
3.51; Table 3.52). IL_10_1 was not integrated into the tree, but exclusion of this 
cytokine from the analysis, resulted in a decreased performance. This suggested that 
IL_10_1 had a supporting role on either IP_10_1 or IL_8_1 but as a predictor would 
be inferior to IL_8_1. Even decreasing of the tree parameter “minimum cases” did not 
result in the inclusion of IL_10_1.  
 
Therefore, we checked for the influence of IL_8_1 in the tree and excluded this 
cytokine for further calculations. This resulted in a tree (SEVERE_CYTOA_89_IL10) 
                                                 
15 IP_10=interferon inducible protein 10; IL_10=interleukin-10; IL_8=interleukin-8; OR=odds ratio; 
CI=confidence interval. 
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(Figure 3.29) that had IL_10_1>6.66 (OR: 5.63; 95%CI: 2.27, 8.98) as the second 
splitting criterium (Table 3.52; Table 3.52) and showed a higher sensitivity (70%) but 
in turn a lower specificity (72%). The overall accuracy was decreased which was 
represented by an AUC of 0.74 (95%CI: 0.62, 0.85) for ‘low’ and a AUC of 0.73 
(95%CI: 0.63, 0.84) for ‘high’ cases. The profit averaged 0.397 with an overall error 
rate of 30.139% (Table 3.54; Figure 3.31).  
ROOT
33 low / 56 HIGH
IP_10_1 <= 1697.9
4 low / 34 HIGH
IP_10_1 > 1697.9
29 LOW / 22 high
IL_8_1 > 3.34
20 LOW / 6 high
IL_8_1 <= 3.34
9 low / 16 HIGH
Figure 3.28: SEVERE_CYTOA_89_IL8: Decision tree for severity prediction calculated on 89 patients 
only including cytokine data and using interleukin-8 as the last splitting criteria. IP_10=interferon 
inducible protein 10; IL_8=interleukin-8. 
 
ROOT
33 low / 56 HIGH
IP_10_1 <= 1697.9
4 low / 34 HIGH
IP_10_1 > 1697.9
29 LOW / 22 high
IL_10_1 > 6.66
21 LOW / 7 high
IL_10_1 <= 6.66
8 low / 15 HIGH
Figure 3.29: SEVERE_CYTOA_89_IL10: Decision tree for severity prediction calculated on 89 
patients only including cytokine data and using interleukin-10 as the last splitting criteria. 
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Table 3.51: SEVERE_CYTOA_89: Decision tree for severity prediction calculated on 89 patients only 
including cytokine data. Statistical analysis of splitting criteria performed on the whole dataset. 
IP_10=interferon inducible protein 10; IL_10=interleukin-10; IL_8=interleukin-8; 1=1st visit data; 
RR=relative risk; OR=odds ratio; CI=confidence interval. 
p value Decision Node Feature RR OR 95% CI (OR) 
IP_10_1 [pg/ml] 5.40 11.20 7.97, 14.44 < 0.001 Cut-off value > 1697.9 
IL_8_1 [pg/ml] 2.57 4.48 1.95, 7.00 0.001 Cut-off value > 3.34 
IL_10_1 [pg/ml] 1.50 1.86 -0.68, 4.40 0.004 Cut-off value > 6.66 
 
Table 3.52: SEVERE_CYTOA_89: Decision tree for severity prediction calculated on 89 patients only 
including cytokine data. Statistical analysis of splitting criteria performed on each subgroup at the 
decision nodes. IP_10=interferon inducible protein 10; IL_10=interleukin-10; IL_8=interleukin-8. 1=1st 
visit data; RR=relative risk; OR=odds ratio; CI=confidence interval. 
p value Decision Node Feature RR OR 95% CI (OR) 
IP_10_1 [pg/ml] 5.40 11.20 7.97, 14.44 < 0.001 Cut-off value > 1697.9 
IL_8_1 [pg/ml] 2.14 5.93 2.52, 9.33 0.003 Cut-off value > 3.34 
IL_10_1 [pg/ml] 2.16 5.63 2.27, 8.98 0.005 Cut-off value > 6.66 
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Table 3.53: SEVERE_CYTOA_89_IL8: Summary of K-fold (k=10) cross validation for severity 
prediction based on 89 patients only including cytokine data and using interleukin-8 as the last splitting 
criteria. 
Overall Evaluation Value (n=89) Confusion Matrix 
Total 
misclassifications 26.0    Predicted Class 
Overall error rate 29.028%    high low 











 (76%) 214%) Average profit 0.419  






(34%) (66%) AUC high 0.7506 
95%CI: 0.64, 
0.86 AUC low 0.7531     
 
 
Figure 3.30: SEVERE_CYTOA_89_IL8: Receiver operating characteristics (ROC) curve for severity 
prediction based on 89 patients only including cytokine data and using IL-8 as the last splitting criteria. 
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Table 3.54: SEVERE_CYTOA_89_IL10: Summary of K-fold (k=10) cross validation for severity 
prediction based on 89 patients only including cytokine data and using IL_10_1 as the last splitting 
criteria. 
Overall Evaluation Value (n=89) Confusion Matrix 
Total 
misclassifications 27.0    Predicted Class 
Overall error rate 30.139%    high low 











 (72%) (28%) Average profit 0.397  






(30%) (70%) AUC high 0.7338 
95%CI: 0.62, 
0.85 AUC low 0.7354     
 
 
Figure 3.31: SEVERE_CYTOA_89_IL10: Receiver operating characteristics (ROC) curve for severity 
prediction based on 89 patients only including cytokine data and using IL-10 as the last splitting criteria. 
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3.1.2.9 Severity Prediction based on Cytokine and Clinical Data but only using 
hospitalized Cases 
 
For the sake of completion, we separately investigated the influence of the cytokine 
data on the prediction of severity by excluding the non-hospitalized cases. This kind of 
analysis might identify cytokines that would be highly specific for severity due to the 
fact that we would classify two groups within a population (hospitalized patients) that 
was already more homogenous than using the total of 125 patients. Hence, the analysis 
was performed on a dataset of 52 cases (36.5% high, 63.5% low) and pruning 
confidence was set to 25% whereas ‘minimum cases’ was programmed to 4. The first 
tree excluding TEMP_1 (SEVHOSP_EXCYT_52) (Figure 3.32) was calculated by 
leaving the cytokine data on the side. PLT<=108 (OR: 15.00; 95%CI: 6.69, 23.31), 
DV_IG_G_1=’positive’ (OR: 4.69; 95%CI: 0.77, 8.62), 
CT_1ST_COLLECTION<=20.94 (OR: 42.00; 95%CI: 28.75, 55.25) and 
MXD_NO_1<=0.1 (OR: 15.00; 95%CI: 1.65, 27.35) were chosen as splitting criteria 
(Table 3.55; Table 3.56)16 and the decision tree was able to correctly classify 43 cases 
with an overall error rate of 16.67% (Table 3.57; Figure 3.33). The sensitivity was 
shown to be 85% and the specificity was 80%. It had a good overall performance of 
0.80 for the classification of low (95%CI: 0.69, 0.92) and high (95%CI: 0.67, 0.94). 
The probabilistic classifier was chosen at an average profit of 0.667. 
 
 
                                                 
16 PLT=platelet count; CT_1st_COLLECTION=viral load whereby a high Ct-value indicates a low viral 
load; DV_IG_G=indicator for primary/secondary infection whereby a positive result indicates a 
secondary infection; MXD_NO= The percentage of the WBC belonging to monocytes, eosinophiles & 
basophiles; 1=1st visit data; OR=odds ratio; CI=confidence interval. 
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ROOT
33 LOW / 19 high
PLT_1 <= 108
14 LOW / 0 high
PLT_1 > 108
19 low / 19 high
DV_IG_G_1 = positive
13 LOW / 6 high
DV_IG_G_1 = negative
6 low / 13 HIGH
CT_1ST_COLLECTION <= 20.94
13 LOW / 1 high
CT_1ST_COLLECTION > 20.94
0 low / 5 HIGH
MXD_NO_1 <= 0.1
4 LOW / 1.43 high
MXD_NO_1 > 0.1
2 low / 11.57 HIGH
 
Figure 3.32: SEVHOSP_EXCYT_52: Decision tree for severity prediction calculated on 52 
hospitalized patients excluding cytokine data. PLT=platelet count; CT_1st_COLLECTION=viral load 
whereby a high Ct-value indicates a low viral load; DV_IG_G=indicator for primary/secondary 
infection whereby a positive result indicates a secondary infection; MXD_NO= The percentage of the 
WBC belonging to monocytes, eosinophiles & basophiles; 1=1st visit data. 
 
Table 3.55: SEVHOSP_EXCYT_52: Decision tree for severity prediction calculated on 52 hospitalized 
patients excluding cytokine data. Statistical analysis of splitting criteria performed on the whole dataset. 
In case of 0 values in the original contingency table, OR calculations were adjusted by adding 1 to each 
table value +1 . PLT=platelet count; CT_1st_COLLECTION=viral load whereby a high Ct-value 
indicates a low viral load; DV_IG_G=indicator for primary/secondary infection whereby a positive 
result indicates a secondary infection; MXD_NO= The percentage of the WBC belonging to monocytes, 
eosinophiles & basophiles; 1=1st st visit data; 1=1  visit data; RR=relative risk; OR=odds ratio; 
CI=confidence interval. 
p value Decision Node Feature RR OR 95% CI (OR) 
PLT_1 [*1000/mm3 +1 ] 1.88 15 6.69, 23.31 0.001 Cut-off  value <= 108 
DV_IG_G_1  1.47 2.94 -0.34, 6.22 0.071 Cut-off value = positive 
CT_1ST_COLLECTION 5.00 14.77 5.63, 23.91 0.007 Cut-off value <= 20.94 
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Table 3.56: SEVHOSP_EXCYT_52: Decision tree for severity prediction calculated on 52 hospitalized 
patients excluding cytokine data. Statistical analysis of splitting criteria performed on each subgroup at 
the decision nodes. In case of 0 values in the original contingency table, OR calculations were adjusted 
by adding 1 to each table value +1 . PLT=platelet count; CT_1st_COLLECTION=viral load whereby a 
high Ct-value indicates a low viral load; DV_IG_G=indicator for primary/secondary infection whereby 
a positive result indicates a secondary infection; MXD_NO= The percentage of the WBC belonging to 
monocytes, eosinophiles & basophiles; 1=1st st visit data; 1=1  visit data; RR=relative risk; OR=odds 
ratio; CI=confidence interval. 
p value Decision Node Feature RR OR 95% CI (OR) 
PLT_1 [*1000/mm3 +1 ] 1.88 15 6.69, 23.31 0.001 Cut-off  value <= 108 
DV_IG_G_1  2.17 4.69 0.77, 8.62 0.05 Cut-off value = positive 
CT_1ST_COLLECTION +1 6.13 42.00 28.75, 55.25 0.001 Cut-off value <= 20.94 
3]  MXD_NO_1 [*1000 cells/mm 3.33 15.00 2.65, 27.35 0.015 Cut-off value <= 0.1 
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Table 3.57: SEVHOSP_EXCYT_52: Summary of K-fold (k=10) cross validation for severity prediction 
based on 52 hospitalized patients excluding cytokine data. 
Overall Evaluation Value (n=52) Confusion Matrix 
Total 
misclassifications 9.0    Predicted Class 
Overall error rate 16.667%    high low 











 (80%) (20%) Average profit 0.667  






(15%) (85%) AUC high 0.8042 
95%CI: 0.69, 
0.92 AUC low 0.8042     
 
 
Figure 3.33: SEVHOSP_EXCYT_52: Receiver operating characteristics (ROC) curve for severity 
prediction calculated on 52 hospitalized patients excluding cytokine data. 
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Calculating a tree (excluding body temperature) with the same technical parameters 
and including the cytokine data did not result in an improvement (data not shown). 
Therefore, we additionally excluded CT_1ST_COLLECTION and found that inclusion 
of only I_TAC_1 along with IL_10_1 would give the best prediction. Pruning 
confidence was still set to 25% whereas ‘minimum cases’ was defined as 10. This, in 
turn, resulted in a tree (SEVHOSP_INCYTA_52) (Figure 3.34) that only used PLT_1 
<=108 (OR: 15.00; 95%CI: 6.69, 23.31) and I_TAC_1<=1255.2 (OR: 26.00; 95%CI: 
16.44, 35.56) as decision criteria ( 17Table 3.58; Table 3.59) . The misclassification rate 
accounted for 20.667% with a sensitivity of 80% and a specificity of 80% (Table 7l; 
Figure 7h). The AUC of the ‘low’ ROC curve averaged 0.84 (95%CI: 0.73, 0.94) and 
classification of ‘high’ cases showed an AUC of 0.84 (95%CI: 0.72, 0.96). 
Furthermore, the classifier chosen at a specific threshold had a lower average profit 
(0.587) (Table 3.60; Figure 3.35). 
ROOT
33 LOW / 19 high
PLT_1 <= 108
14 LOW / 0 high
PLT_1 > 108
19 low / 19 high
I_TAC_1 > 1255.2
12.86 LOW / 3.43 high
I_TAC_1 <= 1255.2
6.14 low / 15.57 HIGH
 
Figure 3.34: SEVHOSP_INCYTA_52: Decision tree for severity prediction calculated on 52 
hospitalized patients including cytokine data. PLT=platelet count; I_TAC=interferon-inducible T cell α 








                                                 
17 CT_1st_COLLECTION=viral load whereby a high Ct-value indicates a low viral load; PLT=platelet 
count; I_TAC=interferon-inducible T cell α chemoattractant; 1=1st visit data; OR=odds ratio; 
CI=confidence interval. 
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Table 3.58: SEVHOSP_INCYTA_52: Decision tree for severity prediction calculated on 52 
hospitalized patients including cytokine data. Statistical analysis of splitting criteria performed on the 
whole dataset. In case of 0 values in the original contingency table, OR calculations were adjusted by 
adding 1 to each table value +1. PLT=platelet count; I_TAC=interferon-inducible T cell α 
chemoattractant; 1=1st st visit data; 1=1  visit data; RR=relative risk; OR=odds ratio; CI=confidence 
interval. 
p value Decision Node Feature RR OR 95% CI (OR) 
PLT_1 [*1000/mm3 +1 ] 1.88 15.00 6.69, 23.31 0.001 Cut-off  value <= 108 
I_TAC_1 [pg/ml] +1 2.09 22.8 14.00, 31.64 < 0.001 Cut-off value > 1255.2 
 
Table 3.59: SEVHOSP_INCYTA_52: Decision tree for severity prediction calculated on 52 
hospitalized patients including cytokine data. Statistical analysis of splitting criteria performed on each 
subgroup at the decision nodes. In case of 0 values in the original contingency table, OR calculations 
were adjusted by adding 1 to each table value +1. PLT=platelet count; I_TAC=interferon-inducible T cell 
α chemoattractant; 1=1st st visit data; 1=1  visit data; RR=relative risk; OR=odds ratio; CI=confidence 
interval. 
p value Decision Node Feature RR OR 95% CI (OR) 
PLT_1 [*1000/mm3 +1 ] 1.88 15.00 6.69, 23.31 0.001 Cut-off  value <= 108 
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Table 3.60: SEVHOSP_INCYTA_52:  Summary of K-fold (k=10) cross validation for severity 
prediction based on 52 hospitalized patients including cytokine data. 
Overall Evaluation Value (n=52) Confusion Matrix 
Total 
misclassifications 11.0    Predicted Class 
Overall error rate 20.667%    high low 











 (80%) (20%) Average profit 0.587  






(20%) (80%) AUC high 0.8398 
95%CI: 0.73, 
0.94 AUC low 0.8373     
 
 
Figure 3.35: SEVHOSP_INCYTA_52: Receiver operating characteristics (ROC) curve for severity 
prediction calculated on 52 hospitalized patients including cytokine data. 
160 
3. Results Investigating the 2005 Singaporean Dengue Outbreak 
 
3.1.2.10 Severity Prediction based on Cytokine Data but only using hospitalized Cases 
 
Finally, we calculated a tree on the hospitalized patients that included only the 
cytokine data. The product was a classifier (SEVHOSP_CYTO_52) (Figure 3.36) 
(pruning confidence set to 25% and minimum cases defined as 4) that had a high 
sensitivity of 84% and a specificity of 65% (Table 3.63; Figure 3.37) . The overall 
performance of the classifier accounted for 0.74 for severe (95%CI: 0.60, 0.87) as well 
as mild cases (95%CI: 0.59, 0.89) with an error rate of 21.333%. The first branch of 
the tree was defined by IL_8_1>3.33 (OR: 19.55; 95%CI: 14.38, 24.72) and patients 
below this threshold were further split by using I_TAC_1>1255.2 (OR: 16.50; 95%CI: 
5.40, 27.60)18. The tree model having a profit of 0.573 used only these two splitting 
criteria (Table 3.61; Table 3.62). It was observed that exclusion of IL_10_1 from the 
decision tree analysis lead to a decrease in classifier performance pointing towards a 
supportive role of IL_10_1 in the prediction of severity.  
ROOT
33 low / 19 high
IL_8_1 > 3.33
23 LOW / 2 high
IL_8_1 > 3.33
10 low / 17 HIGH
I_TAC_1 > 1255.2
5.56 LOW / 1.94 high
I_TAC_1 <= 1255.2
4.44 low / 15.06 HIGH
Figure 3.36: SEVHOSP_CYTOA_52: Decision tree for severity prediction calculated on 52 
hospitalized patients only including cytokine data. IL_8=interleukin-8; I_TAC=interferon-inducible T 
cell α chemoattractant; 1=1  visit data. st
 
                                                 
18 IL_8=interleukin-8; I_TAC=interferon-inducible T cell α chemoattractant; 1=1st visit data; OR=odds 
ratio; CI=confidence interval. 
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Table 3.61: SEVHOSP_CYTOA_52: Decision tree for severity prediction calculated on 52 hospitalized 
patients only including cytokine data. Statistical analysis of splitting criteria performed on the whole 
dataset. In case of 0 values in the original contingency table, OR calculations were adjusted by adding 1 
to each table value +1. IL_8=interleukin-8; I_TAC=interferon-inducible T cell α chemoattractant; 1=1st 
visit data; 1=1st visit data; RR=relative risk; OR=odds ratio; CI=confidence interval. 
p value Decision Node Feature RR OR 95% CI (OR) 
IL_8_1 [pg/ml] 2.48 19.55 14.38, 24.72 < 0.001 Cut-off value > 3.33 
I_TAC_1 [pg/ml] +1 2.09 22.80 13.96, 31.64 < 0.001 Cut-off value > 1255.2 
 
Table 3.62: SEVHOSP_CYTOA_52: Decision tree for severity prediction calculated on 52 hospitalized 
patients only including cytokine data. Statistical analysis of splitting criteria performed on each 
subgroup at the decision nodes. In case of 0 values in the original contingency table, OR calculations 
were adjusted by adding 1 to each table value +1. IL_8=interleukin-8; I_TAC=interferon-inducible T cell 
α chemoattractant; 1=1st st visit data; 1=1  visit data; RR=relative risk; OR=odds ratio; CI=confidence 
interval. 
p value Decision Node Feature RR OR 95% CI (OR) 
IL_8_1 [pg/ml] 2.48 19.55 14.38, 24.72 < 0.001 Cut-off value > 3.33 
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Table 3.63: SEVHOSP_CYTOA_52: Summary of K-fold (k=10) cross validation for severity 
prediction based on 52 hospitalized patients only including cytokine data. 
Overall Evaluation Value (n=52) Confusion Matrix 
Total 
misclassifications 11.0    Predicted Class 
Overall error rate 21.333%    high low 











 (65%) (35%) Average profit 0.573  






(16%) (84%) AUC high 0.7404 
95%CI: 0.60, 
0.87 AUC low 0.7354     
 
 
Figure 3.37: SEVHOSP_CYTOA_52: Receiver operating characteristics (ROC) curve for severity 
prediction calculated on 52 hospitalized patients only including cytokine data. 
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3.2  Sequence Analyses of Virus Isolates from the 2005 Singaporean 
Dengue Outbreak 
 
3.2.1 Description of Differences between Serotype 1 and Serotype 3 
 
During the 2005 Singaporean dengue outbreak, there was mainly a co-circulation of 
DENV-1 and DENV-3. Detection of DENV-2 and especially DENV-4 was very rare. 
From the 133 dengue positive patients, serotyping detected 66 (48.9%) DENV-1 along 
with 62 (46.6%) DENV-3 whereas DENV-2 was only the causative agent in 5 patients 
(3.8%). There was no detection of serotype 4 (Low et al., 2006). Isolation of only 112 
(84.2%) viruses was possible. The isolated viruses were mainly represented by DENV-
1 (57 isolates; 50.8%) along with DENV-3 (50 isolates; 44.6%). Only five serotype 2 
viruses were isolated (Table 3.66). 
 
It is intriguing that 16 (76.19%) of the 21 unisolated viruses (9 DENV-1 and 12 
DENV-3) originated from secondary infections. The viral load was significant lower 
(p<0.001) in the non-isolated viruses than in the isolated ones and indicated that there 
was not enough virus for isolation. 
 
3.2.1.1 Serotype specific Differences with regard to Severity 
 
As a consequence of the severity modeling, we first aimed at investigating whether 
there were serotype specific differences with regard to disease outcome. For this 
purpose, we decided to investigate the parameters that were detected to be important in 
severity modeling and chose as time points the 1st as well as the 2nd visit. Thus, viral 
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load, platelet count, secondary infection, IL-8, IL-10, IP-10 and I-TAC were included 
into descriptive statistical analysis. In addition, we included IFN-α to find out whether 
a virus specific response exists and checked whether there was a difference regarding 
hospitalization. DENV-2 patients were excluded due to only five samples which would 
not give any statistically reliable values. This resulted in a datasheet of 128 cases for 
the analysis of clinical data and 90 cases were used for calculation of cytokine data. 38 
samples were excluded from the cytokine analysis due to lack of data.   Univariate 
analysis identified significant differences in viral load and IFN-α on the 1st as well as 
second visit. On the other hand, IL-8 was significantly different only on the 2nd visit 
(Table 3.64; Table 3.65). 
 
Table 3.64: Median for non-normally b distributed clinical and immunological data collected on the first 
visit. Shapiro-Wilk normality test was performed to check for non-normally distributed parameters 
(p<0.05) which were first log-transformed. If the log-transformation still resulted in a non-normal 
distribution then non-parametric Kruskal-Willis test was used whereas Student’s t test was considered in 
case of normally distributed data. Chi-square test d was used to assess for significance between 
secondary infections (positive/negative), platelet class (low/high) and hospitalization (yes/no); for 
calculations of platelet class, only 86 cases were included g;  absolute counts are indicated below e. 
Significant differences between cytokine data was calculated by using a dataset of 90 patients. Cases 
with missing values were excluded and therefore, the number of cases for  p value calculations differed 
between covariates *. Shading indicates a significant p value < 0.05.  
Dengue positive cases (n=128) * grouped by Serotypes 1&3 
Covariate 
DENV-1  DENV-3  p value 
CT_1ST_COLLECTION b 17.065  19.755  0.002 
PLT_1 b 160.500  166.000  0.453 
 b 1985.950  1722.165  0.205 IP_10_1
I_TAC_1 b 1219.250  1205.700  0.786 
IFN_ALPHA_1 b 1270.500  786.865  0.001 
IL_8_1 b 3.550  2.565  0.120 
IL_10_1 b 6.965  8.715  0.251 
DV_IG_G_1 d, e 16 positive 26 negative 20 positive 28 negative 0.730 
PLT_CLASS d, e, g 18 low 22 high 14 low 32 high 0.163 
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Table 3.65: Median for non-normally b distributed clinical and immunological data collected on the 
second visit. Shapiro-Wilk normality test was performed to check for non-normally distributed 
parameters (p<0.05) which were fist log-transformed. If the log-transformation still resulted in a non-
normal distribution then non-parametric Kruskal-Willis test was used whereas Student’s t test was 
considered in case of normally distributed data. Significant differences between cytokine data was 
calculated by using a dataset of 90 patients. Cases with missing values were excluded and therefore, the 
number of cases for  p value calculations differed between covariates *. Shading indicates a significant p 
value < 0.05. 
Dengue positive cases (n=128) * grouped by Serotypes 1&3 
Covariate 
DENV-1  DENV-3  p value 
CT_2ND_COLLECTION b 26.870  29.570  0.001 
PLT_2 b 92.500  104.000  0.359 
IP_10_2 b 1491.050  1260.250  0.289 
I_TAC_2 b 1121.750  1048.650  0.544 
IFN_ALPHA_2 b 531.840  234.200  0.027 
IL_8_2 b 3.940  2.580  0.002 
IL_10_2 b 24.800  9.790  0.144 
 
3.2.2 Phylogenetic Analysis of 94 Virus Strains from the EDEN Study 
 
The viruses isolated from dengue patients from the 2005 Singaporean dengue outbreak 
were sequenced to identify subgroups that could be related to disease outcome, 
specifically to compare clades with regard to the clinical parameters that resulted from 
the severity modelling.  
 
3.2.2.1 Full Length Genome Sequencing of 94 Virus Isolates 
  
In a first attempt, the preparative RT-PCR step had to be optimized to ensure efficient 
amplification of isolated viral RNA. Amplification of viral RNA was performed by 
using a strategy of five overlapping fragments which approximately measured 2.5 to 3 
kb. Fragment 5 (including the 3’UTR) of dengue serotype 1 represented the main 
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hurdle for the sequencing process and optimization resulted in the finding that a ramp 
speed of 9600 °C/s was essential for cDNA synthesis as well as for cDNA 
amplification. Moreover, a ten fold higher primer concentration with regard to the 
other fragments and serotypes had to be used (Appendix; Page 234). 
 
On the other hand, we faced another problem with fragment 3 serotype 3. Optimization 
was performed by running a gradient PCR to identify the appropriate annealing 
temperature for the two fragment specific primers. This resulted in a temperature 
increase from the commonly used 55°C to the newly used 63.1°C (Appendix; Page 
234). 
 
By using the optimized protocol (Materials & Methods; Page 85), we successfully 
sequenced a total of 94 dengue virus isolates from the 2005 Singaporean dengue 
outbreak (Appendix; Page 238). 53 DENV-1 along with 41 DENV-3 full genome 
sequences were obtained (Table 3.66). Due to the low number of isolated DENV-2, we 
first aimed at completing serotypes 1 and 3 which were eventually used for further 
analysis. 
 
Table 3.66: Overview of the 112 virus isolates & their status of sequencing. One DENV-1 strain and 
four DENV-3 strains were only partially sequenced and thus considered as not sequenced +. 
Description DENV-1 DENV-2 DENV-3 Total 
Number of isolated virus strains 57 5 50 112 
Number of virus isolates that did not grow 2 1 4 7 
Number of virus isolates without any PCR product 1 0 1 2 
Number of virus isolates that were available for 
sequencing 54 4 45 103 
Total number of sequenced virus isolates 53 + 0 41 + 94 
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3.2.2.2 Phylogenetic Analyses of the 94 sequenced Virus Genomes 
 
The obtained full-length genome sequences were aligned and the corresponding 
phylogenetic trees were inferred. Within both serotypes one outlier was detected and 
thus, was excluded from further analysis, which finally resulted in 52 DENV-1 and 40 
DENV-3 sequences incorporated into the respective trees. The mean nucleotide 
difference for DENV-1 was 19.8 (0.184%) and for DENV-3 12.6 (0.118%). Moreover, 
the phylogenetic trees (Figure 3.38; Figure 3.40) revealed one clear early split in both 
serotypes with a bootstrap value of 100%.  
 
Within serotype 1, we observed that further splitting resulted in three clear splits 
showing high bootstrap values which was nicely demonstrated by the unrooted tree 
(Figure 3.39). However, the observed splits were unbalanced and only 11 strains were 
clearly separated from the remaining 41 strains. The next split showed low reliability 
indicated by a bootstrap value of 62% suggesting high similarity within this subgroup 
of EDEN serotype 1. The high variability of bootstrap values made it difficult to 
identify appropriate clades but for ease of comparison, we could still reliably assign 
four clades (EDEN 1.1 – 1.4). The bootstrap values were 100% for splitting EDEN 1.1 
form the rest, 100% for splitting EDEN 1.2 and 99% between EDEN 1.3 and EDEN 
1.4. We decided not to further investigate EDEN DENV-1 clades due to small 
numbers of viruses in the three first clades which would not give any reliable statistical 
values in any comparative analysis against EDEN 1.4. 
 
On the other hand, the tree generated from genomes of strains within serotype 3 
generally had branches with higher bootstrap values than the serotype 1 tree. In 
addition, the unrooted tree (Figure 3.41) described higher diversity between the 
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different strains which was underlined by the longer branch lengths and the star-like 
branching pattern with regard to DENV-1. Nevertheless, it was noticed that also the 
EDEN DENV-3 strains were very similar to each other but we still defined four clades 
(EDEN 3.1 – 3.4) that we would use for further investigations. The bootstrap values 
were 100% for the first split and afterwards 100% for separating EDEN 3.1 from 
EDEN 3.2 and 71% for splitting EDEN 3.3 from EDEN 3.4. 
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EDEN Clade 1.4 
EDEN Clade 1.3 
EDEN Clade 1.2 
EDEN Clade 1.1 
Figure 3.38: Phylogenetic tree based on the whole genome (10,735nt) of 52 EDEN DENV-1 isolates. 
The mean nucleotide difference within EDEN serotype 1 was 19.8 (0.184%). Strain 05K4107DK1 was 
an outlier and thus, was removed to better visualize the tree structure. The tree leaves are labeled with 
the EDEN ID number and the bootstrap value supporting each node is indicated. 
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Figure 3.39: The phylogenetic tree from Figure 3.38 drawn in radiation form. The tree leaves are 
labeled with the EDEN ID number. 
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EDEN Clade 3.4 
EDEN Clade 3.3 
EDEN Clade 3.2 
EDEN Clade 3.1 
Figure 3.40: Phylogenetic tree based on the whole genome (10,707 nt) of 40 EDEN DENV-3 isolates. 
The mean nucleotide  difference within EDEN serotype 3 was 12.6 (0.118%). Strain 05K4440DK1 was 
an outlier and thus, was removed to better visualize the tree structure. The tree leaves are labeled with 
the EDEN ID number and the bootstrap value supporting each node is indicated. 
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EDEN Clade 3.4 
EDEN Clade 3.3
EDEN Clade 3.1 
EDEN Clade 3.2
Figure 3.41: The phylogenetic tree from Figure 3.40 drawn in radiation form. The tree leaves are 
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3.2.3 Comparison of Clinical Parameters between the four EDEN DENV-3 
Clades 
 
After the phylogenetic analysis and after defining significant clades within serotype 1 
and 3, we aimed at identifying whether there might be clades correlating with disease 
severity. For this purpose we compared the clinical parameters identified by the 
severity modeling. Serotype 1 genomes were excluded from the analysis due to their 
high similarity (low bootstrap values) which made it difficult to find appropriate 
clades. Moreover, three of the identified clades (EDEN 1.1, EDEN 1.2, EDEN 1.3) 
consisted of small numbers of viruses which would not give any statistically reliable 
values. Thus, the DENV-3 clades were selected for further analyses. 
 
Using ANOVA, we identified viral load as well as platelet count collected on the first 
visit as the only significant differences between the four DENV-3 clades (Table 3.67; 
Figure 3.42; Figure 3.43). In addition, post-hoc calculations using the Tukey test, 
resulted in the finding that only clades EDEN 3.1 and EDEN 3.2 showed a real 
significant difference (p=0.014) between each other (Table 3.68). The remaining 
clades were not significantly different from each other (p>0.05). Interestingly, we also 
revealed a significant difference between clades EDEN 3.1 and EDEN 3.3 (p=0.041) 
as well as between EDEN 3.3 and EDEN 3.4 (p=0.032) with regard to the platelet 
count on the first visit (Table 3.69). 
 
Calculations within DENV-3 using the two clades showing a 100% bootstrap value 
(EDEN 3.1 combined to EDEN 3.2 and EDEN 3.3 combined to EDEN 3.4) did not 
result in any significant differences. Moreover, we did not identify any clear 
174 
3. Results Investigating the 2005 Singaporean Dengue Outbreak 
 
differences between the DENV-3 clades regarding second visit data by either using 
two or four clades.  
 
Table 3.67: Mean for significant parameters collected on the 1st visit grouped by DENV-3 EDEN 
clades. Cases with missing values were excluded and therefore, the number of cases for  p value 
calculations differed between covariates *. CT_1ST_COLLECTION=viral load whereby a high Ct-
value indicates a low viral load; PLT=platelet count; DV_IG_G=indicator for primary/secondary 
infection whereby a positive result indicates a secondary infection; 1=1st visit data; Shading indicates a 
significant p value < 0.05. 
Serotype DENV-3 (n=40) * grouped by identified DENV-3 EDEN clades 
Covariate 
EDEN 3.1 EDEN 3..2 EDEN 3.3 EDEN 3.4 p value 
21.212 14.917 17.291 19.501 0.014 CT_1ST_COLLECTION 
PLT_1 159.583 153.000 241.571 161.294 0.028 
DV_IG_G_1 3 pos / 9 neg 2 pos / 2 neg 2 pos / 5 neg 6 pos / 11 neg  
PLT_CLASS 2 low / 10 high 2 low / 2 high 3 low / 3 high 3 low / 13 high  
HOSPITALIZED 3 yes / 9 no 3 yes / 1 no 5 yes / 2 no 8 yes / 9 no  
 
Table 3.68: Matrix of pairwise comparison probabilities of viral load between the four DENV-3 EDEN 
clades determined by the Tukey post hoc test. CT =viral load whereby a high Ct-value indicates a low 
viral load.   Shading indicates a significant p value < 0.05. 
Post Hoc Test CT EDEN 3.1 EDEN 3..2 EDEN 3.3 EDEN 3.4 
EDEN 3.1 1.000    
EDEN 3.2 0.018 1.000   
EDEN 3.3 0.105 0.704 1.000  
EDEN 3.4 0.572 0.105 0.505 1.000 
 
Table 3.69: Matrix of pairwise comparison probabilities of platelet count between the four DENV-3 
EDEN clades determined by the Tukey post hoc test. PLT=platelet count. Shading indicates a significant 
p value < 0.05. 
Post Hoc Test 
PLT EDEN 3.1 EDEN 3..2 EDEN 3.3 EDEN 3.4 
EDEN 3.1 1.000    
EDEN 3.2 0.998 1.000   
0.041 0.121 1.000  EDEN 3.3 































Figure 3.42: Comparison of viral load between the four EDEN DENV-3 clades. Viral load is 
represented as Ct-value and high Ct-value indicates a low viral load. We observe that EDEN 3.2 has the 



























Figure 3.43: Comparison of platelet count between the four EDEN DENV-3 clades. A low platelet 
count is considered to be a marker of severity. We observe that  EDEN 3.3 has the highest platelet 
count. However, the error bars show a large range and thus, it is unlikely that there is a real difference 
between the different clades. 
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4.1 Decision Tree Analyses 
 
4.1.1 Modeling of Disease Data 
 
The first part of my master thesis investigated the clinical and immunological factors 
that might play a crucial role in early dengue pathogenesis and might be useful to 
distinguish dengue virus infection from other febrile illnesses in an early stage of 
disease. The second part focused on finding a clinical as well as immunological model 
for severity in dengue disease, especially on finding early markers that might represent 
potential risk factors for the development of more severe disease manifestations.  
 
4.1.1.1 Decision Tree Models 
 
To address the research questions above, C4.5 classification trees (Quinlan, 1993) 
were used which have several advantages over other statistical tools. Briefly, 
classification trees are in principle simple to understand and are able to handle both 
continous and categorical data. A simple model based on clinical parameters, enabling 
diagnoses of dengue disease and prediction of disease severity in an early stage of 
disease is highly desirable and might be of great support in epidemic settings where a 
lack of infrastructure and under representation of trained personal could result in high 
morbidity or eventually death. Furthermore, the C4.5 classification tree algorithm used 
is able to handle missing values which represent a common problem in clinical studies. 
This permitted us to make use of all the clinical data available and thus, we did not 
always have to exclude cases with missing values. In contrast, logistic regression as 
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well as discriminant analyses require much more data preparation and appropriate 
handling of missing values is crucial for reliable calculations (Acuna and Rodriguez, 
2004). Finally, decision trees are easy to interpret, use and validate using common 
statistical techniques. Our data mining approach was able to combine new findings as 
well as established disease mechanisms in dengue pathogenesis.  
 
 4.1.1.2 Modeling of Dengue Infection 
 
The early time point (average 42h of illness) of the patient blood sample represents a 
major advantage over other studies that also aimed at dengue diagnosis and/or disease 
severity which, in contrast, made use of samples collected at later time points. In 
addition, this study is the first to integrate clinical along with immunological factors 
such as cytokines and lymphocyte counts into one predictive model for dengue disease 
which shows a sensitivity of 90%. The use of decision tree modeling is also a novelty 
in the dengue field.  
 
4.1.1.3 Modeling of Disease Severity 
 
Even though, there were only two reported cases of DHF according to the WHO 
guidelines, we were able to find an appropriate severity categorization based on 
platelet counts that might be useful in the assessment of disease severity in adults. The 
validity of our severity models is supported by the high accuracy achieved as well as 
by the correct classification of the two DHF cases. Models either based on clinical 
data, cytokine data or mixed data were always able to correctly classify the two DHF 
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cases.  One aspect that may explain the low DHF incidence in our study is represented 
by the fact that adults have a decreased risk compared to children for the development 
of vascular permeability and thus for DHF/DSS. Therefore, in areas such as Singapore 
where predominantly adults are infected, it is fundamental to get a more detailed 
picture of dengue pathogenesis in adults and our accurate predictive models make a 
significant contribution towards understanding of dengue fever in adult patients.  
 
4.1.1.4 Important Considerations of our Approach 
 
Although our model for dengue diagnosis shows high accuracy, we have to keep in 
mind, that the disease background of the control group is essential. The possibility of 
an overrepresentation of causative agents that are not of viral origin amongst the 
control group, may mean that our diagnostic tool might not be specific for dengue 
infection but might more likely represent a general picture of flaviviral or even viral 
infections. Therefore, it is evident that our models for dengue prediction have to be 
validated in different epidemic settings with higher incidence of other flaviviral 
infections in which infections amongst the controls are clearly identified.  
 
Another drawback of this study may lie in the absence of 2nd as well as 3rd visit data 
for the control group. Having this kind of information might give a better picture of 
dengue pathogenesis in comparison to other febrile illnesses. With regard to cytokines 
and their kinetics it would be especially interesting to investigate the differences over 
the course of an infection and to determine how long cytokine levels remain elevated 
after dengue infection. The next critical point in the presented study involves using 3rd 
visit data of dengue patients as healthy control samples which may fail in detecting 
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elevated cytokine levels because it is not known how long cytokines may remain in 
patient’s serum after dengue infection. Considering the phenomenon of cross-
protection against heterologous serotypes, a time window of several months after 
dengue infection is probably necessary to ensure normal levels of immune mediators 
that could serve as healthy controls. Hence, it would have been very useful to have 
data from a 4th visit after several months that would have represented healthy controls. 
 
Finally, the lack of a substantial number of severe cases in our study could be a 
disadvantage in the generalization of our severity model. Our severity categorization is 
based on low platelet counts and even though the chosen threshold of <50,000 
platelets/mm3 is underlined by two other studies (Balmaseda et al., 2005; Malavige et 
al., 2006), it is necessary that our model has to be evaluated in an epidemic setting that 
shows higher severity than Singapore. Finally, a severity categorization based on more 
than one parameter will probably be more accurate than our proposed categorization 
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4.1.2 Distinguishing Dengue from other Febrile Illnesses in an early Stage of 
Disease 
 
4.1.2.1 White Blood Cell Count, absolute Numbers of Lymphocytes and 
Temperature, but not Symptoms can Diagnose Dengue Infection in an early 
Stage of Disease 
 
A recent study reported a predictive model based on logistic regression to diagnose 
dengue fever within the first two days of admission (Chadwick et al., 2006). This study 
mainly used clinical data combined with symptoms to predict dengue infection and 
showed a sensitivity of 84%. By contrast, our model (DENPRE_TOTAL_453; Figure 
3.1; Page 94) using clinical data within 72 hours of onset of disease also shows a 
sensitivity of 82%, and integration of cytokine data (DENPRE_INCYTA_291; Figure 
3.7; Page 105) resulted in an increased sensitivity of 90%. It is intriguing that our 
classification tree based on clinical data and Chadwick’s model show striking 
similarity to each other. The first split chosen by our tree is represented by a white 
blood cell count equal or lower than 4800 cells/mm3 and this threshold is supported by 
the logistic regression model which defined a white blood cell count of lower than 
5000 cells/mm3 as a genuine risk factor for dengue infection. The logistic regression 
model of Chadwick’s study further used rash, creatine, bilirubin and prothrombin time 
as discriminators whereas our presented classification tree included the absolute 
numbers of lymphocytes and the body temperature as further splitting criteria. We 
were not able to include the clinical data used by the logistic regression model because 
the respective variables were not measured in the EDEN study. Furthermore, model 
calculations only based on symptoms did not result in a reliable classifier suggesting 
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that detection of dengue specific symptoms is only possible in a later stage of disease. 
The advantage of our decision tree over the recently published logistic regression 
model not only lies in the early time point of sample collection but also in the fact that 
we were predicting a PCR positive result which shows a sensitivity higher than 99%. 
The IgM assay that Chadwick and collaborators based their logistic regression on, 
shows a slightly lower sensitivity. PCR is more specific than the IgM assay because 
IgM can be also found in other flaviviruses although these are not frequent in 
Singapore. 
 
In addition, we were able to analyze different subgroups of dengue patients which 
clearly revealed that having a lower white blood cell count represents a main but not 
the only indicator for a positive dengue PCR result. The decision tree especially 
emphasized the decreased numbers of lymphocytes as a main characteristic of acute 
dengue infection. This finding is supported by another study also showing low 
numbers of lymphocytes in an acute stage of dengue disease (Azeredo et al., 2001). 
 
Our clinical model shows a very high accuracy of over 90% and the stability is 
underlined by a narrow confidence interval of the calculated AUC of the ROC curve 
(Table 3.3; Figure 3.2; Page 96). Moreover, the odds ratios calculated either on the 
whole dataset or at each decision node show high level of significance and the 
similarity of the two models based either on the total dataset (453 cases) 
(DENPRE_TOTAL_453; Figure 3.1; Page 94) or on 291 cases 
(DENPRE_EXCYT_291; Figure 3.3; Page 98) proves the validity of our calculations. 
It is important to note that the chosen classifier on the ROC curve is skewed towards 
identifying true negative cases because by definition, the program chooses the model 
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at a specific threshold with the highest profit for the major class. This resulted in the 
lower sensitivity of 82% compared to a higher specificity of 91% (Table 3.3; Figure 
3.2; Page 96). The model was evaluated by stratified k-fold cross validation (k=10) 
which is considered to be a powerful method to prevent data overfitting (Kohavi, 
1995). Nevertheless, it is necessary that our decision tree model gets evaluated in a 
new epidemic setting. Assessment of the classification tree on negative patients 
enrolled in 2006 showed similar classifier performance. However, evaluating the 
classifier in terms of its ability to identify dengue positive cases is of much higher 
relevance, especially in a setting where other flaviviruses and symptomatically similar 
diseases like Chikungunya are frequent.  
 
This presented model includes only basic clinical parameters and is useful in providing 
assistance in dengue diagnosis in an early stage of disease. To some extent, it might be 
a useful substitution in epidemic settings where lack of infrastructure and under 
representation of trained staff exacerbate the implementation of either the commonly 
used virus isolation, the serologic PCR or the IgM assay. Measuring the white blood 
cell count and the number of lymphocytes are commonly used basic hematological 
tests that are not laborious, do not require highly trained staff and are probably more 
economical than the commonly used dengue diagnostic tools. Hence, the model may 
allow early dengue diagnosis at low cost. Combination of this diagnostic model with 
our proposed severity prediction might contribute to better case management and 
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4.1.2.2 Lower IL-2 and decreased TNF-α, but elevated IL-10 Levels along with an 
increase of IP-10 may be highly specific for an early Stage of Dengue Disease 
 
It is known that serum concentrations of cytokines and soluble receptors may be 
significantly increased during dengue virus infection. Different studies showed that, in 
comparison to healthy controls, levels of IL-10 (Fink et al., 2006; Green and Rothman, 
2006; Green et al., 1999a; Libraty et al., 2002; Nguyen et al., 2004), TNF-α (Fink et 
al., 2006; Green and Rothman, 2006; Hober et al., 1996; Nguyen et al., 2004), IFN-γ 
(Kurane et al., 1991; Kurane et al., 1986), IFN-α (Chang et al., 2006; Fink et al., 2006; 
Green and Rothman, 2006) and IL-2 (Kurane et al., 1991; Pacsa et al., 2000) are 
elevated. To our knowledge, only a few studies were performed that compared serum 
cytokine levels of dengue patients to controls suffering from other febrile illnesses. 
Furthermore, these studies were mainly performed on samples collected from children 
and might not be representative for adult infections. In our study, we compared dengue 
cases to other febrile illnesses and identified various cytokines as genuine risk factors 
for dengue infection which were represented by higher levels of IP-10, I-TAC, IFN-α, 
IL-1 as well as IL-10 but by lower serum concentrations of IL-2 and TNF-α. 
 
A decision tree that only included the available cytokine data but excluded the clinical 
data, resulted in a classifier (DENPRE_CYTOA_291; Figure 3.9; Page 108) that used 
IFN-α as the first splitting criterium. Dengue positive patients more often had higher 
levels of IFN-α possibly reflecting an antiviral mechanism. Generally, interferons have 
important functions in different kinds of antiviral responses. In particular, the dengue 
specific immune response is mediated by RIG-1 that recognizes double-stranded RNA 
and activates type I interferon signaling/secretion, especially IFN-α (Chang et al., 
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2006; Green and Rothman, 2006). However, considering the general importance of 
type I interferons in antiviral responses and the fact that the causes of disease amongst 
the controls is not known, we must bear in mind that our results naturally support a 
dengue specific immune mechanism but do not shed light on whether high levels of 
IFN-α are a useful indicator specifically for dengue prediction. This led us to the 
assumption that exclusion of IFN-α from our decision tree analysis might be useful in 
detecting dengue specific cytokines. The resulting tree (DENPRE_CYTO_291; Figure 
3.11; Page 111) chose IL-2 as the first decision criterium which, in contrast, was the 
second splitting criterium in the tree calculated with the inclusion of IFN-α. We 
observed that very low levels of IL-2 represented a high risk of having a symptomatic 
dengue infection which was supported by a high and significant odds ratio. 
Interestingly, we were not able to find any significant changes of IL-2 between the 
three visits which is in contrast to another reported study that showed elevated levels 
of IL-2 during course of infection (Kurane et al., 1991; Pacsa et al., 2000). We explain 
the observed phenomenon with regards to several aspects. IL-2 is an important 
cytokine mainly produced by activated T-cells which supports the activation of naïve 
T-cells and their subsequent proliferation into effector T-cells. It is generally produced 
upon contact with various kinds of antigens and plays a major role in shaping an 
appropriate immune response. Thus, we can assume that IL-2 levels amongst the 
controls suffering from other febrile illnesses are also elevated but due to the lack of 
required data, we were not able to determine differences in cytokine levels between 
our control group and healthy adults. In addition, comparison of IL-2 levels of dengue 
patients on the 1st and 2nd rd visit did not differ significantly from IL-2 levels on the 3  
visit which might be explained by a short time window after infection to detect normal 
cytokine levels. Nevertheless, our findings might be linked to the observed 
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phenomenon of impaired T-cell proliferation in acute dengue infection (Mathew et al., 
1999). Mathew’s study showed that accessory cells obtained from peripheral blood 
mononuclear cells (PBMCs) during acute dengue infection did not provide an adequate 
stimulus to enable T-cell proliferation. The decreased responses of T-cells could be 
partially restored by exogenous IL-2 and IL-4, showing the functionality of T-cells. 
Our results suggest that patients already having significantly lower levels of IL-2 are at 
main risk for symptomatic dengue infection. Upon infection, this subgroup of patients 
is not able to generate an appropriate immune response. In addition, dengue virus 
aggravates this effect by impairing the beneficial T-cell proliferation. This 
subsequently leads to an immediate establishment of dengue infection and probably to 
a higher viral load compared to patients with higher IL-2 levels. Grouping dengue 
positive patients by low (<=2.54 pg/ml) and high levels of IL-2 revealed a higher viral 
load in patients with low IL-2 (p=0.08). Furthermore, it is worthwhile mentioning that 
univariate analysis performed on IL-2 grouping of dengue patients detected significant 
differences with regards to their cytokine levels on all three visits (results not shown) 
suggesting major differences in their immune responses.  
 
Patients showing higher levels of IL-2 were further split into subgroups by either IL-10 
(including IFN-α) or IP-10 (excluding IFN-α). Both trees showed that higher levels of 
either these cytokines are able to correctly predict dengue infection with a sensitivity 
of 84%. It is intriguing that several other studies also showed increased higher levels 
of IL-10 during dengue infection (Fink et al., 2006; Green and Rothman, 2006; Green 
et al., 1999a; Libraty et al., 2002; Nguyen et al., 2004) which serve as valuable support 
for our calculated model. IL-10 is an anti-inflammatory cytokine mainly produced by 
monocytes and regulatory or TH2 cells and inhibits IL-2 secretion which is a cytokine 
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specific for TH1 responses. Its increased secretion in an early stage of an acute dengue 
infection might be another explanation for the unchanged or minimally decreased 
levels of IL-2 and for the impaired T-cell proliferation. Interestingly, recent studies 
showed that IL-10 suppresses the activation of cytotoxic T-cells (Brooks et al., 2006; 
Ejrnaes et al., 2006). Moreover, we observed that IL-10 levels on the 1st and 2nd visit 
were significantly higher than compared to the 3rd visit suggesting IL-10 to be highly 
specific for the early acute phase of dengue infection.    
 
On the other hand, interferon-γ inducible protein 10 (IP-10) is a chemokine specific for 
the CXCR3 receptors which are selectively expressed on activated T-cells. IP-10 plays 
a role in the regulation of lymphocyte recruitment as well as in the recruitment of 
monocytes and NK-cells (Baggiolini et al., 1997). There is still little information about 
IP-10 function during dengue infection but two in vivo studies showed that dengue 
virus induces expression of IP-10 which, in turn, competitively inhibits viral binding 
and is required for resistance to primary dengue infections in mice (Chen et al., 2006; 
Hsieh et al., 2006). Our study is the first to measure IP-10 serum levels in dengue 
patients and decision tree analysis revealed that high IP-10 levels might be specific for 
dengue infection which was additionally backed by a high odds ratio and its narrow 
confidence interval.  
 
Both trees (including or excluding IFN-α) used TNF-α as the last splitting criteria but 
with slightly different thresholds. We identified a lower level of TNF-α as a 
significantly higher risk factor for being dengue positive which represents a clear 
contradiction to other studies which showed that serum concentrations of TNF-α are 
higher during dengue infection, especially in DHF/DSS (Fink et al., 2006; Green and 
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Rothman, 2006; Hober et al., 1996; Nguyen et al., 2004). A possible reason for such a 
contradiction may lie again in our control group which represents patients suffering 
from other febrile illnesses and not healthy adults. TNF-α is a pro-inflammatory 
cytokine and is mainly secreted by macrophages, mast cells as well as lymphocytes. 
TNF-α is the main regulator of pro-inflammatory responses and levels are usually 
increased during a plethora of infections which may allow the conclusion that TNF 
levels must also be elevated amongst our control patients. We were not able to 
determine the levels in respect to healthy controls. Comparison of TNF-α levels of 
dengue patients on all the three visits, did not detect any significant changes in 
concentration. These findings demonstrate some similarity with another study showing 
little to no change in TNF-α levels to healthy control children (Green et al., 1999a). 
Another  possible explanation for our observation of low TNF levels might be the lack 
of a substantial number of DHF/DSS cases in our study which show stronger 
associations to the secretion of TNF-α than the classical dengue fever cases.  
 
In summary, we can conclude that prediction of dengue cases only based on cytokines 
is accurate and that we identified IP-10 as a possible new predictive marker for dengue 
infection. Furthermore, we find lowered TNF-α levels along with higher serum levels 
of IL-10 to be associated to dengue infection in an early stage of disease and compared 
to other febrile illnesses. Our approach is the first to link lower levels of IL-2 derived 
from clinical samples to low lymphocyte numbers which might represent impaired T-
cell proliferation.  
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4.1.2.3 Lower IL-2 Levels, higher IP-10 Levels as well as increased IFN-γ combined 
with clinical Data are strong Predictors for Dengue Infection in an early Stage 
of Disease 
 
Combination of basic clinical data and cytokine data resulted in two different decision 
trees that showed higher accuracies than trees based only on either clinical or cytokine 
data. The first constructed tree including IFN-α (DENPRE_INCYTA_291; Figure 3.5; 
Page 101) did not change its first two splitting criteria compared to the tree which was 
based only on cytokine data. IFN-α was followed by IL-2 but, in turn, the white blood 
cell count was used as a third splitting criteria for patients having lower IFN-α along 
with higher IL-2 levels. This suggests that the white blood cell count is probably a 
better predictor than IL-10 which is underlined by the better overall performance 
compared to the tree based only on cytokine data and by the fact that the tree based 
only on clinical data was the better predictor by itself. Furthermore, the odds ratio of 
white blood cell count is four times higher than the one of IL-10. The decision node 
that further separates patients with a lower white blood cell count was represented by 
IL-1 which is also reported to be secreted during dengue infection (Hober et al., 1993). 
Generally, IL-1 is mainly secreted by macrophages and dendritic cells and has an 
important function in the activation of a specific immune response during 
inflammation. Its effector functions are similar to TNF-α which might be the reason 
for its position in the tree. It is intriguing that higher levels of IL-1 are a significant 
characteristic of dengue positive patients whereas high TNF-α levels are more 
common in other febrile illnesses suggesting that IL-1 is more specific for classical 
dengue fever and TNF-α might be more important in DHF/DSS as reported in other 
studies (Kittigul et al., 2000; Nguyen et al., 2004). 
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Interestingly, our best calculated classification model excluded IFN-α and combined 
other cytokines as well as clinical data (DENPRE_INCYT_291; Figure 3.7; Page 105). 
It achieved an overall performance of 94% with a sensitivity of 90%. In the calculated 
tree, a lower white blood cell count and lower absolute numbers of lymphocytes 
represented the clinical risks for dengue infection. On the other hand, the 
immunological factors were represented by IL-2, IP-10, TNF-α as well as IFN-γ. IFN-γ 
is a pro-inflammatory TH1 specific cytokine and is mainly produced by macrophages. 
Our finding that elevated IFN-γ levels could be an indicator for dengue virus infection 
is consistent with earlier reports demonstrating the induction of IFN-γ secretion upon 
dengue infection (Kurane et al., 1991; Kurane et al., 1986). Due to the early time point 
of sample collection, we expected to observe elevated levels of TH1 cytokines which 
was shown by Pacsa and collaborators (Pacsa et al., 2000). Hence, it is striking that the 
observed cytokines included in our trees do not fully support this hypothesis but rather 
point towards an overlapping of TH1 and TH2 responses. 
 
The decision tree explicitly shows the complex picture of cytokines interacting with 
lymphocytes and is highly predictive in distinguishing dengue patients from patients 
with other febrile illnesses. We can conclude that the cytokines and clinical features 
represented in the combined classification model are of significant importance during 
an early stage of dengue infection. Nevertheless, it is prudent that our classification 
tree has to be closely evaluated in several aspects. Firstly, more detailed statistical 
investigation is needed to identify correlations between the chosen parameters at the 
decision nodes because by only looking at the decision tree, we are unable to detect 
direct interactions. Secondly, cytokine production has to be investigated on a cellular 
level and in vivo to understand the sources, kinetics and functional impacts of 
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cytokines specifically produced upon dengue infection. Finally, the model has to be 
validated in other epidemic settings, especially in regions with a high prevalence of 
other flaviviruses to determine dengue specific cytokines. Moreover, the combined 
model is useful in providing a hint of which cytokines might be of greater interest to 
investigate but it would not be suitable as a diagnostic tool in epidemic settings. The 
major drawback lies in the procurement of cytokine data which entails more labour 
and has higher cost than the commonly used hematological methods.  
 
In summary to the first aspect, we integrated immunological and clinical factors into a 
predictive model for dengue infection, we propose that the combined decision tree may 
be a biological tool for the better understanding of the interplay between humoral and 
cellular factors during an early stage of disease and highlight that the tree based only 
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4.1.3 Severity Prediction in an early Stage of Disease 
 
4.1.3.1 Platelet Group Classification shows Consistency and Coherence with the two 
Cases classified as DHF after the WHO Guidelines 
 
Combination of dengue diagnosis with a model that could predict disease severity 
would be essential for appropriate case management. Hence, we aimed at predicting 
disease severity in dengue patients. In a first attempt, we defined hospitalization as the 
severity categorization which resulted in an accurate classification tree 
(HOSP_TOTAL_133; Figure 3.13; Page 115) including the platelet count at the 
second visit, the number of lymphocytes during the first visit and finally, the body 
temperature at the second visit. Considering our goal to predict severity early on in 
dengue disease by using first visit data only, and considering that hospitalization is 
biased due to its dependency on various factors (Results; Page 123), we decided to find 
a new severity categorization that might be more reflective for adult dengue patients. 
Moreover, a classifier calculated on a smaller dataset (HOSP_EXCYT_95; Figure 
3.15; Page 118) resulted in different splitting criteria and used a slightly different 
threshold than the tree based on the total dataset suggesting instability of classifier 
performance. Even including cytokine data did not result in an improvement and on 
the other hand, a decision tree constructed by only using cytokine data 
(HOSP_CYTO_95; Figure 3.17; Page 121) did not show a reliable overall 
performance. The observed variation in classifier performance is further underlined by 
the calculated statistical values on the whole dataset which show that some of the 
chosen parameters are not real risk factors for hospitalization. 
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As a consequence, we chose a low platelet count as an indicator for severity. A 
threshold of <=50,000 platelets/mm3 on either day five, six or seven of illness defined 
the cases of a more severe group. A low platelet count as a valid indicator for severity 
is underlined by several studies showing association of thrombocytopenia with more 
severe infections (reviewed in (Fink et al., 2006)), especially the threshold of 
<=50,000/mm3 is supported by two studies describing significant associations with 
more severe disease manifestations (Balmaseda et al., 2005; Malavige et al., 2006) and 
by our study, showing nadir of platelet counts to be in the range of 50,000/mm3 on 
either day five, six or seven. Categorization of dengue patients into mild and severe 
cases was also based on the assumption that non-hospitalized cases might be suffering 
from mild infections and therefore were classified as non-severe. Naturally, it is 
deputable that we might have missed some non-hospitalized patients but considering 
the outline of the EDEN study (Low et al., 2006) and the high hospitalization rate in 
Singapore it is unlikely that there were severe cases in the group of non-hospitalized 
cases. 
 
We found that the two platelet groups (low and high) showed significant differences 
and especially the viral load (higher in more severe patients), the platelet count (lower 
in more severe patients), the body temperature (higher in more severe patients) as well 
as the immunological background (more secondary infections in more severe patients) 
represented the genuine risks on the first visit (Table 3.32; Page 130). Interestingly, 
categorization by hospitalization resulted in a slightly different picture. Secondary 
infection as a genuine risk for severity was only found by the platelet categorization. 
We concluded that significant differences with regard to measured clinical parameters 
(Table 3.28;Table 3.29; Table 3.30; Table 3.31; Table 3.32; Pages 127 to 130) only 
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observed by the proposed platelet categorization which are not obvious using 
hospitalization as a severity indicator are highly interesting early features specifically 
correlating with a later platelet decay. Moreover, looking at differences between the 
two categorization methods with regard to cytokine patterns revealed only three 
differences in hospitalization but, in turn, seven differences in platelet groups which 
additionally highlights a higher sensitivity of platelet categorization in detecting more 
severe patients (Table 3.33; Table 3.34; Table, 3.35; Table 3.36; Table 3.37; Table 
3.38; Pages 131 to 133). This is backed by the common assumption in the dengue field 
that cytokines play a crucial role in disease pathogenesis. Finally, it is important to 
mention that all calculated models predicting severity were able to correctly classify 
the two DHF cases in our study as more severe cases which confers validity to the used 
classification scheme. 
 
4.1.3.2 A high viral Load combined with a secondary Infection is a genuine Risk 
Factor for the Development of Thrombocytopenia 
 
We investigated the possibility of predicting development of a low platelet count on 
day five, six and seven by including clinical as well as immunological data into one 
reliable model. In a first attempt, we only exploited clinical data collected on the 1st 
visit which resulted in a classification tree (SEVERE_TOTAL_125; Figure 3.20; Page 
135) with a sensitivity of 81% and a specificity of 83%. The fist decision node made 
use of the platelet count as a splitting criteria with a threshold set to <=108 
platelets/mm3. It is evident that patients already having a low platelet count on the first 
visit are at greater risk for the development of an even lower platelet count during 
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infection. Consequently, we considered the group of patients presenting a higher 
platelet count at the first visit as more interesting with regard to severity prediction.  
 
Remarkably, we observed that dengue patients having a higher viral load along with a 
secondary infection are at major risk to become thrombocytopenic during infection. 
The calculated decision tree explicitly shows that having a high platelet count in 
combination with a low viremia in an early stage of disease is almost no risk for the 
progression into severe disease manifestations and shows a relative risk reduction 
(RRR) of 91%19. The RRR value may be an important consideration regarding drug 
discovery and vaccine development. Our model clearly shows that development of a 
drug and/or vaccine that may reduce viral load in a very early stage of disease is highly 
desirable and might prevent the progression to the more severe dengue forms. 
Furthermore, it highlights secondary infections as a risk factor which is a major 
challenge in vaccine implementation. 
 
The presented model also supports the finding of another study which clearly showed 
that high viremia titers 3 days after onset of fever correlated with severe disease 2 days 
later at the time of defervescence (Vaughn et al., 2000).  We observed that there was 
no correlation regarding viral load and secondary infection on the whole dataset as 
well as at the specific decision node (results not shown). Hence, we can consider viral 
load and secondary infections as two independent risk factors that, in combination, 
may have a significant influence on disease outcome. This is contradictory to the 
theory of antibody dependent enhancement (ADE) which, strictly applied, defines a 
direct relationship of viral load with secondary infections (Halstead, 2003). Briefly, it 
                                                 
19 RRR of people with a high platelet count along with a low viral load is calculated by 1/(Relative Risk 
of people having a high platelet count along with a high viral load)-1; 1/11.34-1=-0.912 (For values 
please refer to the results section: Ta ; Page 136) ble 3.40
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is thought that binding of cross-reactive antibodies from a primary infection enhances 
uptake of virus via Fc-receptors into target cells and subsequently leads to higher 
replication causing higher viremia. Our observations would not be against the theory 
of cross-reactive T-cells which are thought to be triggered upon a secondary infection 
and which subsequently influence disease outcome (reviewed in (Green and Rothman, 
2006)). Looking at the sequence of decision nodes and at the frequency distributions in 
our proposed model, we hypothesize that a higher viral load might trigger a stronger 
immune response and a combined secondary infection enhances the risk of an 
increased inflammatory response which finally causes a more severe disease outcome.  
We can assume that the calculated decision tree and its chosen features based on the 
overall dataset (125 cases) are reliable because constructing a tree on a dataset with 
smaller sample size (89 cases) results in the exact same tree (SEVERE_EXCYT_89; 
Figure 3.24; Page 143) with similar performance. The importance of platelet count, 
viral load and secondary infections in an early stage of infection is further underlined 
by the models constructed only on the data of hospitalized cases. The two constructed 
trees (SEVHOSP_TOTAL_71; Figure 3.22; Page 139 and SEVHOSP_EXCYT_52; 
Figure 3.32; Page 155) (71 cases or 52 cases) both include as a first splitting criteria 
the platelet count with the same threshold and use as a second decision node secondary 
infections followed by viral load. The switch in the splitting criteria between 
secondary infections and viral load might be caused (1) by the smaller datasets used, 
(2) by the fact that the datasheets represent more similar cases with regard to viral load 
thus removing statistical significance and creating higher data entropy, (3) by the fact 
that the frequency distribution of secondary infections still shows the same strength 
because its dependency on the platelet groups rather than on hospitalization and (4) by 
the change in class majority meaning that, in this situation, the more severe group 
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represents the major class. The latter suggests that the further splitting criteria were 
caused by data overfitting of the tree and do not indicate genuine differences which is 
finally underlined by comparable weak statistical values on the whole dataset. 
 
By way of example, taking the two correctly classified DHF cases and following them 
through the classification steps in our decision tree, validates the calculated model. 
One patient was presented with a platelet count lower than the chosen threshold and 
was therefore not further classified. The other patient showed a higher platelet count, a 
higher viral load (meaning the Ct-value was lower than the chosen threshold) and in 
addition, was positive for IgG antibodies indicating a secondary infection. The 
simplicity of the model along with the chosen features that are easy to measure as well 
as the high accuracy of 83% represent advantages with regard to the early assessment 
of disease severity in dengue patients. Hence, implementation of the model based on 
clinical data in combination with the severity model may have an important share in 
tackling severe dengue epidemics. 
 
4.1.3.3 Higher IP-10 Levels show strong Correlation to viral Load and a similar 
Classifier Performance 
 
In a first round, including cytokine data along with clinical data into the decision tree 
modeling did not result in an improvement but rather in a decreased overall 
performance. This suggested data interference of clinical data with immunological 
data. Thus, we excluded viral load from the analysis and the resulting tree substituted 
viral load by IP-10 (SEVERE_INCYTA_89; Figure 3.26; 147). Further investigations 
of the interaction between IP-10 and viral load identified a strongly significant 
198 
4. Discussion Investigating the 2005 Singaporean Dengue Outbreak 
 
correlation (R=-0.466; 95%CI: -0.610, -0.292; p value < 0.001). This was underlined 
by the fact that excluding IP-10 from decision tree modeling did result in the same 
overall performance as calculated by exclusively using clinical data. These findings 
support that secretion of IP-10 is directly dengue virus induced (Chen et al., 2006; 
Hsieh et al., 2006). It is not clear from our data whether IP-10 and/or viral load are/is 
the factor influencing disease outcome. On the other hand, its appearance in all the 
calculated trees for severity prediction including cytokine data, and its predictive 
power in distinguishing dengue from other febrile illnesses point towards a possible 
function as a biomarker for dengue diagnosis as well as severity estimation. However, 
more epidemiological studies based on patient’s serum samples as well as in vitro 
experiments are required to elucidate the exact role of IP-10 in disease pathogenesis.  
 
4.1.3.4 IL-10 as an early Predictor of severe Dengue Infection shows higher 
Sensitivity than IL-8, but has a narrower predictive Window 
 
In a second round, we calculated a decision tree only based on cytokine data. The goal 
was to find early immunological predictors of thrombocytopenia in a later stage of 
disease. This approach resulted in two decision trees which were always using IP-10 as 
the first splitting criteria but exploited either IL-8 (SEVERE_CYTOA_IL8; Figure 
3.28; Page 150) or IL-10 (SEVERE_CYTOA_IL10; Figure 3.29; Page 150) at the 
second decision node. We observed that the two models still showed a good overall 
performance but were slightly worse when compared to the clinical trees. Furthermore, 
the confidence intervals for the AUCs of the ROC curves were comparably large 
which suggests some instability of the classifiers possibly caused by the smaller 
dataset. However, the choice of taking IP-10, IL-8 and IL-10 with the defined 
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threshold into our decision tree modeling is backed by the calculated odds ratios and 
their confidence intervals. Univariate analysis also showed significant differences of 
these three variables between the severe and the mild group. It is important to note that 
analysis of second visit data still detected significant differences of IP-10, IL-8 and IL-
10 whereas the discrepancies were reduced between the two groups on the third visit. 
These findings point towards an important general role of these three cytokines during 
dengue disease, especially in influencing the development of thrombocytopenia.  
 
We identified IL-8 in combination with IP-10 as a better early predictor for severity 
which showed an overall accuracy of 75% with a sensitivity of 66%. In addition, it is 
worthwhile mentioning that IL-8 levels detected on the second visit correlated with 
viral load on the first visit (R=-0.368; 95%CI: -0.542, -0.162; p value = 0.001) which 
highlights the importance of an early high viral load in disease outcome. Interestingly, 
we did not detect any significant differences in IL-8 levels between dengue and other 
febrile illnesses on the 1st visit. This directly supports the finding of another study 
showing that IL-8 levels of classical dengue fever patients are not elevated within the 
first 4 days whereas patients suffering from more severe disease already showed 
elevated IL-8 levels between day one and day four (Raghupathy et al., 1998). 
Furthermore, a study investigating IL-8 secretion in PBMCs detected delayed peaking 
of IL-8 levels between days three and four of infection which they explained that a 
certain threshold of viremia has to be obtained in order to induce chemokine 
transcription through NS5 (Medin et al., 2005). 
 
IL-8 is secreted by macrophages as well as epithelial cells during an inflammation and 
is a chemokine that mainly attracts neutrophiles to the site of infection (Baggiolini et 
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al., 1997). Secretion of IL-8 is linked to pleural effusion (Baggiolini et al., 1995; Pace 
et al., 1999) and IL-8 levels are elevated in more severe dengue patients (Juffrie et al., 
2000; Raghupathy et al., 1998). Induction of IL-8 secretion is controlled by the 
cytokine network which includes IL-1 and TNF-α. Because of elevated IL-1 levels in 
dengue patients with regard to our control group but no significant changes in levels 
TNF-α, we think that IL-1 is the main inducer of IL-8 during dengue infection and that 
there might be a direct induction by NS5 as proposed by Medin and collaborators 
(Medin et al., 2005). Expression of IL-8 may be used to counteract the anti-viral 
effects of innate immunity, allowing further spreading of dengue virus to neighboring 
cells (Medin et al., 2005). Such a mechanism was also observed to enhance viral 
replication in other viruses (Lane et al., 2001; Murayama et al., 1994).  
 
Substitution of IL-8 with IL-10 in the final decision tree resulted in a higher sensitivity 
of 71% but lower overall performance of 73%. This reflects a slightly narrower 
predictive window but a higher predictive power in detecting severe cases in an early 
stage of disease. We have to consider the fact that our chosen model is skewed towards 
the major class which is in our case the mild group. In such class distributions, a better 
overall performance is achieved by having a higher specificity or lower 
misclassification rate of mild cases. On the other hand, Increasing the sensitivity and 
thus decreasing the specificity leads in a higher overall error rate caused by the higher 
misclassification rate of the major class which decreases the overall performance of the 
classifier. Thus, we can assume that IL-8 is a better general predictor and that IL-10 is 
more specific for more severe infections.  
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There are several reports describing elevation of IL-10 levels during dengue infection 
(Libraty et al., 2002; Nguyen et al., 2004) and association of IL-10 with 
thrombocytopenia as well as plasma leakage (Green et al., 1999b) which clearly 
maintained our calculated model. One explanation for its important role in an early 
prediction of severity could be its inhibitory effect on IL-2 and therefore on T-cell 
proliferation. We were able to observe this in the first part where we attempted to find 
a clinical as well as immunological model that was able to distinguish dengue from 
other febrile illnesses. This impaired T-cell proliferation may lead to a higher viral 
load and finally, as observed in our clinical severity model, combined with secondary 
infections to a more severe disease outcome. Briefly, more IL-10 in an early stage of 
infection and lower IL-2 may lead to a higher viremia which subsequently affects 
disease outcome.  
 
In summary, we showed that increased levels of IP-10 in combination with higher 
serum concentrations of either IL-10 or IL-8 are a good predictive indicator for the 
development of more severe disease. Due to the fact that adults are at lower risk to 
develop DHF/DSS it is possible that the observed picture of these three cytokines may 
be important mostly in disease severity of adult patients which do not show DHF/DSS. 
This is underlined by the fact that IL-8, IL-10 and IP-10 were still elevated on the 
second visit and that no differences in TNF-α were observed. Such a picture leads to 
the assumption that TNF-α is more characteristic for DHF/DSS which, in turn, is very 
rare in adults and therefore, other immunological factors such as IL-8, IL-10 and IP-10 
may have a more important role in disease outcome of adult infections. Another 
explanation might be the fact that we predicted thrombocytopenia and therefore, only 
immunological factors specific for a low platelet count were identified. 
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4.1.3.5 Higher Levels of I-TAC are highly predictive of severe Cases in a more 
homogenous Population 
 
In a third round, we calculated a cytokine model using only the hospitalized cases 
(SEVHOSP_INCYTA_52; Figure 3.34; Page 158 and SEVHOSP_CYTOA_52; Figure 
3.36; Page 161). Assuming that the hospitalized cases are already more similar in 
terms of clinical data, we were aiming at identifying markers that might show a higher 
predictive performance in a more homogenous population. Both trees (either including 
cytokines along with clinical data or only including cytokine data) showed a good 
overall performance but had comparable large confidence intervals for the AUC of the 
ROC curve. A tree based on mixed data showed an accuracy of 83% and used platelet 
count along with I-TAC as splitting criterium. On the other hand, the tree based only 
on cytokine data used IL-8 instead of a platelet count as splitting criterium with an 
accuracy of 73%. This tree supports the important role of IL-8 in disease outcome. 
Interestingly, both trees showed I-TAC as the last splitting criteria which might be an 
indicator that I-TAC is more specific for the identification of severity in a more 
homogenous population. I-TAC is a chemokine that binds the same receptor than IP-
10 and also attracts lymphocytes to the site of infection. Currently, the exact role of I-
TAC during dengue infection is still not fully understood. Generally, this chemokine is 
secreted upon virus infections and plays a role in viral clearance. Our analyses did not 
yield any specific conclusions but were able to observe that I-TAC is induced in 
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4.1.4 Concluding Remarks and Outlook 
 
This study is the first to integrate immunological and clinical data into a predictive 
model for dengue diagnosis as well as to analyze possible risk factors in an early stage 
of disease by exploiting the approach of classification trees. We showed that decision 
trees are a powerful tool for data analysis and highlighted the novelty in the dengue 
field using this kind of approach. The study gave new insights into dengue diagnosis 
and severity prediction in adult patients. It may have a contribution in the re-
assessment of the urgently needed severity definition in adult patients and hopefully 
has a share in tackling future dengue epidemics.   
 
Using our models for dengue prediction, we were able to distinguish dengue fever 
from other febrile illnesses with high accuracy. This diagnostic model may be used in 
epidemic settings where lack of infrastructure and under representation of well trained 
staffs caused major difficulties in case management. In addition, the combined model 
of immunological factors and clinical data represents a useful picture of highly 
important host factors influenced by dengue infection. We were able to provide a link 
to new mechanisms with already well established findings in dengue pathogenesis and 
contribute in a better understanding of dengue. 
 
Our models for severity prediction showed interesting aspects and included secondary 
infection and viral load into one model. The study provides a comprehensible model 
for the early prediction of dengue severity that may improve the present severity 
definitions for adults. It could be a useful tool in the assessment of dengue severity and 
combined to the diagnostic model, may contribute to a better prevention of more 
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severe disease manifestations in dengue outbreaks. The model using immunological 
information reveals important cytokines involved in disease severity, especially in 
thrombocytopenia. 
Nevertheless, it is essential that our calculated models have to be further validated in 
other epidemic settings where other flaviviruses show a higher prevalence than in 
Singapore. This will hopefully lead to the validation of dengue specific immunological 
and clinical factors useful for dengue diagnosis along with severity prediction. More in 
vitro and epidemiological studies are required to validate our findings, especially to 
reveal the complex network of immunological and clinical factors involved in dengue 
pathogenesis. A better understanding of dengue pathogenesis is urgently needed to 
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4.2 The Virus and its Effect on Clinical Outcome 
 
In the third part of my thesis, I pursued the goal to find differences within the viral 
genome that might correlate with disease severity. For this purpose, we sequenced 94 
full length genome sequences and analyzed them with regard to their phylogeny. 
Finally, clinical parameters found to be important by severity modeling were compared 
between identified clades within a serotype. 
 
4.2.1 Serotype specific Differences in Clinical Outcome 
 
It is known that distinct serotypes can be associated with different disease outcomes 
and a recent study compared two periods when either DENV-1 or DENV-2 
predominated (Balmaseda et al., 2006). This study revealed serotype specific 
differences in clinical manifestations which showed that shock and hemorrhage were 
more likely to occur during the DENV-2 period whereas DENV-1 infection were more 
strongly associated with vascular permeability. Our study also pointed towards the 
possibility of serotype specific clinical differences with regard to disease severity. We 
compared the clinical parameters identified by severity modeling between DENV-1 
and DENV-3 (Table 3.64; Page 165 and Table 3.65; Page 166) and found that IFN-α 
along with viral load collected on the first visit showed higher levels in patients 
infected by DENV-1. The differences in IFN-α serum levels might be explained by the 
fact that viruses induce different IFN-α responses and would underline the low levels 
of phylogenetic similarities observed between the four dengue serotypes (Holmes and 
Twiddy, 2003). Moreover, IL-8 was additionally increased during DENV-1 infections 
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on the second visit which, connected to the above presented severity model, might 
have a major impact on disease outcome. 
 
Our results suggest that serotype 1 had higher potential to cause more severe disease 
during the 2005 Singaporean dengue outbreak than serotype 3 which is in 
disagreement with other studies indicating that DENV-3 and DENV-2 may be 
correlated with higher grades of severity (Nisalak et al., 2003; Vaughn et al., 2000). 
The observed differences in viral load might point towards a replicative advantage of 
DENV-1 over DENV-3. A higher virus titer in an early stage of disease as possible 
risk factors for the progression into more severe disease manifestations was identified 
in our presented severity model as well as in another study (Vaughn et al., 2000). 
Moreover, it is thought that mutations affecting viral fitness might be associated with 
disease outcome which was observed between DENV-2 subtypes (Cologna et al., 
2005; Leitmeyer et al., 1999) as well as within serotype 3 variants (Messer et al., 2003; 
Messer et al., 2002). The finding that DENV-1 still showed higher viral load on the 
second visit would be in line with another study which showed slower rates of viral 
clearance in patients with dengue hemorrhagic fever (Wang et al., 2006).  
 
It is intriguing that IL-8 levels were significantly higher in patients suffering from 
DENV-1 than DENV-3, which underlines the correlation of this chemokine to viral 
load and supports the assumption that a specific viremia threshold is required for the 
induction of IL-8 (Medin et al., 2005). Combining this finding to the importance of IL-
8 during disease severity, which was clearly shown and extensively discussed in the 
above calculated severity models, points towards a serotype specific role in disease 
severity.  
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Another interesting aspect lies in the idea of a possible direct activation of IL-8 
expression by NS5 which was proposed by Medin and collaborators (Medin et al., 
2005). Our findings might suggest that DENV-3 NS5 is inferior to DENV-1 NS5 with 
regard to direct activation of IL-8 expression and it would be highly interesting in 
comparing the IL-8 in vitro expression induced by DENV-1 NS5 to the expression 
induced by DENV-3 NS5. Finding differences in such a setting where levels of NS5 
are not viral load dependent are essential to exactly elucidate the impact of IL-8 
induction during severe dengue infections.  
 
In summary, and with regard to the calculated severity models, we can conclude that 
serotype specific differences occurred during the 2005 Singaporean dengue outbreak 
whereby DENV-1 might be considered as the more severe serotype. But we have to 
keep in mind that disease severity is highly dependent on both host as well as viral 
factors. Intriguingly, we detected more hospitalized patients suffering from serotype 1 
infections than cases which were positive for serotype 3. Furthermore, we must not 
ignore the possibility that the particular sequence of the infecting serotypes can 
influence disease severity (Graham et al., 1999). In our study, we did not determine the 
serotype of the previous exposure of dengue patients suffering from a secondary 
infection and thus the observed differences in clinical manifestations might be 
influenced by previous exposures to other serotypes. This might be especially 
important in Singapore which is a hyperendemic region where co-circulation of 
multiple serotypes is common. This could be a possible explanation for the 
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4.2.2 Phylogeny of the 2005 Singaporean Dengue Outbreak  
 
4.2.2.1 Isolated Serotype 1 and Serotype 3 Viruses show different phylogenetic Tree 
Structures suggesting evolutionary Differences 
 
Our phylogenetic analysis revealed a high degree of similarity between strains of the 
same serotype but identified different tree structures in serotype 1 and serotype 3. 
DENV-1 isolates did not clearly group into clades of reasonable virus numbers and the 
tree branches were represented by low evolutionary lengths (Figure 3.38; Page 170 and 
Figure 3.39; Page 171). On the other hand, DENV-3 isolates showed a clearer tree 
structure which was defined by longer branch lengths (Figure 3.40; Page 172 and 
Figure 3.41; Page 151). These two major differences possibly suggest evolutionary 
differences between DENV-1 and DENV-3 isolates from the 2005 Singaporean 
outbreak.  
 
In this respect, it is interesting to note that a DENV-3 strain showing a high level of 
similarity to the EDEN DENV-3 isolates was already detected in 2003 and might 
represent a common ancestor of the EDEN DENV-3 viruses isolated during the major 
outbreak in 2005 (Ong Swee Hoe, personal communication). In addition, DENV-1 was 
predominant in 2004 as well as in 2005 and occurrence of dengue cases was increasing 
since 2004 and peaking in 2005 with a sharp decrease of dengue cases in 2006 (MOH, 
2006). Hence, we can assume that DENV-3 was present in Singapore earlier than 
DENV-1 and that a newly arisen DENV-1 strain might have triggered the increase of 
dengue cases. Moreover, the fact that DENV-1 was predominant over DENV-3 might 
support the idea of a replicative advantage of DENV-1 which was additionally 
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supported by the observed significant differences in viral load. A possible explanation 
might lie in host immune recognition. Longer maintenance of DENV-3 in Singapore 
possibly resulted in a higher proportion of people who had already been exposed to 
serotype 3, whereas serotype 1 was newer for the host immune system, thus resulting 
in a higher proportion of susceptible individuals which would finally lead to a 
replicative advantage of DENV-1 over DENV-3. Such a phenomenon had also been 
proposed to explain the differences in transmission patterns of DENV-2 and DENV-4 
in the Americas (Carrington et al., 2005).  
 
Another study observed that an increase in clade diversity of one serotype leads to a 
decrease in prevalence of another serotype (Zhang et al., 2005). This might be another 
possible explanation for the observed differences in the tree structures of DENV-1 and 
DENV-3. Diversity of DENV-1 strains (0.184%) is higher than diversity of DENV-3 
strains (0.118%) and the observation of four clear established clades in DENV-3 stay 
in contrast to many small subgroups all over distributed in the DENV-1 clade EDEN 
1.4. We could suggest that the replicative advantage of DENV-1 led to a higher 
mutation frequency and thus to an increase in clade diversity whereas the four DENV-
3 clades were well established and showed no increase in clade diversity. This was 
further supported by the longer branch lengths observed in the DENV-3 phylogenetic 
tree. 
 
Further phylogenetic analysis of EDEN DENV-3 revealed that the strains belonged to 
DENV-3 subtype 3. It was additionally found that the strains showed a higher level of 
similarity to a Sri Lankan strain which belonged to clade A of subtype 3 (Ong Swee 
Hoe, personal communication). This may underline the observation that DENV-3 was 
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associated to a lower degree of severity because earlier studies showed that subtype 3 
clade A (pre-DHF) variants were associated with milder disease manifestations 
whereas the occurrence of subtype 3 clade B (post-DHF) strains directly correlated 
with the emergence of DHF in Sri Lanka (Messer et al., 2003; Messer et al., 2002).  
 
The discussed potential reasons for the observed differences in the structures of the 
phylogenetic trees are hypothetical and more investigation is needed to elucidate the 
evolutionary mechanisms involved. Furthermore, we have to bear in mind that the 
mean nucleotide difference was almost negligibly small that an overall comparison of 
the isolated EDEN strains to geographically and temporally different isolates would 
naturally result in one EDEN cluster as observed in an overall DENV-3 tree including 
virus isolates collected throughout the globe (Ong Swee Hoe, personal 
communication).  
 
4.2.2.2 Serotype 3 Clades show Differences with regard to viral Load and Platelet 
Count 
 
Comparison of the observed EDEN clades within serotype 3 revealed differences in 
viral load. More specifically, the significant difference was between EDEN 3.1 
(highest viral load) and EDEN 3.2 (lowest viral load) (Figure 3.42; Page 143). This 
difference is supported by a high bootstrap value and leads to the assumption of a real 
mutation affecting viral replication and thus disease severity. However, the identified 
mutation responsible for the clear split between these two clades was a synonymous 
mutation (Asparagine) in the E protein (EDEN 3.1: 2083C; EDEN 3.2: 2083T) The 
fact that we do not see any amino acid mutation leads to the assumption that the 
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observed difference occurred by chance due to only four viruses in clade EDEN 3.2. 
Furthermore, it is unlikely that a synonymous substitution in the E protein would lead 
to differences in viral load or host immune responses because the amino acid sequence 
of the E protein is the main antigenic determinant during dengue virus infection. By 
way of example, it was reported that a unique amino acid mutation in the E protein of 
DENV-2 was responsible for the loss of a N-linked glycosylation site which led to a 
decreased infectivity (Ishak et al., 2001). 
 
4.2.3 Concluding Remarks and Outlook 
 
In summary, we revealed that different serotypes have the ability to influence disease 
outcome but it turned out to be difficult to find any severity related differences 
between strains within a serotype. In our study, the lack of a substantial number of 
DHF/DSS cases combined with the high level of similarity between the dengue 
isolates were the main reasons that exacerbated the search for viral determinants. In 
addition, we only had the sequence of one virus that was isolated from a DHF patient. 
It is worthwhile mentioning that studies determining genome related differences with 
regard to disease severity mainly used strains isolated during different outbreaks over 
several years (Leitmeyer et al., 1999; Messer et al., 2003; Rico-Hesse et al., 1997) 
whereas only a few studies compared more similar viruses isolated from a single 
outbreak (Pandey and Igarashi, 2000; Rodriguez-Roche et al., 2005). This would 
support the fact that multi loci mutations would be more likely to be determinants of 
disease severity than single mutations (Zhou et al., 2006). Thus, it would be interesting 
to repeat our study during the next big dengue outbreak in Singapore and to compare 
the sequences to the 2005 EDEN sequences with regard to disease severity. This may 
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finally lead to a better picture of virus evolution along with viral determinants 
correlating with disease severity.  
 
Nevertheless, the isolation and sequencing of 94 strains obtained during one outbreak 
is unique and our study is the first to report such a high number of full length genome 
sequences. Integration of temporal, geographical and phylogenetic information can be 
used to determine evolutionary trends along with transmission dynamics that occurred 
during the 2005 Singaporean dengue outbreak. This would represent a first study of its 
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6.1 Sequencing Report and Optimization 
6.1.1 Virus Propagation 
Viruses where propagated by passages in C6/36 mosquito cell culture. Viral titer was 
measured using the plaque assay technique described in Liu et al 2004 Report. Viral 
titers of at least 1x106 were found to be required for optimal success in subsequent RT-
PCR steps. 
All procedures were performed in a class II biosafety cabinet (BSC) in a certified 
biosafety level 2 laboratory designated for Dengue virus work at NITD, in accordance 
with NITD BSL2 policy 5.1 and NITD Work Instructions on working with Dengue 
virus. 
6.1.2 RNA Extraction 
Viral RNA was extracted from the culture supernatant using the QiaAmp extraction 
protocol: 
1. Pipet 560 µl of prepared Buffer AVL containing carrier RNA(stored at 4°C, 
before usage let crystals dissolve by putting in 37°C water bath) into a 1.5 ml 
microcentrifuge tube. Aliquoting buffer reduces negative effects of repeated thaw-
freezing. 
2. Add 140 µl virus-cell-culture to the Buffer AVL carrier RNA in the 
microcentrifuge tube. Mix by pulse-vortexing for 15 s. 
3. Incubate at room temperature for 10 min. 
4. Briefly centrifuge the tube to remove drops from the inside of the lid.  
5. Add 560 µl of ethanol (96-100%) to the sample, and mix by pulse-vortexing for 
15 s. After mixing, briefly centrifuge the tube to remove drops from inside the lid. 
6. Carefully apply 630 µl of the solution from step 5 to the QIAamp Mini spin 
column (in a 2 ml collection tube) without wetting the rim. Close the cap, and 
centrifuge at 8000 rpm for 1 min. Place the QIAamp spin column into a clean 2 ml 
collection tube, and discard the tube containing the filtrate. 
7. Carefully open the QIAamp Mini spin column, and repeat step 6. Repeat this step 
until all of the lysate has been loaded onto the spin column.  
8. Carefully open the QIAamp Mini spin column, and add 500 µl of Buffer AW1. 
Close the cap, and centrifuge at 8000 rpm for 1 min. Place the QIAamp Mini spin 
column in a clean 2 ml collection tube (provided), and discard the tube containing 
the filtrate. 
9. Carefully open the QIAamp Mini spin column, and add 500 µl of Buffer AW2. 
Close the cap and centrifuge at full speed 13,000 rpm for 3 min.  
10.  Place the QIAamp Mini spin column in a new 1.5 ml collection tube (not 
provided), and discard the old collection tube with the filtrate. Centrifuge at full 
speed for 1 min.  
11.  Place the QIAamp Mini spin column in a clean 1.5 ml microcentrifuge tube (not 
provided). Discard the old collection tube containing the filtrate. Carefully open 
the QIAamp spin column and add 60 µl of Buffer AVE equilibrated to room 
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temperature. Close the cap, and incubate at room temperature for 1 min. 
Centrifuge at 8000 rpm for 1 min. Store at -80°C 
 
6.1.3 RT-PCR of DENV RNA 
The extracted RNA was copied to cDNA using an RT reaction followed by PCR 
amplification. The virus was amplified as five overlapping fragments. Unless specified 
below the same conditions were used for all five fragments. 
6.1.3.1 RT of DENV RNA 
RT of fragments 1, 3 and 4 was performed in a single tube. RT of fragments 2 and 5 
was performed in separate tubes. Samples were kept on ice and pipetting was carried 
out using RNAase free filter tips. 
The reaction volume was 20µL and consisted of 8µL of master mix 1, 6 µL of RNA 
and 6µL of master mix 2. Master mix 1 and the RNA were pre-incubated at 65°C for 5 
minutes and then on ice for 3 minutes before the addition of master mix 2. 




Antisense primer 1µL 
RNAase free H2O 5µL 
Table 6.2: RT Master Mix 2 
Reagent Volume 
5xFS buffer 4µL 
RNAse out 1µL 
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The following primers were used in the RT reaction. 
 
Table 6.3: Overview of RT primers 
Serotype Fragment Primer Sequence Postion 
DENV-1 F1 d1a17 CCAATGGCYGCTGAYAGTCT 2540-2559 
 F2 d1a13a CCTACTTGGGACCTGCCCA 4611-4629 
  d1a13b GGGACCTGCCCAACAGTCCT 4603-4622 
  d1a13c TGCCCAACAGTCCTCTCTGC 4597-4616 
 F3 d1a9 CCAGTYARCACAGCTATCAAAGC 6551-6573 
 F4 d1a4 CACTCCACTGAGTGAATTCTCTCT 9068-9091 
 F5 d1a23 AGAACCTGTTGATTCAACAG 10716-10735 
DENV-3 F1 d3a18 GATTCCTATCGCAATGCATG 2361-2380 
 F2 d3a14 ACTGTGATCATTAARTTGTGGGA 4334-4356 
 F3 d3a10 GCYGCAAARTCCTTGAATTCCT 6339-6360 
 F4 d3a6 GCATTRACATGTCGRGTTCC 8342-8361 
 F5 d3a23 AGAACCTGTTGATTCAACAG 10688-10707 
 
Table 6.4: RT reaction conditions 
Step Temperature (°C) Time 
1 65 5 min 
2 0 (ice) 1 min 
3 25 5 min 
4 42 1 hr 
5 70 15 min 
6 4 Hold 
 
 
6.1.3.2 PCR of DENV cDNA 
The five RT fragments were subsequently amplified by PCR. All components were 
kept on ice. Each reaction was performed in a volume of 50µL consisting of the 
following reagents: 
Table 6.5: Overview of PCR Reagents 
Reagent Volume 
Pfu buffer 5 µL 
dNTP’s 1 µL 
H2O 39 µL 
Pfu Turbopolymerase 1 µL 
Primer (antisense) 1 µL 
Primer (sense) 1 µL 
cDNA 2 µL 
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The following PCR primers were used to amplify the RT fragments. 
Table 6.6: Overview of PCR primers 
Serotype Fragment Primer Sequence Position 
DENV-1 F1 d1a17 CCAATGGCYGCTGAYAGTCT 2540-2559 
  d1s22 AGTTGTTAGTCTACGTGGAC 1-20 
 F2 d1a13 TTCCACTTCYGGAGGGCT 4544-4561 
  d1s6 GGYTCTATAGGAGGRGTGTTCAC 2201-2223 
 F3 d1a9 CCAGTYARCACAGCTATCAAAGC 6551-6573 
  d1s10 RGCYGGSCCACTAATAGCT 4213-4231 
 F4 d1a4 CACTCCACTGAGTGAATTCTCTCT 9068-9091 
  d1s14 ATGGRGAAAGGAACAACCAG 6216-6235 
 F5 d1a23 AGAACCTGTTGATTCAACAG 10716-10735 
  d1s18c GGTGAGTCCTCTCCAAACCC 8015-8034 
DENV-3 F1 d3a18 GATTCCTATCGCAATGCATG 2361-2380 
  d3s23 AGTTGTTAGTCTACGTGGAC 1-20 
 F2 d3a14 ACTGTGATCATTAARTTGTGGGA 4334-4356 
  d3s5 TGAACCTCCTTTTGGGGAA 2035-2053 
 F3 d3a10 GCYGCAAARTCCTTGAATTCCT 6339-6360 
  d3s9 GAAAACAGATTGGCTCCCAA 4030-4049 
 F4 d3a6 GCATTRACATGTCGRGTTCC 8342-8361 
  d3s13 CCAGCTCTCTTTGAACCAGAAA 6032-6053 
 F5 d3a23 AGAACCTGTTGATTCAACAG 10688-10707 
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PCR of the RT fragments was carried out in a thermal cycler with the following 
program. For DENV-1 a ramp speed of 9600 was used for fragment 5. All other 
fragments from DENV-1 and DENV-3 were cycled at maximum ramp speed. 
 
Table 6.7: PCR program 
Serotyp
e 
Fragment Cycles Initial Cycle Extend Hold 
DENV-
1 
F1 35 95°C 95°C 55°C 72°C 72°C 4°C 
2 min 30 sec 1 min 3.5 min 2 min 
 F2 35 95°C 95°C 58°C 72°C 72°C 4°C 
2 min 30 sec 1 min 3.5 min 2 min 
 F3 35 95°C 95°C 63.1°C 72°C 72°C 4°C 
2 min 30 sec 1 min 3.5 min 2 min 
 F4 35 95°C 95°C 58°C 72°C 72°C 4°C 
2 min 30 sec 1 min 3.5 min 2 min 
 F5 40 95°C 95°C 55°C 72°C 72°C 4°C 
2 min 30 sec 1 min 4 min 2 min 
DENV-
2 
F1 45 95°C 95°C 55°C 72°C 72°C 4°C 
2 min 30 sec 1 min 3.5 min 2 min 
 F2 45 95°C 95°C 55°C 72°C 72°C 4°C 
2 min 30 sec 1 min 3.5 min 2 min 
 F3 45 95°C 95°C 63.1°C 72°C 72°C 4°C 
2 min 30 sec 1 min 3.5 min 2 min 
 F4 45 95°C 95°C 55°C 72°C 72°C 4°C 
2 min 30 sec 1 min 3.5 min 2 min 
 F5 45 95°C 95°C 55°C 72°C 72°C 4°C 
2 min 30 sec 1 min 3.5 min 2 min 
 
6.1.3.3 Gel Electrophoresis 
Gel electrophoresis was used for visualization of products as well as gel extraction and 
purification of products. The products were separated in 1% agarose TBE gels after 
visualization of ethidium bromide stained bands under UV light. 
 
6.1.3.4 Gel Extraction of DNA 
DNA was extracted from bands excised from agarose gels. A Qiagen QiaQuick 
extraction kit was used with the following protocol: 
1. Weigh the gel slice. Add 3 volumes of Buffer QG to 1 volume of gel (100 mg ~ 
100 µl).  
2. Incubate at 50°C for 10 min (or until the gel slice has completely dissolved). 
To help dissolve gel, mix by vortexing the tube every 2-3 min during the 
incubation. IMPORTANT: Solubilize agarose completely.  
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3. After the gel slice has dissolved completely, check that the color of the mixture 
is yellow .  
4. Place a QIAquick spin column in a provided 2 ml collection tube.  
5. To bind DNA, apply the sample to the QIAquick column, and centrifuge for 1 
min. For sample volumes of more than 750 µl, simply load and spin again.  
6. Discard flow-through and place QIAquick column back in the same collection 
tube. Collection tubes are re-used to reduce plastic waste.  
7. Add 0.5 ml of Buffer QG to QIAquick column and centrifuge for 1 min. 
8. To wash, add 0.7 ml of Buffer PE to QIAquick column. Let the column stand 5 
min after addition of Buffer PE, before centrifuging for 1 min.  
9. Discard the flow-through and centrifuge the QIAquick column for an additional 
1 min at 13,000 rpm  
10. Place QIAquick column into a new clean 1.5 ml microcentrifuge tube.  
11. To elute DNA, add 50 µl of Buffer EB (10 mM Tris•Cl, pH 8.5) or H2O to the 
center of the QIAquick membrane, wait 1 min and centrifuge the column for 1 
min. Ensure that the elution buffer is dispensed directly onto the QIAquick 
membrane for complete elution of bound DNA. 
 
 
6.1.4 Results (or Method validation) 
6.1.4.1 Optimization of Ramp Speed. 
For DENV-1 fragment 5 we found that the specificity of the PCR step of RT-PCR was 
sensitive to the “ramp speed” (the time it takes to heat and cool the thermal block) of 
the machine. When the ramp speed was set to the maximum for the machine non-
specific products formed and the desired band was weak. The ideal setting was found 
to be 9600. This result is shown in figure 6.1. Notably this was not found to be the case 
on all machines even those of the same make. As can be seen from the results of 
Machine B in figure 6.1 the use of maximum ramp speed was best in this machine. We 
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Figure 6.1: Optimization of ramp speed. 
Ed142 Ed148 Ed203(1)L L 39153908Ed203(2)
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L indicates a 1KB ladder. Ed142, Ed148, Ed203, 3908 and 3915 indicate independent 
isolates. 
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6.1.4.2 Typical RT-PCR results 
Figure 6.2 shows a typical RT-PCR result for DENV-1 prior to gel purification. Figure 
6.3 shows a typical result for DENV-3 
Figure 6.3: DENV-1 RT-PCR result 
3908
F4-67






























































   
   
   
   
   
   
   



























































































































   
   
   
   
   
   
   



































































L indicates a lane with a 1KB ladder. Other lanes have viral isolates indicated by their 
number. 
 
Figure 6.4: DENV-3 RT-PCR result 
F5F4F2F1L F3
 
L indicates a 1KB ladder, F1-F5 indicate fragments 1 through 5. 
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6.1.4.3 Typical gel purification results 
Because of the presence of non-specific products bands gel purification was used to 
clean up the fragments. The result of gel purification of DENV-1 fragments is shown 
in figure 6.4 while DENV-3 results are shown in figure 6.5 
Figure 6.5: Gel purification of DENV-1 RT-PCR products 
F1 F2 F3 F4 F5 F1 F2 F3 F4 F5L L
F1 F2 F3 F4 F5L F1 F2 F3 F4 F5 L
4621 4622
4632 4820  
Figure 6.6: Gel purification of DENV-3 RT-PCR products 
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6.2 Identities of sequenced Virus Isolates 
D105k2398DK1 D1SG05ED111 D1 Singapore 2005 
D105k2402DK1 D1SG05ED114 D1 Singapore 2005 
D105k2887DK1 D1SG05ED134 D1 Singapore 2005 
D105k2895DK1 D1SG05ED142 D1 Singapore 2005 
D105k2901DK1 D1SG05ED148 D1 Singapore 2005 
D105k2916DK1 D1SG05ED167 D1 Singapore 2005 
D105k2928DK1 D1SG05ED179 D1 Singapore 2005 
D105k3297DK1 D1SG05ED200 D1 Singapore 2005 
D105k3300DK1 D1SG05ED203 D1 Singapore 2005 
D105k3301DK1 D1SG05ED204 D1 Singapore 2005 
D105k3318DK1 D1SG05ED221 D1 Singapore 2005 
D105k3886DK1 D1SG05ED234 D1 Singapore 2005 
D105k3894DK1 D1SG05ED243 D1 Singapore 2005 
D105k3903DK1  D1 Singapore 2005 
D105k3904DK1  D1 Singapore 2005 
D105k3905DK1  D1 Singapore 2005 
D105k3908DK1  D1 Singapore 2005 
D105k3910DK1  D1 Singapore 2005 
D105k3911DK1  D1 Singapore 2005 
D105k3915DK1  D1 Singapore 2005 
D105k3916DK1  D1 Singapore 2005 
D105k3930DK1  D1 Singapore 2005 
D105k3933DK1  D1 Singapore 2005 
D105k3934DK1  D1 Singapore 2005 
D105k3935DK1  D1 Singapore 2005 
D105k4138DK1  D1 Singapore 2005 
D105k4139DK1  D1 Singapore 2005 
D105k4140DK1  D1 Singapore 2005 
D105k4142DK1  D1 Singapore 2005 
D105k4147DK1  D1 Singapore 2005 
D105k4152DK1  D1 Singapore 2005 
D105k4172DK1  D1 Singapore 2005 
D105k4173DK1  D1 Singapore 2005 
D105k4174DK1  D1 Singapore 2005 
D105k4175DK1  D1 Singapore 2005 
D105k4183DK1  D1 Singapore 2005 
D105k4443DK1  D1 Singapore 2005 
D105k4468DK1  D1 Singapore 2005 
D105k4479DK1  D1 Singapore 2005 
D105k4480DK1  D1 Singapore 2005 
D105k4604DK1  D1 Singapore 2005 
D105k4605DK1  D1 Singapore 2005 
D105k4606DK1  D1 Singapore 2005 
D105k4609DK1  D1 Singapore 2005 
D105k4620DK1  D1 Singapore 2005 
D105k4621DK1  D1 Singapore 2005 
D105k4622DK1  D1 Singapore 2005 
D105k4632DK1  D1 Singapore 2005 
D105k4820DK1  D1 Singapore 2005 
D105k814DK1 D1SG05ED025 D1 Singapore 2005 
D105k847DK1 D1SG05ED059 D1 Singapore 2005 
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D105k872DK1 D1SG05ED084 D1 Singapore 2005 
D105k4154DK1  D1 Singapore 2005 
D305k2400DK1 D3SG05ED112 D3 Singapore 2005 
D305k2406DK1 D3SG05ED118 D3 Singapore 2005 
D305k2418DK1 D3SG05ED130 D3 Singapore 2005 
D305k2899DK1 D3SG05ED146 D3 Singapore 2005 
D305k2918DK1  D3 Singapore 2005 
D305k2933DK1 D3SG05ED184 D3 Singapore 2005 
D305k3305DK1 D3SG05ED208 D3 Singapore 2005 
D305k3312DK1 D3SG05ED215 D3 Singapore 2005 
D305k3314DK1 D3SG05ED217 D3 Singapore 2005 
D305k3316DK1 D3SG05ED219 D3 Singapore 2005 
D305k3324DK1 D3SG05ED227 D3 Singapore 2005 
D305k3325DK1 D3SG05ED228 D3 Singapore 2005 
D305k3329DK1 D3SG05ED232 D3 Singapore 2005 
D305k3887DK1 D3SG05ED235 D3 Singapore 2005 
D305k3897DK1 D3SG05ED246 D3 Singapore 2005 
D305k3900DK1  D3 Singapore 2005 
D305k3912DK1  D3 Singapore 2005 
D305k3913DK1  D3 Singapore 2005 
D305k3927DK1  D3 Singapore 2005 
D305k3928DK1  D3 Singapore 2005 
D305k4141DK1  D3 Singapore 2005 
D305k4144DK1  D3 Singapore 2005 
D305k4157DK1  D3 Singapore 2005 
D305k4159DK1  D3 Singapore 2005 
D305k4168DK1  D3 Singapore 2005 
D305k4176DK1  D3 Singapore 2005 
D305k4182DK1  D3 Singapore 2005 
D305k4440DK1  D3 Singapore 2005 
D305k4454DK1  D3 Singapore 2005 
D305k4647DK1  D3 Singapore 2005 
D305k4648DK1  D3 Singapore 2005 
D305k791DK1 D3SG05ED002 D3 Singapore 2005 
D305k797DK1 D3SG05ED008 D3 Singapore 2005 
D305k802DK1 D3SG05ED013 D3 Singapore 2005 
D305k805DK1 D3SG05ED016 D3 Singapore 2005 
D305k827DK1 D3SG05ED038 D3 Singapore 2005 
D305k843DK1 D3SG05ED055 D3 Singapore 2005 
D305k845DK1 D3SG05ED057 D3 Singapore 2005 
D305k863DK1 D3SG05ED075 D3 Singapore 2005 
D305k868DK1 D3SG05ED080 D3 Singapore 2005 
D305k871DK1 D3SG05ED083 D3 Singapore 2005 
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